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De illustratie op de omslag van deze publicatie is een schilderij van Gerrit Knikker, getiteld: 
 
"Who I am ? !" 
 
Gerrit is lange tijd ondernemer geweest, maar diep van binnen voelde hij zich kunstenaar. Na 
een moeilijke periode in zijn leven besloot hij zijn gevoel te volgen en is gaan schilderen. 
 
 
Gerrit heeft deelgenomen aan een interview over herstel, en vertelde toen: 
 
Wat er ook gebeurt………..ik ga gewoon door. 
 
Dus ben ik gaan schilderen, 7 dagen in de week. 
 
Ik heb altijd gezegd, ik wil mijn schilderijen uithangen. Ze in één keer laten 
zien. Zo van kijk eens hoe gaaf, hoe mooi dit is. Ik wil een galerie beginnen. 
Daar kunnen dan mensen in werken en dan ga ik door met schilderen. Als ze 
mij maar laten schilderen!   
 
 
 
 
 
 
Toen ik een aantal jaren later op een goede dag over de Thorbeckegracht in het mooie Zwolle 
fietste viel mijn oog op een galerie met de naam "Atelier Knikker". Onmiddellijk was mijn 
nieuwsgierigheid gewekt. Ik besloot naar binnen te stappen, en belandde in een wereld van 
kunst en kleur. Al gauw doemde Gerrit op, die mij onmiddellijk herkende en een tevreden 
indruk maakte. Hij was zijn gevoel trouw gebleven, en had het hieruit voortvloeiende doel tot 
werkelijkheid weten te maken. Iets wat me niet verbaasde, Gerrit had er immers zijn hele 
leven al blijk van gegeven over het nodige doorzettingsvermogen te beschikken. Over het 
antwoord op mijn vraag om een illustratie voor de omslag van deze publicatie te maken hoefde 
Gerrit niet lang na te denken. Het resultaat mag er wezen, en ligt thans voor u. 
 
Dank je wel Gerrit!!! 
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Dual diagnosis (also called co-occurring disorders) is a general description used in the 
field of mental health care for patients with a substance use disorder accompanied by 
one or more other mental disorders. The DSM-IV classification of Substance Use 
Disorders (SUD) includes substance abuse and substance dependence. According to 
epidemiological surveys, the global lifetime prevalence of SUD in the general 
population is between 10-20%1,2 and about two-thirds of SUD patients are dual diagnosis 
patients3. In this thesis, the focus is on the dual diagnosis of SUD with Attention 
Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD). 
 
ADHD, ASD and SUD 
The worldwide prevalence of childhood ADHD is about 5%4,5 and the prevalence of adult 
ADHD is 2.5% to 4%6-8. ADHD patients are characterized by (1) problems with attention 
and concentration, (2) hyperactivity or (inner) agitation and (3) impulsivity.  
Nowadays, heredity is considered the main risk factor for ADHD: 60% to 70% of the 
within-group variance in the prediction of the occurrence of ADHD has been found to be 
accounted for by genetic factors9,10. ADHD is a heterogeneous, neurobiological, 
developmental disorder. A genetically driven, hypodopaminergic neurotransmission is 
considered to be crucial for ADHD to become manifest11-13. Compared to children, 
adults with ADHD have to face different demands; they mainly have problems with 
attention (i.e., organizing and planning), concentration, making decisions, being on 
time, arranging one's affairs, and keeping a goal-oriented focus12. 
 
ASD is present in 0.6% to 1.0% of the general population in Western countries14,15. 
Patients with ASD can have (1) serious qualitative shortcomings in social interaction, (2) 
qualitative limitations in communication and (3) limited, repeating stereotypical 
patterns of behaviour and interests. Like ADHD, ASD is a heterogeneous, 
neurobiological, developmental disorder which can manifest itself in different ways 
during each life stage. Compared to children, adults with ASD have to face different 
demands; transformation into adulthood brings along an increase of demands and 
expectations regarding responsibility for one's choices, structuring one's life, being 
independent and filling in life. ASD patients not only experience problems with social 
interaction and communication but also have difficulties with the organization and 
planning of daily activities, particularly when creativity and flexibility are required.  
 
ADHD and ASD show remarkable similarities. Both are chronic developmental disorders 
which usually manifest themselves in (early) childhood, frequently persist into 
adulthood and have some overlapping symptoms (i.e., organizing and planning). 
Furthermore, both ADHD and ASD show heterogeneous, complex courses; result in 
lifetime limitations in various areas of functioning; and create major problems in many 
domains of adult life16,17. A review of studies in clinical samples shows that 30-80% of 
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children with ASD also show typical ADHD symptoms while 20-50% of children with 
ADHD also show typical ASD symptoms18. At the diagnostic level, 28% of the children 
with ASD from a general population study also met DSM-IV diagnostic criteria for 
ADHD19. 
 
SUD is also considered to be a neurobiological (developmental) disorder. According to 
Van Wijngaarden and Van der Gaag, genetic vulnerability and changes in the 
neurobiological reward processes play a crucial role in the development of SUD20. These 
vulnerabilities can be reinforced by co-occurring impulsivity (e.g. ADHD) or 
compulsivity (e.g. ASD)20. In a recent meta-analysis of patients with a SUD, 25% also 
met criteria for adult ADHD21 while the lifetime prevalence of SUD in patients with ASD 
has been reported to range from 11% to 29%22-25. A recent study by Smith et al.26 
further reports that a gene linked to ASD has also been found to play a critical role in 
the incidence of addiction-related behaviours.  
 
To summarize: SUD, ADHD and ASD 1) are all developmental disorders with an 
overlapping neurobiological basis, 2) all show relatively high prevalence rates, 3) all 
frequently manifest themselves as co-occurring dual disorders and 4) all are chronic 
disorders. 
 
Given that SUD, ADHD and ASD - considered either alone or as co-occurring disorders - 
are chronic disorders which can lead to persistent limitations in many areas of life, 
patients with these disorders are of particular relevance to nursing professionals. When 
it comes to nursing interventions, however, ADHD is rarely addressed in the guidelines 
and toolkits for the care of adults with a dual diagnosis and ASD is not addressed at all. 
 
Aim of the present research 
In order to develop evidence-based nursing interventions for mental health care, 
greater insight is needed into the needs of particularly mental health patients with a 
dual diagnosis. The present research was performed to help fill this knowledge gap. For 
the development of evidence-based nursing interventions, the systematic Intervention 
Mapping Protocol (IMP) formulated for the development of health promotion 
interventions can be used27. The IMP distinguishes six steps for the development of an 
intervention: (1) assessment of needs and their underlying determinants; (2) definition 
of performance and change objectives; (3) selection of theory-based intervention 
methods and practical applications to change; (4) production of program components, 
design and production; (5) anticipation of program adoption, implementation and 
sustainability; and (6) anticipation of process and effect evaluation.  
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This thesis concerns the first two steps of the IMP: patient needs assessment and their 
underlying determinants; and a first orientation on performance and change objectives. 
Based on an initial review of the literature and a subsequent in-depth study of SUD 
patients with and without a comorbid diagnosis of ADHD or ASD, the needs of these 
dual disorder patients were identified.  
 
A search of the relevant research literature unfortunately showed that data on the 
needs of the target population of SUD patients with a dual diagnosis of ADHD or ASD 
was very scarce. In fact, not a single paper was found. It could thus be concluded that 
little is known about the needs of such patients and their families despite both ADHD 
and ASD frequently being present in patients with SUD.  
 
The next step, in light of the absence of information yielded by the literature review, 
was to undertake a study of the needs of patients with SUD and co-occurring ADHD or 
ASD. While doing this, also information on patient quality of life, the coping styles of 
the patients and the care burden of informal caregivers for such patients was collected. 
For an orientation on the second step of the IMP, namely the definition of performance 
and change objectives, a start was made by mapping the recovery process for patients 
with a dual diagnosis of SUD and ADHD or ASD. 
 
Given the results of the literature review and study of the needs of patients with SUD 
and a co-morbid diagnosis of ADHD or ASD the following research questions were 
formulated: 
- What are the needs and what are the differences, if any, in the needs of SUD 
patients with and SUD patients without a co-occurring diagnosis of ADHD or ASD?  
- What are the everyday life consequences, and what are differences, if any, in these 
consequences in SUD patients with and SUD patients without a co-occurring diagnosis 
of ADHD or ASD, from the patient's perspective? 
- What are the coping styles and what are the differences, if any, in the coping styles 
of SUD patients with and SUD patients without a co-occurring diagnosis of ADHD or 
ASD? And how do the coping styles of these patients differ from those of people in 
the general population? 
- What is the perceived burden and Expressed Emotion (EE) of informal caregivers of 
adult SUD patients either with or without a co-occurring diagnosis of ADHD or ASD? 
And how does EE correlate with caregiver burden? 
- What are the main elements in the process of personal recovery for SUD patients 
with a co-occurring diagnosis of ADHD or ASD? 
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Methods and outline of the thesis 
Between April 2010 and October 2013, 122 adult SUD patients either with or without a 
co-occurring diagnosis of ADHD or ASD were recruited from a specialized dual diagnosis 
and addiction treatment facility in the Netherlands. Quantitative studies were 
performed administering the EuropASI, CAN, MANSA and UCL questionnaires. From this 
population, 23 patients with SUD and co-occurring ADHD or ASD also took part in a 
qualitative in-depth study. A topic list was used to semi-structure the interviews. 
Furthermore, 60 informal caregivers recruited form the group of 122 adult SUD patients 
either with or without a co-occurring diagnosis of ADHD or ASD took part in a 
quantitative study. The IEQ, GHQ and LEE questionnaires were administered. Last, 
21 patients with SUD and a co-occurring diagnosis of ADHD or ASD were recruited from 
a specialized double diagnose treatment facility. They took part in a qualitative study. 
Again, a topic list was used to semi-structure the interviews 
 
All studies were approved by a certified medical ethics committee and by the 
institutional review boards from the participating organizations. 
 
The thesis is composed of seven chapters. This introduction constitutes Chapter 1. In 
Chapter 2, a quantitative study of the problems, needs and self-perceived quality of 
life for SUD patients either with or without a co-occurring diagnosis of ADHD or ASD is 
presented. In Chapter 3, the results of a semi-structured qualitative interview about 
the everyday life consequences of SUD for adult patients with a co-occurring diagnosis 
of ADHD or ASD are presented. Chapter 4 turns to the differences in the coping styles 
of SUD patients either with or without co-occurring ADHD or ASD and the findings are 
compared with the coping styles of a general population sample. In Chapter 5, a study 
about the burden and expressed emotion of informal caregivers for SUD patients either 
with or without co-occurring ADHD or ASD is presented. Informal caregivers were 
considered within the context of the present research not only because they have been 
shown to be an important factor in the recovery of patients but also because informal 
caregivers are at risk of becoming sick themselves and therefore in need of help 
themselves. In Chapter 6, a qualitative study of the process of personal recovery of 
SUD patients with co-occurring ADHD or ASD is presented. In Chapter 7 the final 
chapter of this thesis, the main results are summarized and discussed together with 
some methodological considerations, recommendations for practice and suggestions for 
future research. 
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ABSTRACT 
Purpose: To identify care needs of adult substance use disorder (SUD) patients with and 
without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism 
spectrum disorder (ASD). 
Design and methods: An exploratory study using the European Addiction Severity Index, 
the Camberwell Assessment of Needs, and the Manchester Short Assessment of Quality 
of Life to assess and compare care needs and perceived quality of life. 
Findings: All patients are dissatisfied with parts of their existence. SUD patients have 
fewer care needs than SUD patients with co-occurring ADHD or ASD. The SUD and 
SUD+ADHD groups report needs in similar domains. The SUD+ASD group shows a greater 
number of and more extensive care needs. 
Practice implications: Differences in the care needs of adult SUD patients with and 
without ADHD or ASD should be taken into account when developing evidence-based 
nursing care interventions. 
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INTRODUCTION AND REVIEW OF THE LITERATURE 
The DSM-IV classification of substance use disorders (SUDs) includes substance abuse 
and substance dependence. According to epidemiological surveys, the global lifetime 
prevalence of SUD in the general population is between 10% and 20%1,2. The 12-month 
prevalence of SUD in Europe is >4%3,4. 
 
Treatment of SUD is improving, but it is not always effective due in part to the 
presence of comorbid psychiatric disorders5-7. For example, a number of studies have 
documented the co-occurrence of schizophrenic, bipolar, psychotic, depressive, and 
anxiety disorders with SUD8-10. Attention deficit/hyperactivity disorder (ADHD) has also 
been shown to co-occur with SUD, but the aspects of comorbidity documented to date 
have been mainly the epidemiological, pharmacological, and psychotherapeutic 
aspects. Very little is known about the care needs of patients with SUD and ADHD. For 
individuals with SUD and a co-occurring autism spectrum disorder (ASD), knowledge is 
scarce on all fronts. The aim of the present study was therefore to fill these identified 
gaps by mapping the nursing aspects of the treatment of adult patients with SUD and a 
co-occurring ASD or ADHD. 
 
Dual diagnosis 
Mental disorders frequently co-occur, and the co-occurrence with SUDs is therefore 
often referred to as a dual diagnosis. According to Drake et al.11, however, this 
practice is misleading because the individuals with a dual diagnosis constitute a 
heterogeneous group and frequently have more than one comorbid disorder. Moreover, 
the term dual diagnosis can refer to either lifetime comorbidity or current comorbidity 
while current comorbidity is most important for needs assessment and clinical 
purposes. The term "co-occurring disorders" is thus deemed to better describe the 
situation.  
 
The co-occurrence of SUD with other psychiatric disorders is very common: About 50% 
of individuals with severe and persistent mental disorders (e.g., schizophrenia and 
bipolar disorder) are affected by substance abuse9,12,13. Viewed the other way around, 
about 66% of people with an SUD have a co-occurring psychiatric disorder, which may 
include traumatic distress, depression, conduct disorder, and/or ADHD.14 Co-occurring 
psychiatric disorders in patients with SUD are associated with a variety of negative 
outcomes, including more severe psychiatric symptoms15,16, higher rates of relapse in 
substance abuse17,18, higher risk of hospitalization19, more frequent incarceration20,21, 
unstable housing or homelessness,19,22,23 and serious infections such as human 
immunodeficiency virus and hepatitis24,25. The treatment and care for patients with 
SUD and co-occurring psychiatric disorders is also often fragmented and 
ineffective6,11,17. For those reasons, clinicians, administrators, researchers, family 
2 
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organizations, and clients have been calling for the integration of mental health care 
and addiction treatment6,11. That is, the same clinicians or teams of clinicians, working 
in one setting, provide appropriate mental health and substance abuse interventions in 
a coordinated fashion11.  
 
ADHD and ASD 
ADHD and ASD are developmental disorders that generally manifest themselves in early 
childhood and frequently persist into adulthood26,27. Reviews show the worldwide 
prevalence of childhood ADHD to be about 5%28,29. The prevalence of adult ADHD is 
estimated to be 3–4%30,31. These figures show a high persistence of ADHD from 
childhood into adulthood30. 
The co-occurrence of SUD with ADHD in adults has been studied extensively27,32-36. 
Between 17% and 45% of ADHD adults have histories of alcohol abuse or dependence; 
between 9% and 30% have histories of drug abuse or dependence.36 The co-occurrence 
of adult ADHD with alcohol abuse ranges from 35% to 71%; the co-occurrence of adult 
ADHD with substance abuse ranges from 15% to 25%37. In a recent meta-analysis of 
patients with SUD, 25% met the criteria for adult ADHD38.  
 
According to Fombonne39, ASD is present in 0.6–0.7% of the general population in 
Western countries. ASD and ADHD seem to be co-occurring disorders. Simonoff et al.40 
reported 28% of a group of 112 children with ASD to also meet the criteria for ADHD. In 
the same year, Nicholas et al.41 observed that although the DSM-IV-TR (Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision) diagnosis of 
ADHD is not permitted when there is already a diagnosis of ASD, ADHD-like symptoms 
were detected in more than 80% of children diagnosed with ASD. 
The literature on the co-occurrence of SUD with ASD is scarce42. Santosh and Mijovic43 
found ASD in adolescents to be only associated with drug and alcohol abuse when ADHD 
was comorbid. Furthermore, there are no methodologically sound studies, but clinical 
probing of families and professionals with regard to their experiences with the co-
occurrence of SUD and ADS showed substance-related problems to be common among 
both adolescents and adults with ASD44. In the relatively small sample of 70 adults with 
ASD studied by Sizoo et al.44, 20 showed a lifetime incidence of SUD (29%). 
 
Based on these figures, it can be concluded that about 1% of the general population has 
adult ADHD with a comorbid SUD and about 0.1–0.2% of the general population has ASD 
with a comorbid SUD. This comorbidity is associated with ineffective treatment and 
care, and therefore an unfavorable course and unsuccessful treatment outcomes are to 
be expected. ADHD and ASD are assumed to be chronic disorders, which means that 
treatment should focus on helping patients live their lives to the fullest extent 
possible. The goal of treatment should be symptom reduction, enhancement of social 
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functioning, and maintenance of the highest quality of life as possible. And the latter—
enhancement of social functioning and maintenance of the highest quality of life as 
possible—fall within the domain of nursing. 
 
Care needs of patients with SUD and ADHD or ASD 
Very little is known about the care needs of patients with SUD and ADHD or ASD. This is 
reflected in the results of a search of the PubMed, Embase, and CINAHL databases for 
nursing interventions aimed at patients with SUD and co-occurring ADHD and/or ASD: 
not a single paper was found. It can thus be concluded that, although ADHD, ASD, or 
both are present in many patients with SUD, there is little knowledge of their nursing 
needs or the effects of nursing interventions when undertaken with this population. 
 
In order to develop evidence-based nursing interventions in the future, more knowledge 
about the care needs of the relevant patient groups is needed. We therefore performed 
a first exploratory study of limited sample size to get a first impression of the problems 
of these patients and to answer the following question: What are the nursing care 
needs of SUD patients with a co-occurring diagnosis of ADHD or ASD, and do these 
nursing care needs differ from each other and from those of patients with SUD but no 
co-occurring diagnosis of ADHD or ASD? 
 
METHODS 
Design 
A cross-sectional study was conducted among a treatment seeking population of 
patients with SUD with a comorbid diagnosis of ADHD or ASD and an otherwise 
comparable population with no diagnosis of comorbid ADHD or ASD. The study was 
approved by a certified medical ethics committee and by the institutional review 
boards from the participating organizations. All patients received both verbal and 
written information about the study and signed an informed consent form. 
 
Population 
The target population consisted of (a) patients with SUD together with their significant 
others and (b) patients with SUD accompanied by a comorbid ADHD (SUD+ADHD) and/or 
a comorbid ASD (SUD+ASD) together with their significant others. Participation in the 
study was based on the following inclusion and exclusion criteria. Inclusion: inpatient or 
outpatient treatment for SUD; age 18–65; IQ >80; DSM-IV diagnosis of SUD with or 
without DSM-IV diagnosis of ADHD and/or ASD; mastery of the Dutch language; and 
significant others. Exclusion: somatic complaints not directly related to SUD. 
 
All of the patients were recruited from mental health services and addiction treatment 
services on the basis of information from clinical screening and clinical diagnostic 
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procedures. First, 175 patients from an outpatient's dual diagnosis department were 
approached: 59 indicated that they were not interested in participating in the study; 25 
showed an interest but could not be contacted; 18 did not show up for their first 
appointment and could not be contacted anymore. Finally, 73 patients participated in 
the study from which one was excluded (response rate of 42%). Second, 170 patients 
from an addiction treatment service were approached: 72 indicated they were not 
interested; 39 showed an interest but could not be contacted; 8 did not show up for 
their first appointment and could not be contacted anymore. Finally, 51 patients 
participated in the study from which one was excluded (response rate of 29%). 
 
Diagnoses 
In all cases, the diagnoses were based on semi-structured interviews administered by a 
psychiatrist or clinical psychologist. The DSM-IV diagnoses of SUD were based on the 
Mini International Neuropsychiatric Interview45. The DSM-IV diagnoses of ADHD were 
based on either the protocol for the semi-structured assessment of the DSM-IV criteria 
for adult ADHD, which included an interview with the patient and an interview with a 
close relative46, or on the Diagnostics Interview for ADHD in Adults47. The DSM-IV 
diagnoses of ASD were based on the guideline diagnostics for adults with (assumed) 
ASD48, and therefore either based on the Rimland49, the Diagnostic Interview for Social 
and Communicative Disorders50, or the Autism Diagnostic Interview-R51. 
 
Assessment of care needs 
In order to assess the problems of the patients and their care needs, we administered 
the European Addiction Severity Index (EuropASI), the Camberwell Assessment of Needs 
(CAN), and the Manchester Short Assessment of Quality of Life (MANSA). The Europ ASI 
identifies care needs from the professional’s point of view; the CAN assesses care needs 
from the point of view of the patient; and the MANSA identifies the patient's self-
perceived quality of life.  
 
The EuropASI52 is a semistructured interview that can be conducted to identify 
problems in eight domains such as health, employment, and family/social relations. 
This is done on the assumption that addiction is not an isolated problem, and the 
EuropASI can thus be seen as an indicator of the care needs of addicted patients 
independent of the severity of their addiction. The EuropASI has been shown to have 
good validity and good internal consistency53,54 . In the current study, we used severity 
ratings of 0–9. A score ranging from 2 to 3 indicates a minor problem, a score between 
4 and 5 a moderate problem, and a score between 6 and 9 a severe to very severe 
problem. In the present study, a score > 3.5 was judged to indicate a need for care. 
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The CAN is a questionnaire that can be administered to assess care needs in 22 areas of 
life including housing, employment, safety, alcohol, and drugs. The CAN is valid, 
reliable, and usable in a variety of fields55,56. Responses to items are scored as 0 (no 
need), 1 (met need),or 2 (unmet need). 
 
The MANSA is a questionnaire that can be used to assess self-perceived quality of life in 
12 domains of life, including daytime activities, physical health, and psychological 
distress, and is specifically developed for use in mental health settings. Items are 
scored along a 7-point Likert scale representing the following: could be no worse, 
dissatisfied, mostly dissatisfied, mixed dissatisfied/satisfied, mostly satisfied, 
satisfied, or could be no better. The MANSA is a concise instrument for assessing 
quality of life with satisfactory psychometric properties57,58. 
 
The three questionnaires were administered in a single session. A logbook was used to 
record notable details that would otherwise not be recorded. And given that the 
EuropASI, CAN, and MANSA measure human responses to disorders in several life areas, 
the instruments were judged suitable to assess nursing care needs—the focus of this 
study. According to the American Nurses Association59, nursing is the protection, 
promotion, and optimization of health and abilities, prevention of illness and injury, 
alleviation of suffering through the diagnosis and treatment of human response, and 
advocacy in the care of individuals, families, communities, and populations. 
 
Analyses 
This is a first cross-sectional exploratory study of limited sample size. Given the nature 
of the study and the risk of type II errors in such a study, no formal significance testing 
is undertaken. However, to gain insight into the magnitude of the possible differences 
between the groups (SUD, SUD+ASD, and SUD+ADHD) and also guide the interpretation 
of the observed differences, we calculated standardized effect sizes using Cohen's d.60 
Cohen's d values were then interpreted as follows: d < 0.20 no relevant difference; d = 
0.20–0.30 small difference; d = 0.30–0.80 moderate difference; and d > 0.80 large 
difference.60  
 
Only nine patients were diagnosed with SUD and both ADHD and ASD, so this group was 
excluded from the analyses. 
 
RESULTS 
Overview of diagnoses and function of substance use for patients 
A total of 122 patients participated in our study in the end: 50 with SUD, 41 with SUD 
plus ADHD, and 31 with SUD plus ASD. Most of the patients were in treatment at the 
time of assessment although a small percentage (13%) was not.  
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On average, the interviews with the patients with SUD lasted 96 min. The interviews 
with the patients with SUD+ADHD lasted an average of 125 min, and the interviews with 
the patients with SUD+ASD lasted an average of 133 min.  
 
Inspection of the logbook revealed some very notable details. First, many of the 
participants mentioned their enjoyment of participating in the study. Second, when the 
participants were asked at the end of the interviews if all their care needs had been 
discussed, they all responded affirmatively. Third, patients from all three of the 
diagnostic groups frequently mentioned found it difficult to ask for help and difficult to 
accept help; they would rather sort things out themselves and felt that they should be 
able to do this as well.  
 
Some interesting differences between the diagnostic groups were also revealed in the 
logbook. With regard to the functions of substance use for the patients in the different 
groups, the group with SUD indicated seeking relief from negative feelings that are 
often associated with painful—if not traumatic—experiences. The group with SUD+ADHD 
sought mainly a calming effect, tranquility, and reduction of feelings of chaos. The 
group with SUD+ASD sought a variety of functions: to forget problems, to clear their 
minds, to act more socially, to attain peace of mind, to get through the day, or to get 
over frustrations.  
 
Finally, the respondents in our study frequently reported a lack of inquiry into sex 
addiction as a shortcoming of treatment. According to many of the male respondents, 
the combination of alcohol, drugs, and women forms a frequently occurring triad. Many 
men, in particular, suffer from sex addiction. But therapists do not ask about this—
according to the participants in our study. 
 
Clinical characteristics of patients 
Table 1 shows the main demographic and clinical characteristics of the three groups of 
patients included in our study. Men were overrepresented in all groups, especially in 
the group with SUD+ASD. There were substantial group differences in the living 
conditions and employment statuses of the participants. The patients with SUD+ASD 
were more likely to live alone or in a protected setting (52%) than the patients with 
SUD (38%) or SUD+ADHD (15%). Furthermore, the patients with SUD+ASD were more 
often judged to be unfit to work than the patients with SUD and SUD +ADHD.  
 
The different patient groups did not show major differences with regard to level of 
education and type of treatment at the time of the study. 
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Table 1. Demographic and clinical characteristics (N=122) 
 
  SUD SUD+ASD SUD+ADHD 
N 50 31 41 
 Male (%) 72 94 68 
 Age mean  46 40 37 
        
Living (%)       
Alone 38 52 15 
With parents 16 10 5 
With partner and children 12 7 29 
With children alone - - 5 
Protected living - 19 2 
Otherwise 6 - 5 
Income (%)       
Employed 30 26 39 
Partner, family, friends 12 3 2 
Social welfare unemployment 28 29 27 
Social welfare; declared unfit to work 26 42 27 
Otherwise 4 - 5 
Education (%)       
None 8 3 7 
Primary Education 24 36 44 
Secondary Education 38 39 35 
College 28 16 15 
University 6 7 - 
Type of treatment (%)       
None 8 5 12 
Outpatient detox 2 - - 
Clinical detox 6 3 12 
Outpatient drug free treatment 58 65 59 
Clinical drug free treatment 10 3 5 
Daycare 14 - 2 
Mental health hospital 2 7 - 
Otherwise - 7 7 
Primary drugs (%)       
None 4 3 2 
Alcohol 66 71 39 
Heroin 4 - 2 
Cocaine 8 7 7 
Amphetamines - 3 15 
Cannabis 18 13 24 
More than one - 3 10 
All respondents are normal intelligent (IQ > 80). ADHD, attention deficit hyperactivity disorder; 
ASD, autism spectrum disorder; SUD, substance use disorder 
 
Patient care needs from the perspective of professionals: EuropASI outcomes 
Figure 1 shows the presence of substantial differences in the perceived care needs for 
the three groups of patients when viewed from the perspective of care professionals. 
The SUD group only needed care in the domains of alcohol and psychiatric health 
(EuropASI score > 3.5). The group with SUD+ADHD only needed care in the domains of 
drugs and psychiatric health. In contrast, the group with SUD+ASD needed care in many 
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more domains—including alcohol, employment, family/social relationships, and 
psychiatric health.  
 
Figure 1. Mean ratings for eight domains of care need according to professionals for SUD, 
SUD+ASD, and SUD+ADHD groups of patients (EuropASI outcomes) 
 
 
 
 
The magnitude of the difference between the SUD group and the combined groups with 
SUD+ADHD and SUD+ASD (SUD + group) when averaged across all the domains of 
possible care needs was small (d = 0.36).The magnitude of the overall difference 
between the SUD and SUD+ASD groups was moderate (d = 0.54). The magnitude of the 
overall difference between the SUD and SUD+ ADHD groups was small (d = 0.25) and 
that between the SUD+ASD and SUD+ADHD groups was also small (d = 0.25).An overview 
of the moderate to large effects is presented in Table 2. 
 
 
0
1
2
3
4
5
6
7
Physical health Alcohol Legal Status Psychiatric health
SUD
SUD+ASD
SUD+ADHD
0-1 No problem 
2-3 Minor problem 
4-5 Moderate problem 
6-7 Quite serious problem 
8-9 Extreme problem  
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Table 2. Differences between diagnostic groups   
 
Domain Difference between groups Cohen's d Effect size 
Employment SUD versus SUD+ASD 0.70 Moderate 
Alcohol SUD versus SUD+ADHD 0.56 Moderate 
Drugs SUD versus SUD+ADHD 0.97 Large 
Drugs SUD+ASD versus SUD+ADHD 0.93 Large 
Family/Social relations SUD versus SUD+ASD 0.60 Moderate 
Psychiatric health SUD versus SUD+ASD 0.74 Moderate 
Psychiatric health SUD+ASD versus SUD+ADHD 0.53 Moderate 
 
Care needs from the perspective of the patients: CAN outcomes 
Figure 2 shows substantial differences between the diagnostic groups in their perceived 
care needs. In the group with SUD, approximately 50% of the reported care needs are in 
the domains of only alcohol and psychological distress. In contrast, both the group with 
SUD+ADHD and SUD+ASD report care needs in many domains. In the SUD+ADHD group, 
approximately 50% of the reported care needs are in the domains of alcohol, 
psychological distress, physical health, drugs, and money. In the group with SUD+ASD, 
approximately 50% of the reported care needs are in the domains of looking after the 
home, alcohol, psychological distress, daytime activities, company, and money. 
 
Substantial differences were also found between the diagnostic groups for those 
domains in which 10% or more of the patient's care needs were reported as unmet. For 
the group with SUD, the domains were only alcohol and company. For the group with 
SUD+ADHD, the domains were only psychological distress and money. In contrast, for 
the group with SUD +ASD,10% or more of the patient's needs in the following domains 
were reported as unmet: alcohol, psychological distress, company, and intimate 
relationships. 
 
The magnitude of the overall difference between the reported care needs averaged 
across the different domains for the SUD group and the combined SUD+ADHD and 
SUD+ASD groups (SUD + group) was moderate (d = 0.50). However, the magnitude of the 
overall difference between the SUD group and the SUD+ASD group was large (d = 0.82); 
that between the group with SUD and the group with SUD+ADHD was moderate (d = 
0.5); and that between the group with SUD +ADHD and the group with SUD +ASD was 
small (d = 0.27) 
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Patients' perceived quality of life: MANSA 
Figure 3 shows the self-perceived quality of life defined in terms of satisfaction to be 
very similar for the different groups of patients. The patients in the group with SUD 
look most dissatisfied with being unemployed and are not entirely satisfied with their 
financial situations, sexual lives, lives as a whole, and living alone. The patients in the 
group with SUD+ASD were most dissatisfied with their sexual lives and mental health; 
they were not entirely satisfied with life as a whole, their finances, their physical 
health, and living alone. The patients in the group with SUD+ADHD were most 
dissatisfied with their finances, mental health, and unemployment; they were not 
entirely satisfied with life as a whole and their sexual lives. 
 
Figure 3. The patients' perspectives on Quality of life for SUD, SUD+ASD, and SUD+ADHD groups of 
patients (MANSA outcomes) 
 
 
 
0
1
2
3
4
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7
SUD
SUD+ASD
SUD+ADHD
2 
0  Could be no worse  
1  Dissatisfied 
2  Mostly dissatisfied 
3  Mixed dissatisfied/satisfied 
4  Mostly satisfied 
5  Satisfied 
6 Could be no better  
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The overall magnitude of the difference in life satisfaction averaged across domains for 
the group with SUD versus the combined groups with SUD+ADHD and SUD+ASD (SUD + 
group) was very small (d = 0.17). The overall magnitudes of all other differences were 
also very small: SUD group versus SUD+ASD group (d = 0.15); SUD group versus 
SUD+ADHD group (d = 0.18); and SUD+ASD group versus SUD+ADHD group (d = 0.05). 
 
DISCUSSION 
The results of the current study show that nursing care needs of SUD patients with and 
without a comorbid diagnosis of ADHD or ASD seem to differ substantially. The nursing 
needs of SUD patients without ADHD or ASD are primarily in the domains of alcohol, 
psychiatric health, and unemployment. The nursing care needs of SUD patients with co-
occurring ADHD are similar to those of SUD patients without a comorbid disorder and 
are concentrated in the domains of alcohol/drugs, psychiatric health, unemployment, 
physical health, and finance. The nursing care needs of SUD patients with co-occurring 
ASD are more extensive and more severe covering the domains of alcohol, psychiatric 
health, unemployment, finance, family/social relations, daytime activity, looking after 
the home, and sexual life. Furthermore, the study shows that all patient groups have 
unmet needs and are dissatisfied with certain domains of their existence. However, the 
differences between the groups with regard to self perceived quality of life are 
strikingly small when compared to the group differences based on the objective 
assessment of their care needs by professionals (i.e., the EuropASI outcomes) and the 
subjective assessment of their care needs by the patients themselves (i.e., the CAN 
outcomes). This latter finding is mainly related to the fact that the extent and severity 
of care needs in the SUD +ASD group is not negatively related to the perceived quality 
of life for the group with SUD+ASD. This is consistent with a finding of Renty and 
Roeyers61 in adults with ASD; support is related to the quality of life while disability is 
not. More generally, the self-perceived quality of life did not differ greatly between 
the groups of patients in our study while the extent of their care needs did. 
 
The apparent connection between the needs of the SUD+ADHD group of patients and 
drug use problems can possibly be explained by the co-occurrence of still other 
psychiatric disorders. The lifetime rates of mood, anxiety, and antisocial disorders are 
high in adult patients with ADHD62. And these co-occurring disorders are known to be 
related to both alcohol and drug use63. The frequent use of illegal drugs and thus the 
need to attain expensive drugs might also explain the frequent and often serious 
financial and mental health problems that characterize the group with SUD +ADHD. 
 
While clinical research suggests that adult patients with ASD who turn to alcohol and 
drugs are more socially engaged than those who do not do this and thus more socially 
engaged than those ADS patients who do not have a comorbid history of SUD64, social 
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and communicative impairments are nevertheless characteristic of ASD. This pattern of 
findings may explain why the patients with SUD+ASD were less likely to use illegal drugs 
and more likely to use alcohol, which is legal, and cannabis, which is semi-legal in the 
Netherlands; these patients might be less likely to use illegal drugs because such drug 
use requires complex social and communicative skills for attainment. The problems of 
the SUD+ASD group of patients in our study were indeed mainly related to alcohol. 
 
Considering the nature of the problems the SUD+ASD group is facing, social and 
everyday life, alcohol could be a better match than drugs for the purpose of self-
medication. 
 
Strengths and limitations of the present study 
The broad view taken on the areas of life and care need of patients in the present 
study constitutes a strength of this study. Other strengths are independent assessment 
of two researchers, together with the gathering of real-life examples in semi-structured 
interviews to support the responses provided on questionnaires. The use of 
standardized questionnaires with respondents representing different perspectives on 
the care needs of patients and assessment of self-perceived quality of life in addition 
to care needs are also clear strengths. Furthermore, the use of three as opposed to 
only two patient groups provides insight into the role of co-occurring psychiatric 
disorders in the needs of patients with SUD. 
 
A limitation of this study is the relatively small sample size for some of the patients 
groups. Statistical evaluation of the results was thus precluded and, as a consequence, 
we cannot rule out the possibility of falsely positive findings (type I errors). Replication 
of this research using larger patient samples is thus needed. 
 
The questionnaire results show a picture that is similar, but the validity of the use of 
the questionnaires with the research groups has yet to be documented. The patients 
with SUD+ASD tended to discuss items at great length, for example, and found it 
difficult to choose between the responses of "moderately" and "considerably". This may 
have introduced a response bias in our data, particularly with regard to the MANSA 
measure of quality of life. In other words, it cannot be ruled out that the patients in 
the SUD+ASD group underestimated their problems and that significant quality of life 
differences between the groups of patients in our study do exist in reality. 
 
The population of patients in our study was heterogeneous with regard to phase of 
treatment: some of the participants were in clinical detoxification; some were 
receiving outpatient treatment; and some were no longer in treatment. These 
differences in treatment phase may have influenced the amount of met and unmet 
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needs. However, the vast majority of the study participants were receiving some form 
of nursing care at the time of the interviews, which means that at least some of their 
care needs were currently being met and therefore not reported. 
 
Directions for future research 
The importance of significant others in treatment, for relapse prevention, and for the 
rehabilitation of mental health patients is widely recognized. Efforts were made to also 
include them, and thus their perspectives on the care needs of patients, in the present 
study, but many of the patients in our study did not want to "further burden" their 
significant others. In addition, many of the significant others of the patients 
participating in our study were not willing to come for an interview or to complete a 
questionnaire. Some of the significant others stated that they had distanced themselves 
from the patient. Considering the importance of significant others for patients with SUD 
and co-occurring ADHD or ASD, research should be conducted in the future to gain 
knowledge insight into not only their perspectives on the needs of such patients but 
also the degree and type of burden that they experience in their role as significant 
other.  
 
In this first study on the need for care in patients with SUD and ADHD/ASD, the 
influence of gender could not be addressed due to the small number of female patients 
in the study. However, gender-specific information is needed for the development of 
effective evidence-based nursing interventions65-67. Therefore, future research should 
address this issue using larger samples and/or oversampling of female patients. 
 
Finally, qualitative research is needed to obtain in-depth knowledge and thus a better 
understanding of the problems and care needs reported here, and also the coping 
strategies that patients with SUD and co-occurring ADHD or ASD use to deal with these 
problems and the related care needs. 
 
Clinical implications 
One of the main findings in our study is that patients with SUD+ASD appear to have 
serious needs in many domains of life (EuropASI, CAN), on the one hand, but express 
relatively little dissatisfaction with their quality of life (MANSA), on the other hand. 
This is a dissociation that is not observed for SUD patients or SUD+ADHD patients. 
SUD+ASD patients have either reconciled themselves to their situation or are less 
capable of expressing dissatisfaction with their quality of life. This means that this 
group of patients may suffer more than is generally thought. Only follow-up research 
will tell. But in the meantime, nurses and other clinicians should be aware of this 
possibility. 
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When the needs of the patients in the 22 living areas from the CAN are classified into 
the four categories of day-to-day needs, mental health care needs, rehabilitation 
needs, or facility needs of van Busschbach and Wiersma68, clear differences for nurses 
and other clinicians to be aware of present themselves. SUD patients report needs with 
respect to only mental health care. Patients with SUD+ADHD report both mental 
healthcare needs and facility needs. Patients with SUD+ASD report needs in all four 
categories. The care for SUD+ADHD and SUD+ASD patients is thus likely to be more 
intensive and also requires greater planning and coordination, which nurses must 
recognize. The group with SUD+ASD in the present study showed a relatively high 
percentage (16%) of unmet needs in the area alcohol. It is, however, unclear whether 
this incidence of unmet needs is due to the needs not being identified, not being 
addressed, or perhaps being misinterpreted. Only increased awareness on the part of 
nurses and further inquiry will tell.  
 
On a final note, it is remarkable that ADHD is hardly addressed and ASD not addressed 
at all in the available guidelines and toolkits for dealing with a dual diagnosis in mental 
health. The outcomes of the present study show SUD patients with a co-occurring ADHD 
or ASD disorder to suffer a substantial number of care needs along Axis IV of the DSM-IV 
(i.e., psychosocial and environment problems). Nurses and other clinicians can construe 
this knowledge as an indicator of need and thereby tailor their care efforts to the care  
needs of these specific diagnostic groups. 
 
This study suggests the presence of substantial differences in the care needs of adult 
SUD patients with and without ADHD or ASD; differences that should be taken into 
account when developing evidence-based nursing care interventions for these different 
patient groups. 
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ABSTRACT 
Background: Although the prevalence of substance use disorder (SUD) with co-occurring 
attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) is 
relatively high in adult patients, there is hardly any knowledge about these dual 
diagnoses. A recent study reported met- and unmet needs for several life domains 
regarding these patient groups. To improve treatment, it is necessary to identify the 
everyday life consequences of SUD and co-occurring ADHD or ASD in adult patients. 
Methods: Qualitative study using in-depth interviews. 11 SUD+ADHD and 12 SUD+ASD 
patients participated in the study. The interview transcripts were coded and analysed 
according to the seven steps for descriptive phenomenology by Colaizzi. 
Results: Both patients with ADHD and patients with ASD can get caught in a jumble of 
thoughts and emotions which can often lead to agitation and impulsivity in the case of 
ADHD or passivity and melancholia in the case of ASD with co-occurring SUD in both 
cases. Initially substance use ameliorates the symptoms and related problems, but both 
patient groups can later experience even greater problems: difficulties with the 
structuring of daily life due to a lack of planning (SUD+ADHD) or due to a lack of 
initiative (SUD+ASD). Both groups indicate that structure helps them function better. 
They also recognize that substance use disorganizes their lives and that an absence of 
structure contributes to substance use in what becomes a vicious circle which needs to 
be broken for effective treatment and care. 
Conclusions: This study provides insight into the daily life consequences of SUD with a 
co-occurring ADHD or ASD. Substance use is reported to solve some ADHD- or ASD-
related problems in the short run but have negative consequences in the long run (i.e., 
contribute to already impaired cognitive functioning). Insight is provided into what 
clinicians can do to break this vicious circle and thus help ADHD patients to refrain from 
action and ASD patients to take action. 
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BACKGROUND  
Mental disorders can frequently co-occur with a substance use disorder (SUD) or some 
other disorder. Such co-occurrence is often referred to as a dual diagnosis, which can 
itself refer to either life-time co-occurrence or current co-occurrence. For clinical 
purposes and needs assessment, current co-occurrence is more important than life-time 
co-occurrence. 
 
The co-occurrence of SUD and other mental disorders is very common: about 50% of 
individuals with severe and persistent  mental disorders are affected by substance  
use1-3. Some studies have specifically examined the co-occurrence of SUD with 
schizophrenia, bipolar disorder, psychosis, depressive disorder or anxiety disorder1,4,5. 
Similarly, the co-occurrence of SUD with attention deficit/hyperactivity disorder 
(ADHD) has been examined quite extensively. And a recent meta-analysis of the 
prevalence of attention deficit/hyperactivity disorder in substance use disorder 
patients showed 23% of all patients with SUD to meet the criteria for adult ADHD6. 
Studies of the co-occurrence of SUD and autism spectrum disorders (ASD) are scarce7. In 
recent research, however, the lifetime prevalence of SUD in connection with ASD has 
been reported to range from 11% to 29%8-10. The sample sizes have been limited (n = 
122, n = 54 and n = 70 respectively) in these studies, however. 
 
A very recent study showed about 1% of the general population to have adult ADHD 
with a co-occurring SUD while 0.1-0.2% of the general population has an ASD with a co-
occurring SUD11. 
 
Studies have further shown the co-occurrence of SUD with other psychiatric disorders to 
be associated with not only ineffective treatment and care but also an unfavourable 
treatment course and outcome12-14. In a recent study the objective care needs of SUD 
patients with co-occurring ADHD or ASD were determined11. Met- and unmet needs 
were reported for several life domains and it was suggested that further research 
should focus on the (subjective) psychological consequences of substance use in SUD 
patients with ADHD (SUD+ADHD) or ASD (SUD+ASD). This calls for in-depth, qualitative 
study of substance use and related daily problems. 
 
In light of the above, we undertook a qualitative, interview study to answer the 
following research question: What are the everyday life consequences of substance use 
in adult patients with a substance use disorder (SUD) and co-occurring attention 
deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) from a 
patient's perspective? 
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METHODS 
Study design and procedure 
A qualitative, interview study was conducted among a population of treatment-seeking 
patients with a dual diagnosis of SUD and ADHD or SUD and ASD. 
 
Open, in-depth semi-structured interviews were used in which patients in both groups 
were questioned about the consequences of their illness for everyday life using the 
patient's perspective as the guiding principle. The study was approved by a certified 
medical ethics committee (Commissie Mensgebonden Onderzoek Regio Arnhem-
Nijmegen) and by the institutional review board of Dimence (Commissie 
Wetenschappelijk Onderzoek). All participants signed informed consent for 
participation in the study. 
 
The interviews were conducted first with a group of SUD+ADHD patients in the period 
of December 2011 to May 2012 and then with a group of SUD+ASD patients in the period 
of June 2012 to October 2012. All of the interviews were conducted by one of two 
researchers who thus conducted half of the interviews for each patient group. The 
interviews were then transcribed verbatim. 
 
Target patient population and selection criteria 
Patients with SUD and a co-occurring ADHD or ASD were recruited using the following 
inclusion and exclusion criteria. Inclusion: outpatient treatment for SUD; age 18–65; IQ 
>80; current DSM-IV diagnosis of SUD and current DSM-IV diagnosis of ADHD or ASD; 
mastery of the Dutch language. Exclusion: diagnoses of SUD and both ADHD and ASD. All 
patients were recruited from an outpatient, dual diagnosis, treatment facility in the 
Netherlands. 
 
Out of 122 patients, 72 told that they were willing to participate in the further study. 
Of these 72 patients, nine were diagnosed with both ADHD and ASD in addition to SUD 
and therefore excluded from further inclusion, leaving a total of 63 eligible patients. 
 
A total of 37 SUD+ADHD patients were then approached for this study: seven patients 
could no longer be reached and 13 refused to participate despite their initial 
willingness to do so. An interview was thus planned for 17 patients, but 5 did not show 
up then. One patient also had to be excluded due to hospitalization at the time of the 
planned interview. This left 11 SUD+ADHD patients to participate in the study. 
 
A total of 26 SUD+ASD patients were approached for this study as well: 5 could no 
longer be reached and 7 refused to participate despite initial willingness to do so. An 
interview was planned for 14 patients, but 2 of them did not show up. In the end, 
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12 SUD+ASD patients were interviewed for a total of 23 patients participating in the 
present study. 
 
Interview topics 
The in-depth interviews were conducted with the aid of a topic list which draws upon 
the results of a previous study11. Impairments, unmet needs, and clearly met needs 
were probed for a number of life domains (see Table 1). 
 
Table 1. Interview topic list (i.e., domains of life for which impairments and needs were probed) 
 
Life domains indicated from previous study  Topics for present study 
Psychiatric health 
Psychological distress 
Mental health 
 
Mental health 
Drugs 
Alcohol 
 
Addiction 
Unemployment 
Day time activity 
Looking after the home 
 
Daily activities 
Family/ social relations 
Company  
 
Social functioning 
Money 
Finances 
 
Finance 
Physical health*  Physical health 
Sexuality**  Sexuality 
* SUD+ADHD only 
** SUD+ASD only 
 
The topic list was used as guidance during the interview. By posing open questions, the 
patients were invited to describe in detail their ideas, attitudes, experiences, and 
behaviour. Sample questions were: What are your problems like, and how do they 
relate to your alcohol or drug use? What does this combination of SUD and ADHD/ASD 
mean for you? and How does the combination of SUD and ADHD/ASD relate to your 
everyday life? 
 
Coding and analysis of the interview transcripts 
Given the qualitative nature of our study, the interview transcripts were coded and 
analyzed in a cyclic process. However, keeping the groups separated helped to focus on 
the in-depth knowledge within each group. Throughout this process, the routines 
followed and the coding procedures applied were discussed between the researchers 
and, in this manner, consistency of assessment was assured. The coding and analysis of 
the data was performed using the MAXQDA2010 software. And, in doing this, the seven 
steps for descriptive phenomenology outlined by Colaizzi15 were followed. 
In order to gain an overall impression of the data, the interview transcripts were first 
read as a whole (step 1). Then both interviewers independently selected and coded 
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significant statements (steps 2 and 3). Related codes were then identified and grouped 
together under the themes they represented (step 4). Thereafter, a subset of 6 of the 
23 interview transcripts was coded by both researchers and the findings compared. 
After the completion of the first 7 interviews for each of the patient groups, an interim 
analysis was performed (step 5). The results of this analysis were then used to guide 
the subsequent interviews. The emerging themes and insights were thoroughly 
discussed in preparation for the subsequent interviews. 
In the subsequent interviews, the themes identified in step 5 were used to determine 
whether new codes would emerge which could not be grouped within the existing 
themes or data saturation was reached. 
In the next step of the analyses, the interviews from the two groups were examined as 
a whole but also compared to identify general and group-specific themes (step 6). The 
outcomes of the analyses were then summarized and sent to the participants for 
feedback and validation of the results (written member check, step 7). Unfortunately, 
none of the participants responded to our request for a written member check. 
 
RESULTS 
For both patient groups (SUD+ADHD n=11; SUD+ASD n=12), the need for care according 
to the Euro-pASI11 was very similar to that of the total group of eligible patients (n=63) 
for 5 of the 8 EuropASI domains. Only small differences were detected for the other 
3 domains. More SUD+ADHD patients in the current sample were living alone and in 
both diagnostic groups in the current sample more patients were employed compared 
to the total eligible group. However, the differences were small and we thus conclude 
that the research groups were comparable to the total group of eligible patients. 
 
The interviews with the patients lasted 60 minutes on average. The two patient groups 
were similar with regard to most socio-demographic characteristics; they only differed 
on gender composition and primary substance use. The SUD+ASD group included only 
males and 10 out of the 12 patients reported alcohol as their primary substance of use. 
The SUD+ADHD group included three women and eight men; primary substance use 
varied (see Table 2). 
 
Comparison of the initial steps in the coding and analysis of the interview transcripts 
showed that the researchers had selected the same statements as significant, assigned 
largely similar content codes to the selected statements, and also grouped the coded 
statements into similar themes. 
 
Following the seven-step analytic procedure, the everyday life consequences of a dual 
diagnosis of SUD and ADHD or SUD and ASD were found to revolve around three main 
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themes: (1) jumbled thoughts and emotions, (2) ambiguity of substance use, and (3) 
structure. 
 
In the following, we further describe the everyday consequences and supply illustrative 
quotations (with the patient group and respondent number indicated in parentheses). 
 
Table 2.  Demographic and clinical characteristics of two dual-diagnosis patient groups (n=23) 
 
     SUD+ADHD  SUD+ASD  
Total n 11 12 
Male n (%) 8 (73%) 12 (100%) 
Age (mean) 43 37 
Living   
Alone n (%) 6 (55%) 5 (42%) 
With other(s) n (%) 5 (45%) 7 (58%) 
Employment   
Employed n (%) 6 (55%) 6 (50%) 
Substance of abuse (more than 3 years)   
Alcohol n (%) 2 (18%) 3 (25%) 
Cannabis n (%) - 1 (8%) 
Alcohol + cocaine n (%) 3 (27%) - 
Alcohol + cannabis n (%) 1 (9%) 5 (42%) 
Alcohol + medication n (%) - 1 (8%) 
Alcohol + cocaine + amphetamine + ecstasy n (%) 2 (18%) - 
Alcohol + medication + cocaine + amphetamine + cannabis n (%) 1 (9%) - 
Alcohol + heroine + cocaine + amphetamine + ecstasy n (%) 1 (9%) - 
Alcohol + cocaine + amphetamine + cannabis + XTC n (%)  - 1 (8%) 
Extreme variety of substances (>6) n (%) 2 (18%) 1 (8%) 
 
Jumble of thoughts and emotions 
Both groups stated that they experience a jumble of emotions, including anger, distress 
and anxiety. Participants also said that they did not recognize emotions very well, and 
had difficulties understanding them. Furthermore, they were not able to handle their 
emotions and found it hard to sort them out and to put them into perspective. They 
often failed to make the connection between event and feeling, and vice versa. 
 
Distressed, sad, happy…. those things actually blend in my case, so to name 
how I'm feeling, that's hard to do. (…) And that's what sometimes happens to 
me, that I’m really not feeling good and things just get worse because I can't 
figure out the reason why. (SUD+ASD 2) 
 
The jumble of emotions experienced by both groups of patients led to a vicious circle 
of negative thinking and feeling which led to vicious circle of symptoms and substance 
use. Both groups mentioned getting caught in this vicious circle and not being able to 
get out of it by, for instance, stopping the flow of negative thoughts and emotions. 
 
3 
48 Chapter 3 
That's because of us [people with ADHD] thinking that fast and much, and 
often we [people with ADHD] fill in many things by ourselves, and pick 
things up, a lot. 
That's why things come on stronger to us [people with ADHD] and stick 
longer. (SUD+ADHD 11) 
 
The patients in the SUD+ADHD group frequently stated that they could not handle the 
flood of thoughts and emotions which they experienced. This could lead to agitation, 
which could trigger further impulsiveness. What is meant here is that patients cannot 
put the break on and therefore race past their own and others limits with serious 
negative consequences, such as using more addictive substances and/or experiencing 
more interpersonal conflicts. 
 
In contrast, patients in the SUD+ASD group frequently expressed that the overload of 
stimuli caused by the jumble of thoughts and emotions made them passive and 
melancholic. This obviously had a negative impact on their quality of life. Feeling 
lonely and searching for some perspective in life are frequently mentioned by patients 
with SUD+ASD. In a relationship or similar contact, passive and melancholic feelings 
were also often reported to stand in the way of sexual activity. 
 
I always go on, and on, and on (…) you just get tired and more tired. The 
consequence of this is becoming less focused, and that makes you more and 
more impulsive. (SUD+ADHD 11) 
 
Especially when I'm tired and worn out, I become very hyper (…) then you go 
bouncing. Becoming more inefficient. (…) what I'll often do then, when I'm 
totally worn out, is use drugs … really lots of them.... (SUD+ADHD 7) 
 
I've got the idea that I can get lost in my head, in thought, which makes me 
lose time sometimes and that is what's keeping me from getting to action. 
(SUD+ASD 3) 
 
By now I know my mind is processing data very slowly, and if I want to live a 
pleasant and meaningful life then I’ll have to stop working as hard as I did 
before and I shouldn't want to anymore. But that's a hard nut to crack. (…) 
and to me that's still intense and it really makes me worry about if I'll get a 
girlfriend ever? Will I ever get to live with someone? (…) And sometimes that 
really makes me sad (…). It makes me feel lonely. (SUD+ASD 2) 
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I was longing for a relationship for a long time, because that's the standard. 
However, it being the standard is not a very good reason to have a relation, 
I guess. (…) I've been in bed with a girl sometimes, and then I'm lying there 
and I just don't know what to do, how to act, what's normal. (SUD+ASD 4) 
 
Ambiguity of substance use 
Substance use was reported to serve a clear purpose for both of the patient groups. It 
suppressed the jumble of thoughts and emotions, the agitation, and the melancholia. 
For the SUD+ADHD group, substance use served to decrease the level of hyperactivity 
but was also often boundless: one bottle of beer led to the drinking of an entire case. 
For the SUD+ASD group, substance use was reported to help suppress the jumble of 
thoughts and emotions, to help them relax and get through the day, and to help them 
escape feelings of pure boredom. 
 
Giving myself a bit of peace, so it doesn't get out of control. That my brain 
stops thinking, particularly. Stops going on, and on, and on. (SUD+ADHD 8) 
 
Then we had children, and the stress got higher. (…) Well, I started 
drinking, just to inhibit the stimuli, to subdue them. ( .) that helped me get 
through the evening. It was just to survive, not for the booze. (SUD+ASD 3) 
 
At the same time, the patients from both groups reported substance use to worsen 
their symptoms and the problems stemming from their ADHD or ASD. 
 
Especially when I had a relapse or used again, then I noticed becoming 
disordered for a long period. (…) and that’s when you let impulses rule you. 
(SUD+ADHD 11) 
 
It has the effect that I don't function properly, and that I hardly eat (…) 
Everything gets worse by using. (SUD+ASD 10) 
 
Stopping with substance use was reported to produce clear benefits by most of the 
SUD+ADHD patients. They experienced better physical and mental health as a result of 
quitting. They nevertheless indicated that quitting was a struggle because everything 
which their substance use had suppressed came to the surface and then more 
intensively. They further observed that balanced use or controlled substance use in 
moderation was something which they could not manage and therefore not an option. 
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I can't restrain that, I just do it. I'll blow, quaff or snort, there's no restraint 
whatsoever. I can’t go and drink one beer, one beer becomes a case. 
(SUD+ADHD 6) 
 
One of the SUD+ASD patients reported that it had been relatively simple to stop and 
that he was not using anymore, but the remainder of the SUD+ASD group reported still 
using. These patients also reported searching for a way to achieve a kind of balanced 
use — mostly with professional guidance. 
 
… I have decided that I won't be quitting drinking fully, because I noticed a 
great part of my social life will be gone and to me that's not worth it, and I 
don't know how it could be done without the booze. (SUD+ASD 2) 
 
Structure 
Both groups indicated that structure made them function better in many areas of life: 
daily activities, social relationships, finances, physical health, and sexuality. Having 
daily activities, a job, and family further helped them structure their lives and gave it 
meaning. Structure contributed to break out of passivity and control impulsiveness. 
 
But, if you get me sitting at home, then you've got another alcoholic, that 
doesn't work out. To me, that’s my structure, my work and so forth. 
(SUD+ADHD 5) 
 
A company for career counselling helps me to reintegrate in work, and I told 
them I don't want to work in a big warehouse or with a boss or colleagues 
that will rouse me, because that will go wrong. And I don't want to go back 
to my old lifestyle, that I'll just have to smoke a joint in the evening. 
(SUD+ASD 6) 
 
I noticed that when I neglect the housekeeping I also get more noise, more 
thoughts in my head (…) so I am very occupied with getting more discipline 
in housekeeping. (SUD+ASD 2) 
 
Both groups further noted — as indicated in the preceding and following quotations — 
that substance use disorganized their lives. In a vicious circle, lack of structure 
contributed to substance use and substance use contributed to a further lack of 
structure. 
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When I don't have a reason to get up in the morning (…) then I tend to stay 
in bed and take it easy. I'll smoke a joint in the morning and will go back to 
sleep again. So, I noticed, I need structure in my life. (SUD+ADHD 3) 
 
I find it hard to fill my time — I don't have many hobbies — although 
structure is very important. It happened that I got so bored that it made me 
think: let's drink tonight, so tomorrow I'll sleep it off and then another half 
day is filled. (SUD+ASD 5) 
 
Patients in the SUD+ADHD group reported frequent problems with the actual structuring 
of activities. They mentioned knowing what they wanted to do, having the necessary 
skills for social relationships or to make plans, and believing that they could handle 
matters effectively. But they found it hard to prioritize, keep focus on the task at 
hand, and stay tuned into not only their own needs but also the needs of others. The 
result was major difficulties with maintaining structure, sustaining relationships, and 
managing finances. 
 
I plan my time very inaccurately, and that takes a lot of energy, takes a lot 
of effort. (…) Yes, that's the result. I get distracted by impulses, and I get 
distracted easily, and that is what makes you spend time on the wrong 
things. (SUD+ADHD 11) 
 
I don't know what to do if someone shares his emotions, that makes me 
become very nervous. So I'll walk away. I had an affair with a woman for 
four years, and when things went wrong I walked away. I don't know how to 
handle that. That's not my cup of tea. (SUD+ADHD 5) 
 
A lot of debts, once 3000 euros (…) because of my impulsivity, of course. 
Not because of using weed, no, I just bought all kinds of things. 
(SUD+ADHD 10) 
 
The SUD+ASD patients also experienced problems with structure but, in contrast to the 
SUD+ADHD group: they hardly knew how to spend their spare time, how to initiate a 
social relationship, and how to handle other matters; such as their finances or 
household. 
 
Things get into a routine, that's what I don't recognize. (…) It may happen 
that I don't get myself to work or do other things for half a day (…) things 
seem to get stuck in my head, like a needle in the groove of a record, and I 
can't get out of it. (SUD+ASD 11) 
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It doubles the handicap that you've got, makes it really hard to take stock of 
situations. And the drugs make you think even more … like … well … like 
passive. You get even more passive. (SUD+ASD 6) 
 
The thought of starting a social relationship or becoming socially active is reported to 
make most of the patients in the SUD+ASD group feel anxious and insecure. They 
reported not being able to easily join in with others and use substances to help them do 
this. Substance use suppressed feelings of insecurity and overstimulation/ 
oversensitivity, made it easier for them to tune into people/situations, and helped 
them focus and react during interactions. 
 
But, when I have got to sit in sober, that really gives me the jitters. 
(SUD+ASD 5) … it [using alcohol] makes it easier to put things in words, put 
it in words more quickly, react faster. (SUD+ASD 3) 
 
A number of the patients in the SUD+ASD group also reported lacking sufficient insight 
in their finance because they did not take initiative and felt they were not able to keep 
track of their finances. 
 
I handed over financial and administrative matters to an administrator, 
voluntarily. In the past, those were daily activities that I didn't get to. I 
noticed it, of course, that pile of bills lying there. But no, I was too scared 
to start on them. (SUD+ASD 4) 
 
Overall, the interviews showed the patients getting caught in a vicious circle of 
symptoms and substance use in every life domain. 
 
DISCUSSION 
With regard to the everyday life consequences of SUD with co-occurring ADHD or ASD, it 
can be concluded that the underlying mechanisms appear to differ for the groups (i.e., 
impulsivity vs. passivity) but that the everyday life consequences of having a dual 
disorder are similar: both groups get caught in a vicious circle of symptoms and 
substance use. The cycle is more or less the same for the two groups: a jumble of 
thoughts and emotions; increased symptoms (i.e., impulsiveness or passivity); 
decreased structure; increased substance use; and occurrence of even more jumbled 
thoughts and emotions (see Figure 1). For both groups of patients, the jumble of 
thoughts and emotions can lead directly to agitation and substance use, which initially 
ameliorates the symptoms but exacerbates them later: for the SUD+ADHD group, 
substance use typically leads to increased impulsiveness; for the SUD+ASD group, 
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substance use typically leads to increased passivity. In the long run, SUD increases the 
ADHD or ASD symptoms and interferes with self-management. 
 
Both groups function better when there is sufficient structure. However, substance use 
destroys structure, and this lack of structure can lead to a vicious circle of increased 
substance use. The SUD+ADHD group of patients mainly lacks inhibition of impulsiveness 
and therefore has considerable difficulties focusing as well as maintaining structure. 
This created a situation of agitation and thereby increased substance use and 
heightened impulsivity, with a further loss of structure and increased substance abuse 
as an outcome. In contrast, the SUD+ASD group has problems with initiation, the 
management of daily responsibilities, and getting into and holding on to structure. The 
outcome is passivity and melancholia, which can lead to substance use as a form of 
coping (see Figure 1). 
 
Figure 1. Vicious circle entailed by dual diagnosis of SUD with ADHD or ASD 
 
 
 
In their review, Kushner & Mueser19 described four models explaining the high 
prevalence of comorbid substance use disorders and other psychiatric disorders; the 
common factor model, the secondary substance abuse model, the secondary 
psychopathology model, and the bidirectional model. The current study contains 
various examples of processes consistent with each of these models: impulsivity as a 
common vulnerability factor, substance abuse to reduce dysphoria or to facilitate social 
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engagement, substance abuse leading to impulsive behaviour or passivity, and — most 
of all — the presence of (bidirectional) vicious circles of increasing substance abuse and 
increasing psychopathology. 
 
Dealing with impaired executive functioning 
A possible key to treatment of SUD with a co-occurring ADHD or ASD and thus breaking 
the vicious circle of symptoms and substance use is attention to their cognitive or so-
called executive functioning (EF). The problems that are solved by EF are essential for 
adequate social functioning. EF is essential for adequate functioning in two main 
domains: inhibition and meta-cognition. Inhibition refers to the ability of the individual 
to inhibit motor, verbal, cognitive, and emotional activities. Meta-cognition refers to 
the individual's nonverbal working memory, verbal working memory, planning abilities, 
problem-solving abilities, and emotional self-regulation.16 
 
For alcohol-dependent patients, research shows that almost all executive functions are 
impaired.17-21 For the patients in our study and thus patients with a dual diagnosis of 
ADHD or ASD and a co-occurring SUD, an accumulation of EF impairments may thus be 
the case. 
 
Barkley16 recently found ADHD patients to have both impaired inhibition and impaired 
meta-cognitive functioning (i.e., both non-verbal and verbal working memory 
limitations). Not being able to concentrate or remember things for a longer period of 
time, patients with ADHD may move from task to task without re-engaging or finishing a 
task and thus leave a series of uncompleted tasks behind them. This is consistent with 
what we found in the present study for SUD+ADHD patients who reported being 
impulsive, problems focusing, trouble keeping focused, and difficulties maintaining 
structure in several areas of their lives. SUD may thus worsen the problems of patients 
with ADHD. This means an accumulation of EF impairments. 
 
ASD is also associated with impairments of both inhibition and meta-cognition.22,23 
Patients with ASD have been shown to have problems with intention formation (i.e., 
performance planning), intention initiation (i.e., switching, time monitoring) and 
execution (i.e., task completion, switching, planning adherence, efficiency). Flexibility 
remains particularly impaired across ages in ASD, whereas working memory, initiation, 
and organization become increasingly problematic over time. SUD may thus worsen the 
problems for patients. This means an accumulation of EF impairments. This pattern of 
findings is consistent with what we detected in the present study for the SUD+ASD 
patients who reported being passive, difficulties with structure, and problems 
organizing various areas of their lives. 
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Clinical implications 
The results of this qualitative, interview study show how SUD creates a vicious circle of 
symptoms and substance use in patients with a dual diagnosis of SUD and ADHD or ASD. 
We also gained insight with this information into what clinicians can do to break the 
vicious circle of symptoms and substance use: SUD+ADHD patients should be helped to 
refrain from action and SUD+ASD patients should be helped to take action. Patients 
should be helped to create and maintain structure in their lives, and their self-
management skills need to be strengthened to do this. In addition, SUD+ASD patients 
may initially be offered controlled substance use in the absence of appropriate 
behavioural alternatives for the realization of a treatment goal. A patient with 
SUD+ASD, for example, may be helped to engage in social activities with reduced 
drinking (i.e., controlled substance use) and thus to master the behavioural repertoire 
needed to participate in social activities.24 
 
Clinicians should nevertheless realize that reduced substance use or total abstinence 
will not always result in better planning, greater structure, or increased initiative. The 
cognitive impairments arising from SUD add to the often chronic, cognitive impairments 
associated with ADHD and ASD, which means that reductions in substance use may help 
but are not very likely to fully restore the cognitive functioning of an individual with a 
dual diagnosis of SUD and ADHD or ASD. The goal of the treatment and care for these 
patients should thus be maximization of their long-term welfare — however the patient 
defines this — by helping them to break the vicious circle of symptoms and substance 
use. Support, reinforcement of available skills, and viable alternatives for cognitive 
impairments should always thus be considered. 
 
Strengths and limitations of the present study 
The conduct of the interviews in the present study by two independent researchers 
increases credibility and reliability25. Analysis of the data was performed by the two 
researchers independently and final coding was based on consensus between the two 
researchers. Data saturation was reached when coding the statements selected from 
the transcripts for discussion topic, main themes, and relevant points, which indicates 
the validity of the study26. 
 
The group of responders and non-responders were comparable with regard to the 
intensity of care, which suggests that our patient population was representative. A 
limitation of the study was that the researchers did not use cross-over blind coding, 
which would have added to the reliability. Other possible limitations were that the 
SUD+ASD group included only males and that co-occurring mental health conditions 
aside from ADHD and SUD or ASD and SUD were not assessed. 
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Conclusions 
With regard to the everyday life consequences of SUD with co-occurring ADHD or ASD, it 
can be concluded that the underlying mechanisms appear to differ for the groups (i.e., 
impulsivity vs. passivity) but that the every-day life consequences of having a dual 
disorder are the same: both groups get caught in a vicious circle of symptoms and 
substance use. Our findings show SUD co-occurring with ADHD or ASD to be associated 
with EF impairments and thus have consequences for the daily life functioning and 
social interactions of patients. To help patients cope with these cognitive deficits, their 
treatment and care should be aimed at the areas of time management, organization, 
problem solving, self-control, motivation, and the regulation of emotions.27 An 
integrated cognitive behaviour therapy protocol28 possibly in combination with 
atomoxetine29 or high doses of methylphenidate30 appears promising for the treatment 
of SUD+ADHD. Further research is nevertheless needed in these areas. To our 
knowledge, the treatment of co-occurring SUD+ASD has not yet been studied. 
Considering the negative consequences for the everyday lives of the patients, the 
treatment possibilities for this dual diagnosis group should be studied. 
 
Further examination of the actual experiences of patients is needed to provide a clear 
basis for their treatment. The treatment and care experiences of patients with ADHD or 
ASD and a co-occurring SUD should be examined, for example, in order to gain insight 
into their opinions about what contributes to their recovery and which coping strategies 
should be reinforced and stimulated. 
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ABSTRACT 
Background: Patients with a substance use disorder (SUD) and co-occurring attention 
deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) often start 
using substances in an attempt to cope with the stress related to their ADHD or ASD. To 
improve treatment for these patient groups, it is important to identify and compare the 
various coping styles between SUD patients with and without ADHD or ASD and with 
subjects from a general population sample. 
Methods: Cross-sectional study using the Utrecht Coping List (UCL) in 50 SUD patients, 
41 SUD+ADHD patients, 31 SUD+ASD patients and 1,200 railway employees.  
Results: Compared with the reference group, all three SUD groups showed a significant 
higher mean on the Palliative reaction, Avoidance, and Passive reaction subscales of 
the UCL. The scores for all UCL subscales of the SUD and the SUD+ADHD groups were 
very similar. However, the SUD+ASD group scored higher on Passive reaction and lower 
on Reassuring thoughts than the SUD and the SUD+ADHD groups and lower on Expression 
of emotions subscale in comparison with the SUD+ADHD group. 
Conclusions: Regardless of the presence of a co-occurring disorder, SUD patients 
reported more palliative, avoidant and passive coping when confronted than people in 
the general population. In addition, SUD patients with co-occurring ASD were different 
from other SUD patients in their coping and professionals should take this into account 
when working on more adaptive coping strategies with these patients. 
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BACKGROUND 
There are many reasons for why people start using substances, continue to use them 
and eventually become dependent on them. Speaking broadly, three core reasons for 
substance use can be distinguished: (a) positive reinforcement (i.e., instant pleasure 
and euphoria provided by substance use); (b) negative reinforcement (i.e., instant 
relief from feelings of anxiety, depression or insecurity provided by substance use and 
thus self-medication); and (c) habitual/compulsive substance use (i.e., substance use is 
no longer associated with positive or negative reinforcement but has become an 
automatic behaviour (e.g. chain smoking)1-7. 
 
People with attention deficit/hyperactivity disorder (ADHD) are more likely to use 
substances and become addicted because they are either looking for thrills (i.e., 
positive reinforcement) or seeking relief from their ADHD symptoms (i.e., negative 
reinforcement)8,9. Cannabis, for example, may be used to cope with insomnia; 
stimulants may be used to cope with hyperactivity and the inattention which this brings 
with it. In contrast, individuals with an autism spectrum disorder (ASD) have been 
shown to mostly use substances to suppress social anxiety, make it easier to get in 
contact with their surroundings and reduce stress (i.e., negative reinforcement).10 
 
In a recent study, we have shown that patients with a substance use disorder (SUD) and 
co-occurring ADHD or ASD initially started to use alcohol and/or drugs to cope with 
ADHD and ASD associated stress. Substance use may initially ameliorate the symptoms 
and the related stress but it may worsen the situation later10. An important question is 
whether this pattern of substance use is specific for the the different groups or part of 
a more general way of dealing with stressful situations (i.e., part of a general coping 
strategy).   
 
Classifications of coping strategies and styles 
Coping refers to the cognitive and behavioural efforts of individuals to manage their 
internal and external demands which are appraised as taxing or exceeding the 
resources of the individual11. People can differ with respect to the general or dominant 
strategy which they use to deal with stressful situations. And a variety of coping styles 
have been identified. In a recent review, Nielsen and Knardahl12 identified the 
following —partly overlapping— coping styles: problem-focused versus emotion-focused 
coping13 , active versus passive coping14-15, adaptive versus maladaptive coping16, and 
engagement versus disengagement coping17. 
 
Unfortunately, there is no consensus on the classification of coping styles or the best 
model of human coping to be used17. For example in a two-year prospective sample of 
3,738 working adults, Nielsen and Knardahl12 found that the use of what can be 
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considered dysfunctional coping strategies was related to poor mental health while the 
use of what could be considered functional coping strategies was related to good 
mental health. Specific coping strategies and overall coping styles showed some 
stability but were nevertheless open to change over time and thus malleable. 
 
Research has shown that ADHD patients use more confrontational and escape-avoidance 
behaviours for the management of stressful situations and less planned problem-solving 
strategies when compared to a control group of individuals without ADHD18-19. However, 
in a different study, ADHD patients also used ‘positive reappraisal’ as an adaptive 
coping strategy intended to give some positive meaning to the stressful situation via a 
focus on personal growth and learning19. 
 
For ASD patients, a disengagement coping style has been found to be associated with 
significantly higher levels of both behaviour and emotional problems20.  
Finally people with a substance use disorder (SUD) reported more disengagement and 
avoidance behaviours than other coping behaviours21-23. 
 
To our knowledge, however, no studies have compared the coping styles of SUD 
patients with and without a co-occurring ADHD (SUD+ADHD) or co-occurring ASD 
(SUD+ASD). It can thus be asked (1) what coping styles are displayed by adult SUD 
patients with and without co-occurring ADHD or ASD and (2) whether significant 
differences emerge when the coping styles of these groups of SUD patients are 
compared to those of a reference group of individuals from the general population. 
 
Hypotheses derived from the available literature 
Based on the literature summarized before, we hypothesize that SUD+ADHD patients 
will report more confronting behaviour and more positive reappraisal than SUD and 
SUD+ASD patients. In contrast, SUD+ASD patients will report more disengagement than 
SUD+ ADHD and SUD patients. We also hypothesize that SUD+ADHD patients will report 
more avoidance behaviour than SUD and SUD+ASD patients. Finally, we expect all of the 
patients to score similarly for socialization behaviours despite stronger limitations in 
the social interaction and communication capacities of ASD patients.  
 
To test these hypotheses, coping style data of SUD patients with and without a co-
occurring ADHD or ASD were compared to each other and to existing coping style data 
for a general population reference group.  
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METHODS 
Study Design 
A cross-sectional study was conducted using the Utrecht Coping List (UCL) in SUD 
patients with and without a comorbid ADHD or ASD and a group of healthy controls.  
 
Participants 
The patient population consisted of SUD patients without and with a comorbid ADHD 
(SUD+ADHD) or comorbid ASD (SUD+ASD). Inclusion criteria: inpatients and outpatients 
seeking treatment for SUD; age 18-65; IQ >80; DSM-IV diagnosis of SUD with or without 
DSM-IV diagnosis of adult ADHD or ASD; and mastery of the Dutch language. Exclusion 
criteria: somatic complaints not directly related to SUD. All 122 patients also 
participated in the study previously reported by Kronenberg et al10. Although ASD and 
ADHD appear to frequently co-occur with each other24,25, the DSM-IV does not allow a 
diagnosis of ADHD and a diagnosis of ASD at the same time. In the present research, 
only nine patients were diagnosed with SUD and both ADHD and ASD but excluded from 
the analyses. 
 
The general population reference group consisted of 1,200 Dutch railway employees 
who were very similar to the patient groups in age (mean 43 years) and gender (5% 
females)26. 
 
A certified medical ethics committee (Commissie Mensgebonden Onderzoek Regio 
Arnhem-Nijmegen) and the institutional review board of Dimence (Commissie 
Wetenschappelijk Onderzoek) approved the study. All patients received both oral and 
written information about the study and signed an informed consent form. 
 
Assessment 
In order to identify coping styles, we administered the Utrecht Coping List (UCL) to all 
patients. The UCL consists of 47 items constituting seven subscales: (1) Active problem 
solving (ACT; confronting, employment of purposeful problem-solving strategies), (2) 
Palliative reaction (PAL; try to feel better by smoking, drinking, distraction of 
problems, relaxing), (3) Avoidance (AVOI; avoid situation, waiting, keeping clear of the 
problem), (4) Socialization (SOC; seeking comfort from other or asking for help), (5) 
Passive reaction (PAS; rumination, drawing back, retreat, pondering, incapacity to do 
something about the situation), (6) Expression emotions (EXP; expression of annoyance 
or anger, letting off of steam), (7) Reassuring thoughts (REA; calms oneself by thinking 
that worse things can happen, self-encouragement). 
All UCL items are rated on a four-point Likert scale ranging from 1 (=never) to 4(=very 
often). A higher score on a coping style thus indicates that this response style is used 
more often. Table 1 shows that the internal consistency of the UCL subscales in the 
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reference group was good (Cronbach's alpha >.70) for most scales and acceptable 
(Cronbach's alpha .50-.70) for the EXP-scale.  
 
In the SUD groups, the internal consistency of the subscales was found to be good for 
four scales (ACT, AVOI, SOC, and PAS) and acceptable for three scales (PAL, EXP and 
REA).  
 
Table 1.  Reliability (Cronbach's alphas) for UCL-scales in the SUD group (n=122) and the reference 
group (n=1,200)  
 
  
ACT 
7 items 
PAL 
8 items 
AVOI 
8 items 
SOC 
6 items 
PAS 
7 items 
EXP 
3 items 
REA 
5 items 
Reference group .82 .76 .73 .75 .70 .64 .70 
Research group  .77 .58 .71 .83 .70 .65 .58 
 
Statistical Analyses 
The UCL scores were normally distributed for all groups. A series of one-way ANOVAs 
(p<.05) was conducted on the UCL scores to test for significant differences between the 
three groups of patients. An additional series of ANCOVAs was performed to control for 
group differences in the living situations of the patients. Post-hoc independent T-tests 
(p<.05) were conducted to clarify the differences between the groups when significant 
differences were revealed by the ANOVAs or ANCOVAs. In addition, the standardized 
effect sizes (Cohen's d) were calculated to facilitate the interpretation of significant 
outcomes: d < 0.20 no relevant difference; d = 0.20–0.30 small difference; d = 0.30–
0.80 moderate difference; and d > 0.80 large difference.27 In order to prevent false 
negative findings in this exploratory study, we decided not to correct the significance 
level for multiple comparison. 
 
RESULTS 
A total of 122 patients participated in the study: 50 patients with SUD only, 41 patients 
with SUD+ADHD and 31 patients with SUD+ASD. Most of these patients were in a 
substance abuse treatment programme at the time of assessment although a small 
percentage (13%) was not. There were substantial group differences in the living 
conditions of the patients compared to each other and compared to the healthy 
controls. There were also substantial differences between the three patient groups in 
the substances which were used (for example: amphetamines F3.413/p= 0.036 and 
cannabis F 4.684/p= 0.011). Based on these findings, the SUD group comparisons were 
adjusted for differences in living conditions (p= 0.025). We decided not to adjust for 
the substances that were used because this could result in overcorrection and produce 
false negative findings.  
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On average, the interviews with the patients lasted 15 minutes. For the ASD group, it 
took a bit more time to complete the UCL interview on average. 
 
Table 2.  Demographic and clinical characteristics of the research and reference groups  
 
 Ref. Group SUD SUD+ASD SUD+ADHD 
N 1200 50 31 41 
Male (%) 95.6 72 94 68 
Age mean 43 46 40 37 
Living (%)     
Alone 9 38 52 37 
With parents  16 10 5 
With partner  28 12 17 
With partner and children 88 12 7 29 
With children alone  - - 5 
Protected living  - 19 2 
Otherwise 3 6 - 5 
Income (%)     
Employed           100 30 26 39 
Partner, family, friends  12 3 2 
Social welfare unemployment  28 29 27 
Social welfare; declared unfit to work  26 42 27 
Otherwise  4 - 5 
Education (%) not applicable    
None  8 3 7 
Primary Education  24 36 44 
Secondary Education  35 39 35 
Highschool  28 16 15 
University  6 7 - 
Type of treatment (%) not applicable    
None  8 5 12 
Outpatient detox  2 - - 
Clinical detox  6 3 12 
Outpatient_ drug free treatment  58 65 59 
Clinical_ drug free treatment  10 3 5 
Daycare  14 - 2 
Mental health hospital  2 7 - 
Otherwise  - 7 7 
Primary drugs (%) no information    
Complete remission  4 3 2 
Alcohol  66 71 39 
Heroin  4 - 2 
   Cocaine  8 7 7 
   Amphetamines  - 3 15 
   Cannabis  18 13 24 
   More than one  - 3 10 
 
Figure 1 shows the similarities and differences in the coping styles of the four groups at 
a glance. 
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Table 3 shows significant differences in coping between the three patient groups, but 
the differences were limited to the coping styles of Passive reaction and Reassuring 
thoughts (ANOVA B-C-D).  
 
Table 3. Overview of differences in coping behaviours 
 
 Ref. groep A 
mean/sd 
SUD B 
mean/sd 
SUD+ADHD-C 
mean/sd 
SUD+ASD-D 
mean/sd 
A-B A-C 
N=1200 N=50 N=41 N=31 t-toets cohen d t-toets cohen d 
ACT 18.40/3.58 17.86/3.56 16.93/4.05 16.87/3.66 .289 .151 .025* 0.388 
PAL 15.32/3.62 19.34/2.89 19.60/3.71 19.70/3.68 .000** -1.227 .000** -1.167 
AVOI 14.71/3.29 17.30/3.69 16.98/3.62 18.47/4.26 .000** -0.741 .000** -0.655 
SOC 11.07/2.95 11.44/3.38 12.43/3.80 12.54/3.51 .442 -0.117 .026* -0.403 
PAS 10.55/2.67 14.98/3.71 15.17/3.27 17.10/4.22 .000** -1.335 .000** -1.502 
EXP 6.25/1.70 6.26/1.95 6.85/1.74 5.93/2.12 .097 -0.005 .032* -0.351 
REA 11.54/2.57 12.18/2.54 12.63/2.72 10.73/2.61 .081 -0.251 .014** -0.414 
* = P < 0.05  
** = p < 0.01 
 
Figure 1. The mean score of coping style for three patient groups and one reference group  
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A-D 
 
B-C 
 
B-D 
 
C-D 
 
Anova; B-C-D groups 
t-toets cohen d t-toets cohen d t-toets cohen d t-toets cohen d f Sign. 
.029* 0.426 .245 0.245 .235 0.277 .949 -0.016 .387 1.1 .35 
.000** -1.200 .698 -0.181 .628 -0.109 .919 0.024 .880 .13 .88 
.000** -0.987 .675 0.089 .2 -0.293 .116 0.377 .246 1.3 .28 
.03* -0.451 .188 -0.278 .171 -0.317 .915 0.026 .288 1.3 .28 
.000** -1.815 .798 -0.055 .022* -0.534 .033* 0.511 .036 3.1 .05 
.419 0.165 .133 -0.322 .484 0.161 .049* 0.511 .121 2 .14 
.101 0.311 .413 -0.172 .017* 0.560 .004** -0.713 .010 5 .008 
 
Similar findings were found when differences in the living situations of the patients 
were controlled for (i.e. living alone or not) (ANCOVA B-C-D). In particular, SUD+ASD 
patients reported more Passive reaction and used less Reassuring thoughts than both 
the SUD group (d=-0.534 and d=0.560) and the SUD+ADHD group (d=0.511 and d=-
0.713). In addition, the SUD+ASD group reported less Expression of emotions than the 
SUD+ADHD group (d=0.511). No significant differences were observed between the SUD 
and the SUD+ADHD group.  
 
From Table 3 and Figure 1, it can be seen that all patient groups showed large 
differences from the reference group: compared to the reference group, patients 
showed (much) more Passive reaction (SUD d=-1.335, SUD+ADHD d=-1.502, SUD+ASD d=-
1.815), more Palliative reaction (SUD d=-1.227, SUD+ADHD d=-1.167, SUD+ASD d=-
1.200) and more Avoidance (SUD d=-0.741, SUD+ADHD d=-0.655, SUD+ASD d=-0.987). 
  
SUMMARY AND DISCUSSION  
Compared to the reference group, all three SUD groups score much higher on the 
Palliative reaction, Avoidance and Passive reaction subscales. The scores for the SUD 
and SUD+ADHD groups are very similar on all UCL subscales. However, the SUD+ASD 
group scores are significantly higher on Passive reaction and lower on Reassuring 
thoughts compared to the SUD and SUD+ADHD groups and lower on Expression of 
emotions compared to the SUD+ADHD group. 
 
These findings only partly supported our first hypothesis, namely that patients with 
SUD+ADHD would show more confronting behaviour but also more positive reappraisal 
than patients with SUD and SUD+ASD. The patients with SUD+ADHD in our study did not 
show more Active problem solving behaviour than the other groups  while their average 
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score on Reassuring thoughts was higher than in the SUD+ASD group but not the SUD 
group.  
 
Our second hypothesis was confirmed: the patients with SUD+ASD in our study reported 
more disengagement behaviour compared to the patients with only SUD and those with 
SUD+ADHD. The SUD+ASD patients scored higher on Passive reaction and lower on 
Expression of emotions than the SUD+ADHD patients.  
 
Our third hypothesis that the SUD+ADHD group would report more avoidance behaviour 
than both the SUD and SUD+ASD groups was not supported. All three patient groups 
scored higher on Avoidance than the reference group with no significant differences 
detected between the three patient groups.  
 
Our fourth and final hypothesis that patient groups would score similarly with respect 
to socialization behaviours (i.e. seeking comfort from other or asking for help) was 
supported: all patient groups scored similar with no significant between groups 
differences. 
 
Our initial hypotheses were derived from a very small body of studies involving mostly 
patients with ADHD or ASD and not for studies with SUD patients with a comorbid ADHD 
or ASD. Data from patients with a single diagnosis obviously cannot be applied 
automatically to patients with co-occurring diagnoses.28 It is certainly possible that the 
symptoms and coping styles associated with specific disorders will interact and affect 
each other. For example, the confronting behaviour which we expected to see in 
patients with ADHD can conceivably be counteracted by palliative behaviour, avoidance 
behaviour or passive behaviour on the part of patients with SUD and ADHD. This would 
then explain why the SUD+ADHD group did not score higher than the other patients 
groups and reference group on confronting behaviour.  
 
In contrast, it was expected that the SUD+ADHD group would show avoidance as a 
particular coping style compared to the SUD and SUD+ASD groups since studies on both 
the single diagnosis of SUD21-23 and the single diagnosis of ADHD18-19 reported that both 
patient groups used more avoidance coping, but this turned out not to be the case.  
 
As expected, the patient groups scored similarly on socialization behaviours despite the 
often strong limitations on the social interaction and skills of patients with SUD+ASD. 
Substance use particularly for the patients with ASD may have facilitated social 
interaction10,29. 
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The results of the current study confirm previous results showing passive 
disengagement coping strategies to be associated with high levels mental health 
problems30. However, the causal nature and exact direction of this association, if 
causal, has yet to be determined. It is certainly possible that passive disengagement 
and mental health problems are causally related, but it is also possible that the two 
simply represent different aspects of the same condition. If the two are causally 
related, moreover, it is not yet clear if passive disengagement as a coping style can 
lead to mental health problems or mental health problems can lead to the increased 
use of passive engagement as a coping strategy. Additional research is clearly needed. 
 
Study strengths, limitations and future research 
The present study has both strengths and limitations. The most important strengths are 
the relatively large subgroups of patients included in the study and the availability of a 
relatively well-matched reference group.  
 
A first limitation is the relatively low internal consistency of some of the UCL subscales 
in the patient group. This is probably due to some of the patients and especially those 
in the SUD+ASD group having difficulties distinguishing between the 'sometimes' versus 
'often' response options. Research assistants were available to assist but may not have 
been approached.  
 
A second limitation is that comorbid conditions other than ADHD and ASD were not 
identified and utilized as an exclusion criterion. A third limitation is that we did not 
take into account the primary substance of abuse as a confounder for the differences in 
coping style between the three patient groups, because this may have lead to 
overcorrection and false negative findings. However, it can not be excluded that 
differences in coping style between the patient groups are partly explained by 
differences in the different patterns of alcohol and drug use. A fourth limitation is that 
patient groups differed considerably in their living conditions. However, statistical 
adjustment for these differences did not change the findings. In order to prevent false 
negative findings in this relatively small study, we decided not to correct for multiple 
comparisons. A fifth limitation is that males were highly overrepresented in all three 
patients groups and in the reference group. We therefore cannot extrapolate from the 
current findings to draw conclusions about female patients with SUD, SUD+ADHD or 
SUD+ASD. This is important, because it is also well known that males and females differ 
considerably in coping strategies26. Finally, we would like to note that this study did 
not include patients with only ADHD or ASD and therefore we have no information 
about the influence of SUD on the coping style of patients with ADHD and ASD. 
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Practice implications  
Overall, the preferred coping styles for all SUD groups were Palliative reaction, 
Avoidance and Passive reaction. These coping styles may be effective in the short run 
because they decrease the jumble of emotions and mixture of agitation, distress and 
anxiety which can plague these patients10. In the long run, however, the use of a 
palliative, avoidance or passive coping style can interfere with the ability of patients 
to effectively deal with their impairments, anticipate possible problems and handle 
problems when they occur. Guiding patients towards a more active, adaptive and 
problem-focused manner of coping should be at least one goal of treatment.  
 
In addition, total abstinence or reduced consumption should be a treatment goal for all 
patients with a combination of disorders. In SUD+ADHD patients, substance use may 
hinder Active problem solving and Reassuring thoughts. For SUD+ASD patients, reducing 
their substance use might even be the primary treatment goal as substance use is 
known to increase passivity. However, in this patient group substance use may also 
enable socialization. The care professional might collaborate with the patient on the 
development of a relapse prevention plan, for example, and help the patient to 
anticipate problems and thus prevent them or be better prepared to deal with them in 
a functional as opposed to dysfunctional manner. 
 
Conclusions 
SUD patients in this study used more Palliative reaction, Avoidance and Passive 
reaction coping styles when confronted with unpleasant events and problems than the 
general population. In addition, patients with SUD+ASD used more Passive reaction and 
less Reassuring thoughts than patients with SUD or SUD+ADHD. These findings are 
important for understanding SUD patients in general and those with a comorbid 
diagnosis in particular. Patients with SUD+ADHD frequently want to become totally 
abstinent because their SUD exacerbates their ADHD symptoms and lead to major 
problems in many domains of adult life. In contrast, patients with SUD+ASD often only 
want to reduce their drinking because it can facilitate their social interaction.   
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ABSTRACT 
Objective: To identify and compare caregiver burden and expressed emotion (EE) in 
adult substance use disorder (SUD) patients with and without co-occurring attention 
deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). To examine 
possible differences in correlations between caregiver burden and EE across patient 
groups.  
Design and Methods: Cross-sectional study with measures of perceived burden 
(Involvement Evaluation Questionnaire: IEQ), subjective stress (General Health 
Questionnaire: GHQ) and perceptions of expressed emotion (Level of Expressed 
Emotion: LEE) in informal caregivers for patients with SUD, SUD+ADHD or SUD+ASD.  
Findings: No differences in caregiver burden or expressed emotion when caregivers for 
patients with SUD were compared to caregivers for patients with SUD+ADHD. A 
moderate but non-significant difference for caregivers of patients with SUD versus 
SUD+ASD, which disappeared when the number of contact hours between patient and 
caregiver for the SUD only group was controlled for. The IEQ sum scores also 
substantially correlated with the LEE sum scores. 
Conclusion: Informal caregivers for patients with only SUD show higher levels of burden 
and EE than informal caregivers for patients with SUD and a co-occurring ASD. This 
difference was largely explained by the higher number of contact hours between 
patient and caregiver in the SUD only group. 
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BACKGROUND AND REVIEW OF THE LITERATURE  
Since the 1950s, it has been acknowledged that informal care for the mentally ill may 
result in psychological problems on the part of caregivers1,2. Goossens et al.3 define an 
informal caregiver as "the person who, in the perception of the patient, is an 
important person in his or her life, who is not a professional and who delivers 
significant support and care for the patient". In this article, this is what we will refer 
to as a "caregiver". In contrast, a professional caregiver will be referred to as 
"clinician". 
 
Caregivers are important partners for clinicians in the care for patients with psychiatric 
disorders. Caregivers can provide companionship and emotional support for patients but 
also assist with their personal care, household tasks, financial tasks and the 
management of medication. Caregivers may also communicate with health 
professionals at times and serve as an advocate for the patient during medical 
appointments and hospitalization. Caregivers can also play a key role as the informal 
care coordinator for a patient4. 
 
Given the importance of caregivers, Schulze and Rossler5 concluded that effective 
mental health service delivery should, among other things, focus on the input of 
caregivers' resources and competences. Therefore caregivers should be considered 
being expert partners in psychiatric practice and research. As Riebschleger et al.6 later 
concluded, however, medical guidelines and the medical education curriculum do not 
pay sufficient attention to the role of families in the care for people with mental 
illness.  
 
Studies show that the burden on informal caregivers for the mentally ill is substantial7-
12. Burden is the personal suffering of a caregiver as a consequence of the illness of a 
family member or friend. Caregiver burden can include grief, loss of hope, dreams and 
expectations, and even despair in cases of relapse. Caregiver burden can also refer to 
the problems and challenges confronting caregivers such as the symptoms of the 
patient's illness, disturbed (family) relationships, limitations of the professional health 
care system, social stigma, economic/financial losses, decreased health of other family 
members, and decreased social networks and support13. Many caregivers report 
experiencing feelings of loss but also anxiety and depression8. If the experienced 
burden exceeds the supportive powers of a caregiver, moreover, they themselves may 
develop mental health problems as well12,14-17. 
 
With regard to the patients receiving the help of informal caregivers, Vaughn and 
Leff18,19 found that patients with schizophrenia needed more relapse care when they 
returned from inpatient treatment to a home environment with high levels of negative 
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expressed emotion (EE) as opposed to low levels of such EE on the part of caregivers. 
Vaughn and Leff further identified four typical characteristic attitudes or response 
styles which tend to distinguish relatives who are highly critical or overinvolved from 
those who are not, as judged by their reported behaviour toward the patient: (1) 
emotional response, (2) attitude, (3) level of tolerance and expectations, and (4) level 
of intrusion in the patient’s life. 
 
EE is important for understanding and preventing relapse among the mentally ill20. 
Informal care can bring benefits but also risks for patients  — depending on  — among 
other things  — the degree of negative EE. Very little is known about caregiver burden 
in relation to EE and, for which matter, caregiver burden in relation to specific 
psychiatric disorders.  
 
According to epidemiological surveys, the global lifetime prevalence of SUD in the 
general population is between 10-20%21,22  and about two-thirds of SUD patients are dual 
diagnosis patients23.  In this current study, the focus is on the dual diagnosis of SUD 
with attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). 
In a recent meta-analysis of patients with a SUD, 25% also met criteria for adult ADHD 24 
while the lifetime prevalence of SUD in patients with ASD has been reported to range 
from 11% to 29%25-28. A recent study by Smith et al.29 further reports that a gene linked 
to ASD has also been found to play a critical role in the incidence of addiction-related 
behaviours. 
 
In a study by Heflinger and Brannan30, similar levels and types of caregiver strain are 
reported for those families caring for youth with SUD and those families caring for 
youth with other mental health problems. However, Cleary et al.31 found the caregivers 
for patients with psychiatric disorders and co-occurring SUD to report significantly 
higher levels of anxiety than the caregivers for patients with psychiatric disorders but 
no SUD. When Werner and Schulman32 recently studied the subjective well-being of 
caregivers for patients with developmental disabilities, moreover, they found their 
subjective well-being to be below the normative score for Western populations and the 
subjective well-being of those caring for individuals with ASD to be particularly low. In 
a recent study of caregiver burden in relation to patients with ASD or ADHD 
transitioning into adolescence and adulthood Cadman et al.33 found both disorders to 
be associated with very high levels of caregiver burden.  
 
According to Cadman and colleagues, ASD leads to even more caregiver burden than 
ADHD. In both groups, caregiver burden is mainly explained by the unmet needs of the 
patient (i.e. depression/anxiety and inappropriate behaviour). For adolescents in the 
same study with ASD only, significant associations between burden and unmet needs 
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are reported for such domains as social relationships and major mental health 
problems. Cadman et al.33 further conclude that the level of burden for the caregivers 
of patients with ASD is comparable to that reported for the caregivers of patients with 
brain injury. In the recent study by Kronenberg et al.34, SUD-only patients were further 
shown to have fewer care needs than SUD patients with co-occurring ADHD or ASD. And 
the SUD patients with co-occurring ASD showed the greatest number of care needs and 
more extensive care needs than the patients with SUD only and the patients with SUD 
and co-occurring ADHD.  
 
In sum, informal caregivers have an important role to play in the care for patients with 
a mental illness. In addition to providing support but also companionship and guidance, 
they can also play a role in relapse prevention and thus help reduce care costs. The 
burden of caring for patients with ASD or ADHD is known to be relatively high. In 
addition, the caregivers for patients with a psychiatric disorder and a co-occurring SUD 
have been found to report significantly higher anxiety levels than the caregivers of 
patients without a co-occurring SUD. To our knowledge, however, the burden of caring 
for adult SUD patients either with or without a co-occurring ADHD or ASD has yet to be 
systematically investigated. These caregivers are nevertheless at a major risk of 
developing mental health problems as our review of the relevant studies has revealed. 
And we therefore conducted the study reported on here in order to answer the 
following research questions. 
 
What is the relative burden of caregivers of adult SUD patients with or without a co-
occurring ADHD or ASD? (alternative hypothesis: Co-occurrence of ADHD or ASD does 
not raise burden of care-givers of patients with SUD).  
 
What is the relative perceived EE of caregivers of adult SUD patients with or without a 
co-occurring ADHD or ASD according to caregivers themselves and patients? (alternative 
hypothesis: Co-occurrence of ADHD or ASD does not raise level of EE for caregivers of 
patients with SUD, from either the perspective of the caregiver or the patient). 
 
Does perceived caregiver EE from the patient's perspective versus the caregiver's 
perspective differ for the three groups of patients? (alternative hypothesis: No 
significant differences in perceptions of caregiver EE across three patient groups when 
viewed from the perspectives of the caregiver versus the patient). 
 
Does perceived caregiver EE correlate with caregiver burden in the three groups of 
patients? (alternative hypothesis: No significant correlations between caregiver EE and 
caregiver burden for different groups of patients). 
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METHODS 
Study design 
A cross-sectional study was conducted with a population of caregivers and treatment-
seeking SUD patients who either had a comorbid diagnosis of ADHD, ASD or not such 
comorbid diagnosis. 
 
The study was approved by the medical ethics committee and by the institutional 
review boards from all participating institutions. All patients and their caregivers 
received both verbal and written information about the study. And the patients and 
caregivers signed an informed consent form prior to the start of the study. 
 
Participants 
The target population consisted of SUD patients either with or without a comorbid 
ADHD or ASD and their caregivers. Participation of patients in the study was based upon 
the following inclusion and exclusion criteria. Inclusion: outpatient treatment for SUD; 
age 18-65; IQ >80; current DSM-IV diagnosis of SUD either with or without current DSM-
IV diagnosis of ADHD or ASD; and mastery of the Dutch language. Exclusion: diagnosis of 
SUD with both comorbid ADHD and comorbid ASD. All patients were recruited from 
mental health services and addiction treatment services which routinely conduct 
clinical screening and diagnostic procedures. The present study follows up on a study of 
122 patients by Kronenberg et al.25. The same 122 patients were asked to participate in 
the present study. In most cases, the patients who had agreed to participate asked 
their own caregivers to participate in the study as well. In some cases, with the 
permission of the patient, the researchers asked the caregivers directly to participate 
in the study. 
 
Data collection    
To measure caregiver burden, the Involvement Evaluation Questionnaire35 was 
administered. The IEQ consists of 81 questions which can be classified into 7 modules 
covering the past four weeks. The first module, items 1-15, address socio-demographic 
information. The second module, items 16-46, constitutes the core module of the IEQ 
and addresses the consequences of a patient's psychiatric disorder for the caregiver. 
The items address the encouragement and care provided by the caregiver; watching for 
dangerous patient behaviour; interpersonal problems between the patient and 
caregiver; caregiver worries; and caregiver coping and expected burden. All of the 
items are scored along a 5-point Likert scale (0=never, 1=sometimes, 2=regularly, 
3=often, 4=always). The third module, items 47-54, assesses the financial burden for 
the caregiver due to the patient's illness. The fourth module, items 55-66, calls upon 
the questions from the General Health Questionnaire36 to assess the mental and 
somatic burden for the caregiver and caregiver distress. All of the items in this module 
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are responded along a 4-point Likert scale (0=better than usual, 1=the same as usual, 
2=worse than usual, 3=much worse than usual). The fifth module, items 67-69, 
addresses whether the caregiver would like to receive professional care and gets it. 
The sixth module, items 70-80, addresses the consequences of the patient's illness for 
the patient's children (if applicable). The seventh and last module is an open question 
intended to give the interviewee an opportunity to provide additional remarks. The 
question "Do you receive help/support in caring for the patient?" was added to the open 
question in this module. If the response to the "help" question is affirmative, the 
caregiver is then asked whether more help/support, the same amount help/support or 
less help/support was needed. 
 
The reliability of the IEQ has been documented for different populations in several 
European countries showing not only good internal consistency for the subscales and 
the total score12 but also sensitivity to change over time37. The IEQ has been validated 
for the caregivers of patients with psychosis, patients with depression12 and patients 
with brain damage38. 
 
The Level of Expressed Emotion (LEE)39 is a questionnaire grounded in a prior study of 
expressed emotion18. The LEE assesses perceptions of expressed emotion on the part of 
the caregiver and is completed by both the patient and the caregiver. The 
questionnaire contains 38 items, which can be classified into four sub-scales (lack of 
emotional support, irritation, intrusiveness, criticism). All of the LEE items are scored 
along a 4-point Likert scale (1=untrue, 2=more or less untrue, 3=more or less true, 
4=true). The time frame for the items is, just as for the IEQ, the prior four weeks. The 
total of the scores for the four sub-scales indicates the perceived extent of caregiver 
expressed emotion.  
 
The LEE has been shown to have good internal consistency, reliability, construct 
validity and independence for gender, age and quantity of contact40-42. 
 
For the patients, the LEE was administered during a face-to-face interview. For the 
caregivers, both the LEE and the IEQ questionnaires were mailed to their home 
addresses. A telephone contact number accompanied the questionnaires for any 
information or other help which the caregivers might need. 
 
Statistical analyses 
Before testing our hypotheses, groups were compared on initial characteristics like the 
kind of relationship between caregiver and patient and weekly contact hours, using 
chi2 test for significance for categorical data and ANOVA for data on interval/ratio 
level (p<.05). 
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For research question 1, the mean subscale scores and overall scores for the core 
module of the IEQ were calculated along with their standard deviations (SDs). Caregiver 
distress was determined on the basis of the number of items from the GHQ for which a 
score of 2 or 3 was assigned by the respondent (i.e. the answer differed negatively 
from the respondent's "usual self"); caregivers responding with 3 or more of these 
scores were considered "distressed" while those responding with 2 or less were 
considered "not distressed". A one-way ANOVA (p<.05) was then conducted to test for 
significant differences in the IEQ and LEE scores for the patient groups with the use of 
the Cohen's d to guide interpretation when significant differences were found [d<0.20 
no relevant difference; d=0.20-0.30 small difference; d=0.30-0.80 moderate difference; 
and d>0.80 large difference43. The Chi² statistic was used to test for significant 
differences between the percentages of distressed versus non-distressed caregivers 
according to the GHQ for the different groups of patients. 
 
For research question 2, the four LEE sub-scale scores were summed to obtain a total 
expressed emotion score. The total LEE scores from the patient's perspective and the 
caregiver's perspective were then compared for each patient group. Just as for the IEQ 
scores, one-way ANOVAs (p<.05) were conducted to test for significant differences in 
the LEE scores across the patient groups with, once again, the Cohen's d used to guide 
the interpretation of significant group differences (see above). 
 
For research question 3, paired t-tests (p<.05) were used to evaluate the differences 
between the perspectives of the patients and the caregivers on expressed emotion for 
the three groups of patients. The Cohen's d was (again) used to guide the interpretation 
of significant differences (see above). 
 
For research question 4, the Pearson correlation coefficients between the sum scores 
for the IEQ and the LEE were calculated to examine the relation between expressed 
emotion and caregiver burden for the three groups of patients. 
 
The three patient groups differed significantly in the average number of weekly contact 
hours with their caregivers. It was therefore decided to also conduct a series of post-
hoc multivariate analyses to see if significant group differences in caregiver burden and 
expressed emotion remained after control for the amount of caregiver/patient contact 
on average. 
 
RESULTS 
Patient characteristics 
Out of the 122 patients who participated in the Kronenberg et al.25 study, a total of 77 
proved willing to complete the LEE. The other 45 patients were not interested in 
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participating because they did not have a caregiver or did not want to bother their 
caregiver more than necessary. Of the 77 caregivers who were approached, 17 did not 
return both the IEQ and the LEE. This left a total of 60 patient/caregiver pairs for 
inclusion in the present study: 20 in each diagnostic group. The numbers being even 
was coincidental. 
 
The intensity of care needed —according to the European Addiction Severity Index 
(EuropASI)— for the subgroup of 60 patients did not differ from the 122 patients 
included in the prior study with the exception of less gambling problems in the 20 
SUD+ASD patients in the current sample than in the previous sample of 31 SUD+ASD 
patients. 
 
Caregiver characteristics 
Table 1 shows some 80% of the patients to be male and some 80% of caregivers to be 
female. The mean ages of the patients and their caregivers were comparable across the 
three groups of patients with the caregivers 5 years older than the patients on average. 
With the exception of the number of contact hours with the patients on average, the 
demographic characteristics of the caregivers were comparable across the three groups 
of patients. In the SUD group, 50% of the caregivers reported more than 32 hours of 
contact per week; this was true for only 20% and 25% of the caregivers in the 
SUD+ADHD and SUD+ASD groups, respectively (p= 0.035). 
 
Table 1. Demographic characteristics of patients and their caregivers (n=60) 
 
  
SUD     SUD+ASD   SUD+ADHD   phi 
N=20   N=20   N=20 
mean  sd mean  sd mean  sd 
Patient gender = female 20%   10%   30%   0.287 
Caregiver gender = female  75%   85%   85%   0.641 
Patient age 45.5    14.4 38.2    13 38.9    11.2 0.086 
Caregiver age 51.4    14.7 45.7     15 46 13.6 0.376 
Time of first mental health problems       0.244  < 3 years 20%  10%  0  3-10 years 10%  15%  15%  > 10 Years  45%  45%  60%  Unknown  25%   30%   25%   
Relation caregiver to patient      0.365 Parent 20%  30%  30% Child/Sibling/family 20%  30%  15% Partner 50%  15%  35% Other 10%   25%   20%     
Hours of contact per week      0.035* <8 45%  65%  45% 9-32 5%  5%  30% >32 50%  20%  25% Missing 0   10%   0   
Caregiver has children under 16 15%   15%   30%   0.392 
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Caregiver burden 
Table 2 presents the IEQ core module scores for the three patient groups. 
A moderate (d=.36) but non-significant difference was found between the total IEQ 
scores for the SUD group versus the SUD+ASD group. A small (d=.28) but non-significant 
difference was found for the SUD+ASD group versus the SUD+ADHD group. And no 
difference (d=-.12) was found in the total IEQ scores for the SUD group versus the 
SUD+ADHD group.  
 
Although the caregivers for patients with SUD and a co-occurring ADHD or ASD both 
showed relatively high frequencies of being distressed compared to the caregivers for 
patients with only SUD (45% and 55% versus 25%), the differences in the GHQ scores for 
the groups were not significant (p= 0.209). 
 
Table 2. Overview of caregiver burden and expressed emotion 
 
Group   IEQ score  
range 0-118 
GHQ   
distressed 
LEE caregivers LEE patients  
    Mean    sd caregivers 
percentage 
Mean    sd Mean    sd 
1 SUD            N=20 18.2    17.3  25%  71.7    15.8 66.4    14.4  
2 SUD+ASD    N=20 13.1     9.1 55% 64 18.1 68.9    17.4  
3 SUD+ADHD  N=20  16.3    13.1  45%  67.2    18.5 64 19   
  IEQ  GHQ LEE caregivers LEE patients LEE persp.  
         CG <-> Pt 
ANOVA (p-value) 0.59       0.573   0.513     
Paired t-test (p-value)                  0.413 
Chi² (p-value)      0.209 (df 3)           
Cohen's d             
groups 1-2  .364   .453   .156   .351 
groups 2-3  .284   .174  -.268  -.276 
groups 1-3 -.123       .262    .142    .171 
 
Inspection of Table 3 further shows no significant differences in caregiver burden across 
the three groups of patients. Financial problems for the caregiver due to patient 
problems did not differ across the groups of patients. The receipt of help and the need 
for additional help according to the caregivers also did not differ across the three 
patient groups. 
 
Table 3.  Further comparison of caregiver burden in terms of finances and help 
 
  SUD SUD+ASD SUD+ADHD Chi² 
  n=20 n=20 n=20 p-value 
Financial consequences 45% 25% 45% 0.714 
Getting help  35% 30% 20% 0.743 
Wanting more help 25% 5% 10% 0.341 
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The total number of caregivers with children under the age of 16 years was small (see 
Table 1). The responses of the caregivers to the sixth module of the IEQ, which 
addresses the consequences of the patient's illness for the patient's children, ranged 
widely and were therefore not analyzed further.  
The open question in module 7 of the IEQ was responded to by 70% of the caregivers, 
but the responses did not provide new information and were therefore not examined 
further.  
 
Expressed emotion according to caregivers and patients 
Additional inspection of Table 2 shows no significant differences in the perceptions of 
caregiver expressed emotion across the three groups of patients: No differences from 
the patient's perspective and no differences from the caregiver's perspective. The total 
LEE scores show no relevant differences in expressed emotion from the perspective of 
the caregiver for the SUD+ASD versus the SUD+ADHD groups or the SUD versus 
SUD+ADHD groups; the SUD group scored moderately (d=.45) but non-significantly 
higher than the SUD+ASD group for expressed emotion from the perspective of the 
caregiver. All of the groups showed similar amounts of caregiver expressed emotion 
when viewed from the perspective of the patient. 
 
The perspectives of the patients and caregivers on expressed emotion of the caregiver 
also did not differ significantly when considered across the three patient groups. 
(p=0.413).    
 
Effects of number of contact hours 
Given the differences in the number of contact hours between patient and caregiver 
across groups on average (p=0.035) (see Table 1), multivariate analyses were 
performed to control for the possibly mediating influence of number of contact hours 
on caregiver burden and expressed emotion. 
 
The number of contact hours significantly affected all indicators of caregiver burden 
and expressed emotion. An additional diagnosis of ASD affected caregiver burden but 
only for "being distressed": A diagnosis of a comorbid ASD was associated with a 
significantly higher level of caregiver distress  
 
Table 4. Effects of comorbid diagnosis and number of contact hours on burden 
 
  IEO GHQ LEE  caregivers  LEE patients 
Variance  
explained by  B Std. Err Sig B Std. Err Sig B Std. Err Sig B Std. Err Sig 
+ASD -.095 .163 .562 .434 .152 .006 -4.965 5.391 .361 5.653 5.321 .294 
+ADHD -.120 .154 .439 .227 .143 .120 -4.164 5.121 .420 -1.585 5.005 .753 
Hours of contact .071  .036 .051 .106 .033 .002 3.881 1.203 .002 3.259 1.161 .007 
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Caregiver burden in relation to expressed emotion of caregivers 
Table 5 shows both the LEE scores from the perspectives of the patients and the 
caregivers to correlate significantly with caregiver burden in general (i.e., the IEQ sum 
score).  
 
For the specific groups of patients, significant correlations were found for the SUD 
group and the SUD+ ADHD group. Perceptions of expressed emotion from only the 
perspective of the caregivers correlated with caregiver burden for the SUD group. 
Expressed emotion from both the perspectives of the caregivers and the patients 
correlated with caregiver burden for the SUD+ADHD group. 
 
No significant correlations between expressed emotion and caregiver burden were 
found for the SUD+ASD group.  
 
Table 5. Correlations between caregiver burden as measured by the IEQ and caregiver expressed 
emotion as measured by the LEE from the perspective of the patients and from the 
perspective of the caregivers 
 
  Sum score IEQ   Sumscore Sumscore Sumscore 
  Pearson Sig. (2-tailed) SUD SUD+ASD SUD+ADHD 
Sums core LEE pt .362**   .288   .302 .599** 
Sums core LEE cg   .500**    .644**  .121  .622** 
 
DISCUSSION 
In contrast to hypotheses 1 and 2, the co-occurrence of ADHD or ASD in addition to SUD 
was not significantly associated with greater caregiver burden or more expressed 
emotion when compared to the occurrence of SUD alone. Hypothesis 3, was also 
rejected: the patients' scores for perceived caregiver expressed emotion did not differ 
significantly from the caregivers' scores. Hypothesis 4 was confirmed: The LEE scores 
from the perspectives of both the patients and the caregivers significantly correlated 
with the IEQ sum scores for caregiver burden. The caregivers for patients with only SUD 
showed higher (although not significantly higher) levels of caregiver burden but also 
expressed emotion when compared to the caregivers for patients with SUD and a co-
morbid ASD. This difference was found to be explained by the relatively higher number 
of weekly contact hours for particularly the SUD alone group. 
 
More contact hours between caregiver and patient appear to be associated with higher 
levels of caregiver burden (IEQ sum scores), higher levels of perceived stress on the 
part of caregivers (GHQ distressed scores) and greater perceptions of expressed 
caregiver emotion (LEE scores from both the perspectives of the patients and the 
caregivers themselves).  
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The finding of a significant role for the amount of caregiver/patient contact is 
consistent with findings for the caregivers of patients with schizophrenia and 
dementia44-46. 
 
When the results for the IEQ in the present study are compared to the results of studies 
examining populations of patients with a bipolar disorder3 or schizophrenia12, the 
burden for the caregivers of patients with SUD —either with or without a co-morbid ASD 
or ADHD— is found to be similar or even worse than the burden for caregivers of 
patients with a bipolar disorder or schizophrenia. 
 
The remaining question to be answered —of course— is just why the caregivers for 
patients with only SUD spend more time with their patients than the caregivers for 
patients with SUD and a co-morbid ADHD or ASD. A potential explanation is that the 
caregivers for patients with SUD and a co-morbid ADHD or ASD were already caring for 
these patients prior to the SUD (i.e. addiction). This care has perhaps occurred since 
childhood and the problems associated with the ADHD or ASD thus become a normal 
part of the caregivers life with strategies developed to deal with the burden of these 
problems and prevent stress, which may include reducing the intensity of the contact 
at times and the reduction of the total number of contact hours. For patients with only 
SUD, such a process is less likely to have taken place because the problems most likely 
started later in life.  
 
A possible explanation for the caregivers of patients with only SUD showing higher 
levels of caregiver burden and expressed emotion is that patients with SUD often are 
subject to the social phenomenon that addiction is presumed to be due to a person 
being weak-willed rather than being ill, thus resulting in engagement with less 
compassion. This concept of disease considers SUD to be a patient's choice instead of 
illness, and thus something which can be controlled by the patient him/herself. In 
contrast, a psychiatric disorder (in this case a co-morbid ADHD or ASD) is considered 
fate/illness, and thus something which cannot be controlled. This social conception of 
disease can presumably influence scores on the IEQ, GHQ and LEE: increase scores for 
patients with only SUD and decrease scores for patients with SUD and a co-morbid 
ADHD or ASD. A similar effect has been reported in the work of Kronenberg et al.25 
where SUD+ADHD and SUD+ASD patients reported that their caregivers became more 
involved and less reproachful once they were also diagnosed with ADHD or ASD. This is 
also a possible explanation for the finding in the present study of no significant 
correlations between caregiver burden (IEQ) and perceptions of expressed emotion 
(LEE) for the SUD+ASD group.  
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Finally, it is certainly possible that SUD patients may just be more "claiming": the 
substance use is persistently demanding the attention in their relationships with 
caregivers. This explanation is supported by: the higher perceptions of expressed 
emotion for the caregivers in the SUD group; the strong correlations between the IEQ 
scores (caregiver burden) and LEE scores (expressed emotion) for this group; and the 
high GHQ scores (distressed caregivers) for this group.  
 
Strengths and limitations of the present study 
To our knowledge, this is the first study to compare caregiver burden in SUD patients 
with and without co-morbid ADHD or ASD. The findings must nevertheless be 
interpreted with caution for a number of reasons. To start with, only 60 of the 122 
patients we approached had caregivers who were willing to participate in the present 
study. When the clinical profiles of the participants were compared to those for the 
total group of 122 patients, the profiles were found to be very similar, which suggests 
that the external validity of the current findings is likely to be good. The 
generalizability of the conclusions with regard to other caregivers needs to be checked, 
however. Second, the sample size was limited. The power of the study was therefore 
restricted, and the possibility of type II errors cannot be excluded. In order to address 
this risk, we used a lenient threshold for statistical significance (p<0.10) and did not 
correct for multiple testing. This means that the findings of the present study must be 
replicated using another, larger sample. Third, the data were obtained using self-report 
questionnaires. When replicating the study in future research, it is therefore 
recommended that in-depth interviews also be conducted with informal caregivers. 
Also, it is recommended to conduct qualitative research using grounded theory. The 
results of a grounded theory project could allow to build a richer narrative that would 
yield a constructive, conceptual framework that would allow for the generation of 
further more targeted hypotheses. Finally, the design of the present study was cross 
sectional. Causal conclusion therefore cannot be drawn and longitudinal research might 
therefore be undertaken in the future. 
 
Clinical implications 
Considering the importance of informal caregivers as partners in the care for patients 
with psychiatric disorders and the relatively high burden of caring for patients with SUD 
and possibly co-morbid ADHD or ASD, clinicians should take this burden into account. 
The results of this study show that the number of contact hours between patient and 
caregiver may be a simple and straightforward indicator of caregiver burden. 
Assessment of expressed emotion and the number of weekly contact hours with 
informal caregivers can therefore be recommended to quickly identify caregivers who 
are vulnerable and thus at a high risk for psychological problems themselves. The LEE is 
easy to administer and, according to the results of this study, the presence of the 
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informal caregiver is not necessarily needed; administration to the patient may provide 
accurate and sufficient information. In the future, the expressed emotion of caregivers 
may be decreased with the use of motivational interviewing and the training of 
interaction skills to improve their strategies47. The number of contact hours with a 
patient might also be decreased for individual caregivers and/or the number of 
informal caregivers increased and, in such a manner, the burden on caregivers for the 
mentally ill be kept to a minimum.  
 
 
5 
88 Chapter 5 
REFERENCES 
1.  Platt S. Measuring the burden of psychiatric illness on the family: an evaluation of some rating 
scales. Psychol Med 1985;15:(2):383-93. 
2.  Yarrow MR, Schwartz CG, Murphy HS, et al. The Psychological Meaning of Mental Illness in the 
Family. J Soc Issues 1955;11(4):12-24. 
3.  Goossens PJJ, van Wijngaarden B, Knoppert-van der Klein EAM, et al. Family Caregiving in Bipolar 
Disorder: Caregiver Consequences, Caregiver Coping Styles, and Caregiver Distress. Int J Soc 
Psychiatry 2008;54(4):303–16. 
4.  Feinberg l, Reinhard SC, Houser A, et al. The Growing Contributions and Costs of Family 
Caregiving. AARP Public Policy Institute 2011, Valuing the Invaluable: 2011 Update. 
5.  Schulze B, Rossler W. Caregiver burden in mental illness: review of measurement, findings and 
interventions in 2004–2005. Curr Opin Psychiatry 2005;18(6):684–91. 
6.  Riebschleger J, Scheid J, Luz C, et al. How are the Experiences and Needs of Families of 
Individuals with Mental Illness Reflected in Medical Education Guidelines. Acad Psychiatry 2008; 
32(2):119-26. 
7.  Caqueo-Urizar A, Gutiérrez-Maldonado J. Burden of care in families of patients with schizophrenia. 
Qual Life Res 2006;15(4):719-24. 
8.  Fadden G, Bebbington P, Kuipers L. The burden of care: the impact of functional psychiatric illness 
on the patient's family. Br J Psychiatry 1987;150:285-92. 
9.  Gutiérrez-Maldonado J, Caqueo-Urízar A, Kavanagh DJ. Burden of care and general health in 
families of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2005;40(11):899-904. 
10.  Hatfield AB, Lefley HP. Families of the mentally ill: Coping and adaptation. New York: Guilford 
Press, 1987. 
11.  Schene AH, Tessler RC, Gamache GM. Instruments measuring family or caregiver burden in severe 
mental illness. Soc Psychiatry Psychiatr Epidemiol 1994;29(5):228-40. 
12.  van Wijngaarden B. Consequences for caregivers of patients with severe mental illness: the 
development of the involvement evaluation questionnaire. Dissertation: Faculty of Medicine; 
University of Amsterdam. Enschede: PrintPartners Ipskamp, 2003. 
13.  Schene AH. Objective and subjective dimensions of family burden: towards an integrative 
framework for research. Soc Psychiatry Psychiatr Epidemiol 1990;25:289–97. 
14.  Barrowclough C, Ward J, Wearden A, et al. Expressed emotion and attributions in relatives of 
schizophrenia patients with and without substance misuse. Soc Psychiatry Psychiatr Epidemiol 
2005;40:884-91. 
15.  Kwekkeboom MH. De zorg blijft. Verslag van een onderzoek onder familieleden en andere relaties 
van mensen met (langdurige) psychische problemen [The care remains. Report of a research into 
family and other relations of people with (long-term) mental problems]. Den Haag: Sociaal en 
Cultureel Planbureau, 2000. 
16.  Möller–Leimkühler AM. Burden of relatives and predictors of burden. Baseline results from the 
Munich 5–year–follow–up study on relatives of first hospitalized patients with schizophrenia or 
depression.  Eur Arch Psychiatry Clin Neurosci 2005;255(4):223-31. 
17.  van Wijngaarden B, Koeter M, Knapp M, et al. Caring for people with depression or with 
schizophrenia: Are the consequences different? Psychiatry Res 2009;169(1):62–69. 
18.  Vaughn CE, Leff JP. Patterns of Emotional Response in Relatives of Schizophrenic Patients. 
Schizophr Bull 1981;7(1):43-44. 
19.  Vaughn CE, Leff JP. Expressed Emotion in Families; Its significance for mental illness. New York: 
The Guilford Press, 1985. 
20.  Butzlaff RL, Hooley JM. Expressed Emotion and Psychiatric Relapse A Meta-analysis. Arch Gen 
Psychiatry 1998; 55:547-52.  
21. Jacobi F, Wittchen HU, Hölting C, et al. Prevalence, comorbidity and correlates of mental 
disorders in the general population: results from the German Health Interview and Examination 
Survey (GHS). Psychol Med 2004;34:597-611. 
22. Kessler RC, Berglund P, Demler O, et al. Lifetime Prevalence and Age-of-Onset Distributions of 
DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 
62:593-602. 
23. Chan Y, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing 
problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse 
Treat 2008;34:14-24. 
 Burden and expressed emotion of caregivers in cases of adult substance use disorder 89 
24. van Emmerik-van Oortmerssen K, van de Glind G, van den Brink B, et al. Prevalence of attention-
deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-
regression analysis. Drug Alcohol Depend 2012;122:11-19. 
25.  Hofvander B, Delorme R, Chaste P, et al. Psychiatric and psychosocial problems in adults with 
normal-intelligence autism spectrum disorders. BMC Psychiatry 2009;9:35. 
26.  Lugnegard T, Hallerback MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical 
diagnosis of Asperger syndrome. Res Dev Disabil 2011;32:1910-17. 
27.  Singh SKB, Hellemans H, Dom G. Autism spectrum disorder and substance use disorder: an unknown 
comorbidity? (Article in Dutch: Autismespectrumstoornis en verslaving: een onbekende 
comorbiditeit?). Tijdschrift voor Psychiatrie 2012;54(10):893-97. 
28.  Sizoo B, van den Brink W, Koeter M, et al. Treatment seeking adults with autism or ADHD and co-
morbid substance use disorder: prevalence, risk factors and functional disability. Drug Alcohol 
Depend 2010;107:44-50. 
29.  Smith LN, Jedynak JP, Fontenot MR, et al. Fragile X Mental retardation protein regulates synaptic 
and behavioral plasticity to repeated cocaine administration. Neuron 2014;82(3):645-58. 
30.  Heflinger CA, Brannan AM. Differences in the Experience of Caregiver Strain Between Families 
Caring for Youth with Substance Use Disorders and Families of Youth with Mental Health Problems. 
J Child Adolesc Subst Abuse 2006;15(3):83-104. 
31.  Cleary M, Hunt GE, Matheson S, et al. The Association Between Substance Use and the Needs of 
Patients With Psychiatric Disorder, Levels of Anxiety, and Caregiving Burden. Arch Psychiatr Nurs 
2008;22(6):375–85. 
32.  Werner S, Shulman C. Subjective well-being among family caregivers of individuals with 
developmental disabilities: the role of affiliate stigma and psychosocial moderating variables. Res 
Dev Disabil 2013;34(11):4103-14. 
33.  Cadman T, Eklund H, Howley D, et al. Caregiver Burden as People With Autism Spectrum Disorder 
and Attention-Deficit/Hyperactivity Disorder Transition into Adolescence and Adulthood in the 
United Kingdom. J Am Acad Child Adolesc Psychiatry 2012;51(9):879-88. 
34.  Kronenberg LM, Goossens PJ, van Etten DM, et al. Need for Care and Life Satisfaction in Adult 
Substance Use Disorder Patients With and Without Attention Deficit Hyperactivity Disorder (ADHD) 
or Autism Spectrum Disorder (ASD). Perspect Psychiatr Care 2015;51(1):4-15. 
35.  van Wijngaarden B, Schene AH. Involvement Evaluation Questionnaire. European version; 1997.    
36.  Goldberg D, Williams P. A user’s guide to the General Health Questionnaire. Windsor: NFER-Nelson, 
1988. 
37.  Stam H, Cuijpers P. Effects of family interventions on burden of relatives of psychiatric patients in 
the Netherlands: A pilot study. Community Ment Health J 2001;37:179-87. 
38.  Geurtsen GJ, Meijer R, van Heugten CM, et al. Experienced emotional burden in caregivers: 
psychometric properties of the Involvement Evaluation Questionnaire in caregivers of brain injured 
patients. Clin Rehabil 2010;24:935–43. 
39.  Gerlsma C, van der Lubbe PM, van Nieuwenhuizen C. Factor analysis of the level of expressed 
emotion scale, a questionnaire intended to measure perceived expressed emotion. Br J Psychiatry 
1992;160:385-89. 
40.  Cole JD, Kazarian SS. The level of expressed emotion scale: a new measure of expressed emotion. 
J Clin Psychol 1988;44(3):392-97. 
41.  Gerlsma C, Hale WW 3rd: Predictive Power and Construct Validity of the Level of Expressed 
Emotion (LEE) Scale: Depressed Out-patients and Couples from the General Community. Br J 
Psychiatry 1997;170(6):520-25. 
42.  Nelis SM, Rae G, Liddell C. The level of expressed emotion scale: A useful measure of expressed 
emotion in adolescents? J Adolesc 2010;34(2):311-18. 
43.  Cohen J: Statistical Power Analyses for the Behavioral Sciences 2nd ed. Hillsdale, New Jersey: 
Lawrence Erlbaum Associates, 1988.  
44.  Lauber C, Keller C, Eichenberger A, et al. Family burden during exacerbation of schizophrenia: 
quantification and determinants of additional costs. Int J Soc Psychiatry 2005;51(3):259-64. 
45.  Scazufca M, Kuipers E. Stability of expressed emotion in relatives of those with schizophrenia and 
its relationship with burden of care and perception of patients' social functioning. Psychol Med 
1998;28(2):453-61. 
46.  Ulstein I, Bruun Wyller T, Engedal K. The relative stress scale, a useful instrument to identify 
various aspects of carer burden in dementia? Int J Geriatr Psychiatry 2007;22(1):61-67. 
5 
90 Chapter 5 
47.  Smeerdijk M, Keet R, Dekker N, et al. Motivational interviewing and interaction skills training for 
parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized 
controlled trial. Psychol Med 2012;42(8):1627-36. 
 
  
 
Chapter 6 
 
Personal recovery in individuals diagnosed with 
substance use disorder (SUD) and co-occurring 
attention deficit/hyperactivity disorder (ADHD) or 
autism spectrum disorder (ASD) 
 
 
 
 
 
 
 
Linda Kronenberg 
Roeliene Verkerk-Tamminga 
Peter Goossens 
Wim van den Brink 
Theo van Achterberg 
 
 
 
 
 
 
 
 
 
 
Archives of Psychiatric Nursing 2015;29:242–248. 
 
92 Chapter 6 
ABSTRACT  
The process of personal recovery in people diagnosed with substance use disorder and 
comorbid attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder 
(ASD) was mapped. Four general themes representing four consecutive stages in the 
recovery process were identified in both patient groups: (1) crisis and diagnosis; (2) 
dealing with agitation, symptoms, and burden; (3) reorganization of life; and (4) 
meaningful life. However, the personal recovery outcomes and the need for support 
was different for the two patients groups. Based on these findings, mental health 
nurses can offer recovery supporting care tailored to the challenging needs of these 
patients. For the SUD+ADHD group, overall, a coaching attitude is preferred. For the 
SUD+ASD group, overall, instructional, supportive and directive attitude is needed. 
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INTRODUCTION 
The majority of people diagnosed with a substance use disorder (SUD) have other 
psychiatric disorders as well and therefore belong to the group of dual diagnosis 
patients1. About half of patients with severe and persistent psychiatric disorders are 
conversely diagnosed with a SUD2-4. "Dual diagnosis" is a general term used for people 
diagnosed with SUD and another psychiatric disorder5. And in a recent review, Gagne et 
al.6 concluded that clinical recovery in dual diagnosis patients is rare. According to 
Slade7, however, long term benefits can be obtained when so-called "personal recovery 
strategies" are introduced into the system of treatment for patients with psychiatric 
disorders. "Personal recovery" is defined by Anthony (1993) as: a deep personal, unique 
process of changing one's attitudes, values, feelings, goals, skills and roles. Stated 
differently, "personal recovery" entails discovering a way of life that is satisfying, 
hopeful, and contributing despite the limitations imposed by illness. "Personal 
recovery" means the development of new meaning and a new purpose for life, i.e. 
meaning and purpose beyond the catastrophic effects of the illness8. 
 
Personal recovery is the newly described goal of mental health policy in many 
countries, including the Netherlands9-11. In the present study, the personal recovery of 
a specific group of dual diagnosis patients is therefore mapped: adult patients with a 
diagnosis of SUD in addition to an attention deficit/hyperactivity disorder (ADHD) or 
autism spectrum disorder (ASD). Both ADHD and ASD develop early in childhood and can 
subsequently lead to major problems in many domains of adult life12,13. The prevalence 
of adults diagnosed with ADHD in the general population is approximately 2.5%14,15. And 
in a recent meta-analysis, 23% of treatment-seeking adults diagnosed with a SUD were 
also found to meet the diagnostic criteria for ADHD16. Data are as yet unavailable on 
the prevalence of ASD among people diagnosed with a SUD although clinical practice 
suggests that SUD and ASD frequently co-occur17. In the Netherlands, Van de Glind et 
al.18 have developed a protocol for the treatment of patients with a SUD and co-
occurring ADHD. And more recently, Matthys et al.19 published an evidence-based 
guideline for the treatment of such a dual disorder (SUD+ADHD) in Belgium. However, 
in both documents, the personal recovery of patients and thus questions about meaning 
and fulfillment are not addressed.  
 
A better understanding of the process of personal recovery in patients with psychiatric 
disorders and particularly disorders with low rates of clinical recovery is thus merited. 
A qualitative study of the personal recovery of patients with a SUD and comorbid ADHD 
or ASD was therefore undertaken to identify the main elements in the process of 
recovery and thereby better understand not only the coping of patients with psychiatric 
disorders but also their care needs. The distinction between groups with co-occuring 
ADHD and co-occuring ASD is based on a recent study about the care needs of SUD 
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patients with or without co-occuring diagnosis of ADHD or ASD, showing substantial 
differences in needs for care between these diagnostic groups20. Also, a recent study 
into the everyday life consequences of illness of these patient groups showed that, 
although the consequences are the same, the underlying mechanisms appear to differ 
for both groups21. Therefore it is expected that the process of personal recovery will 
also show differences between these patient groups.   
 
METHODS 
Study design and procedure 
A qualitative approach, drawing upon the principles of grounded theory was chosen for 
data collection, data analysis and theory development regarding the process of 
personal recovery. Individual experiences of patients were assembled to attain a 
general description of the process of personal recovery. Open, in-depth, semi-
structured interviews were conducted with questions about the ways in which patients 
grow towards personal recovery.  
 
Participants and selection criteria 
Participants were recruited by professionals working at a dual diagnosis, outpatient, 
treatment facility in the Netherlands. All of the clinicians were informed about the 
notion of personal recovery as defined and illustrated by Anthony7. The clinicians were 
then asked to consider their normal caseloads and select patients who would be able to 
talk about the process of personal recovery. Inclusion criteria were: outpatient 
treatment for SUD; age 18-65; estimated IQ >80; current DSM-IV diagnosis of SUD; 
current DSM-IV diagnosis of ADHD or ASD; mastery of the Dutch language; and currently 
in the process of recovering according to patient and clinician. Exclusion criteria were: 
chronic somatic complaints not directly related to SUD. 
 
A total of 43 patients received a letter describing the purpose of the study. A week 
later, they were approached by phone. For the 31 patients who could be reached (see 
Figure 1), the purpose of the study was again described to them and the concept of 
personal recovery introduced. In the same phone call, the patient was asked if they 
would be willing and able to talk about their personal recovery process. When the 
patient agreed to do this, an interview was scheduled. Following each interview, we 
checked —  with the consent of the patient — the diagnoses provided in their medical 
records. A total of 9 patients diagnosed with SUD+ADHD and 12 diagnosed with SUD+ASD 
agreed to be interviewed (see Figure 1). 
 
Data collection and Interview topics 
The in-depth interviews were conducted using a list of topics that address the most 
common elements of recovery as identified by Davidson22: renewing hope and 
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group-specific themes. The results of this final analysis were summarized and sent to 
the participants for feedback and validation. Only one participant coming from the 
SUD+ASD group provided feedback: the descriptions were "very thorough and very 
recognizable". 
 
FINDINGS 
Sample characteristics 
Table 1 shows mostly male participants in both groups. The age, income, education, 
and type of treatment for the patients were very similar for the two groups. However, 
the living conditions of the two groups of patients clearly differed and the period of 
addiction was almost twice as long for those patients diagnosed with SUD+ADHD as for 
those diagnosed with SUD+ASD. However, all of the SUD+ADHD respondents were sober 
at the time of the interview while 50% of the SUD+ASD patients were not.  
 
Table 1. Sample characteristics (n=21) 
 
 SUD+ADHD SUD+ASD 
N 9 12 
Demographics   
Male 8 11 
Female 1 1 
Age   mean(range) 36 (29-57) 40 (27-54) 
Living   
 Alone 1 5 
 With partner 1 3 
 With partner and children 5 1 
 With children only 2 - 
 Sheltered environment - 3 
Income   
 Employed 2 - 
 Unemployed social welfare  7 11 
 Other - 1 
Highest education   
 Primal school - 2 
 Middle School 3 6 
 High school 6 2 
 College/University 3 2 
Substance of abuse (more than 3 years)   
 Alcohol 3 8 
 Cannabis 1 4 
 Alcohol + cannabis 1 - 
 Gambling 2 - 
 Variety of substances (>3) 2 - 
Type of treatment   
 Inpatient detoxification 7 11 
 Outpatient drug free treatment 1 1 
 Otherwise 1 - 
Abstinent 9 6 
Period of addiction   mean/years 22.5 13 
Period sober   mean/years 4.75 5 
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Stages in the recovery process 
Using an inductive approach with an interactive exchange of concept development and 
data checking, we identified four general themes representing four consecutive stages 
in the recovery process could be identified: (1) crisis and diagnosis; (2) dealing with 
agitation, symptoms, and burden; (3) reorganization of life; and (4) meaningful life. 
The general themes and stages were the same for the two groups of patients. However, 
the personal recovery process and outcomes clearly differed for the two groups. First 
we describe the findings that were used for concept generation (stages of recovery) 
and these are followed by our findings on the recovery outcomes (condition of the 
patients at the end of each stage) for the two groups separately. Where relevant, 
illustrative quotations are provided.  
 
Stage 1: Crisis and diagnosis: serious disorganization of life and getting diagnosed 
 
Concept generation 
Patients from both groups mentioned suffering most from jumbled thoughts and 
emotions. They report feeling "caught" in the jumble of thoughts/emotions that they 
experience and thus feeling like their life has been "put on hold". They all report 
thinking that the jumble of thoughts and emotions has led, and still leads, to substance 
use, substance abuse, and SUD. In combination with other mental health problems, SUD 
is further perceived to give rise to a crisis that nevertheless leads to the start of 
treatment. All of the respondents reported being diagnosed during the hospitalization 
and to be the start of personal recovery in part because they finally felt recognized.  
 
They told me I have ADHD…. Knowing that, when they actually told me so, 
that took a weight off my shoulders. It made me realize, damn yeah, that's 
it, that's right. And that eased things up for me. [7 SUD+ADHD, male age 57] 
 
Recovery outcome for the two groups of patients 
The respondents diagnosed with SUD+ADHD report clearly experiencing the crisis 
themselves. Their lives are reported to become a mess. And although they consider 
hospitalization for treatment most unpleasant, they nevertheless recognize that it is 
necessary to bring about changes. They mainly experience hospitalization as being put 
to a hold, which brings them to a tipping point for life change. The hospitalization gives 
them a diagnose and the opportunity to look at what they want and which behaviors 
should be changed to attain this.  
 
Here I go, eight days, not a day more, and then we go for it ....To get my 
hands off that booze and get my life together.  [2  SUD+ADHD, male age 47] 
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Those respondents diagnosed with SUD+ASD indicate that they experience a lot of 
stress as a result of which they are not able to live a "normal" life. However, they do 
not experience the crisis themselves. They perceive the system (i.e., society) to be in 
crisis. They thus experience hospitalization as dreadful, but nevertheless go through 
with it on the assumption that it will somehow prove beneficial. Getting diagnosed can 
be a starting point for accepting their illness. This patient group holds the opinion that 
their surroundings, because of being acquainted with their diagnosis, have to accept 
that they do things in a different way.  
 
Okay, I've been down in the dumps. Tried to solve things with alcohol, so 
um....That's no fun. Spent the past half year in bed so tired, my body was 
done.... My family, my brothers, they noticed: He's not going to get on his 
feet by himself. He needs help. And that’s how things got moving. That's 
how I ended up here, in detox.  [5 SUD+ASD, male age 47] 
 
Stage 2: Dealing with agitation, symptoms, and burden: understanding the 
consequences of the illness causes feelings of doubt, powerlessness, distress and 
anger 
 
Concept generation 
All of the respondents stated that it was a pity that their ADHD or ASD problem had not 
been diagnosed earlier. Related to this the respondents describe feelings of sadness 
and anger. Realizing their illness is chronic and therefore, for example, they will not be 
able to work (so well) anymore or questioning themselves if they ever will get into a 
partner relationship makes them feel sad and insecure. 
 
Sometime you will break down. I have pulled myself out of the gutter, 
I have quitted my own company, I divorced, and then….  I just stopped. 
I just quitted, I just could not do it any longer. [7 SUD+ADHD] 
 
Recovery outcome for the two groups of patients 
The SUD+ADHD patients report feeling that they would have "lost" less, and that they 
would not have gotten into so much trouble if they would have been diagnosed earlier 
in life. Realizing this makes them angry and sad. Furthermore, they report that they 
had to re-invent how to live their live and how to re-establish relations. They 
experience the process of recovery as a painful struggle.  
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Yes, it was hard to get into conversation again. Before it was: I will just hit 
the bottle, I will just go couch surfing and see you later everybody. Striking 
up a conversation with someone, that was out of the question. So, entering 
into conversation with someone is still complicated for me. [3 SUD+ADHD] 
 
In the SUD+ADHD group, being diagnosed with ADHD and starting on medication was 
reported to reduce agitation. Medication also helped these patients to stay abstinent, 
get some peace of mind, sleep better, experience less anxiety, and experience less 
stress. All of this helped them to handle the symptoms and to structure their live.  
 
Ritalin gave me peace of mind, structure. Yeah, um, it's kind of doing the 
same things as the drugs. Only it doesn’t make me hazy. [9 SUD+ADHD, 
female age 33] 
 
The SUD+ASD patients mainly report that if their family and friends had known about 
the ASD earlier, they might have been more supportive… 
 
I was able to explain why, in my opinion, I did things the way I did……. so 
now the bond with my family is much stronger than it used to be. [8 
SUD+ASD, male age 41] 
 
In the SUD+ASD group, the struggle to handle jumbled thoughts and emotions remains, 
even with medication, and is reported to make them feel that they have little or no 
possibilities for participating in society. This raises feelings of powerlessness and 
insecurity. Their medication does not, in their opinion, sufficiently address their 
agitation, restlessness and anxiety. And even when a lower level of agitation is 
achieved, many of them still report feeling like there is no room in their head to 
contemplate taking part in society and this makes them feel sad.  
 
Those thoughts of mine…I often think that I'd like to do a control-alt-delete 
on my brain, just to stop the thoughts once in a while. I want to get rid of 
them. There is too much going on in my head. [2 SUD+ASD, male age 54] 
 
For people diagnosed with SUD+ASD, insight is needed into just how the ASD affects 
their daily lives. What causes agitation? Insight can be gained into these issues by going 
over the past week with a counselor, who can also then help with the development of a 
relapse prevention plan and guide patients with the anticipation and prevention of 
problems. 
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All of the respondents diagnosed with SUD+ADHD stated that it was their goal to never 
use again. Substance use was no longer an option for them because they knew that it 
would disrupt their lives. Quitting and staying abstinent was something that they felt 
they had to do all by themselves and thus by sheer force of will. For some of these 
respondents, the struggle continued to be a day-to-day issue; for others, it had already 
moved into the background of their lives.  
 
The big issue is: This cannot happen again. Then everything will go wrong 
and then I'll be at the Herberg [shelter for the homeless] or even worse. 
[3 SUD+ADHD, male age 57] 
 
Only six of the twelve respondents diagnosed with SUD+ASD reported being interested 
in total abstinence. The other 6 saw controlled substance use as something that can 
help them to take part in social activities and personal interactions. They report 
thinking that controlled substance use makes it easier for them to socially interact by 
helping them stay focused, regulating agitation, reducing restlessness, and allowing 
them to relax. They emphasize that it has to be controlled substance use as only that 
can help them settle down. Four of the six SUD+ASD patients opting for total 
abstinence stated that they were doing worse without their substance use and that 
they experienced their personal recovery as not being very successful.  
 
I felt more comfortable when I used. I know that it may sound funny, but I 
felt good. When I was still using, I was able to go to birthday parties. I didn't 
mind those when I was still using. The agitation, that's the hardest for me. 
[11 SUD+ASD, male age 43] 
 
Stage 3: Reorganization of life: picking up daily life again within the capabilities of 
their chronic disease 
 
Concept generation 
All respondents said that they want a normal life with daytime activities and social 
relations. Respondents who stopped using substances also had to fill the gap in their 
daily activities. They indicate that structure helps them function better. Structure 
prevents them from slipping into past behaviors. Daytime activities provide structure 
but also distraction along with a goal in life, which helps them calm down. 
 
Recovery outcome for the two groups of patients 
SUD+ADHD patients reported still feeling addicted even though they had stopped using 
drugs or alcohol. Their primary goal is to restore their relations. They are still learning 
to accept their limitations. They state that the counselors are helping them define new 
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goals, which they further report to bring them hope. They are thinking about the role 
they want to play in social relationships (e.g., as friend, partner, parent) and recognize 
that family can be a reason to stop using, that being frank about their problems can 
generate support, and that sharing activities and talking can improve social 
relationships. However, maintaining relationships is experienced as tough and to take a 
lot of energy. Some report children bringing considerable agitation but still wanting to 
take responsibility as a parent. 
 
I am trying hard to be a father again …… by keeping my hands off the booze 
and playing a more active role …… and being involved more with the 
children. [2 SUD+ADHD, male age 47] 
 
The SUD+ADHD patients accept that personal recovery is a process with unpredictable 
outcomes, and they acknowledge that they can have an off-day now and then. But they 
are now confident that the off- days will pass — without relapse. 
 
In the past, when you really felt bad, it [substance use] was the solution to 
get rid of that feeling. Now, when I'm having a really rough time, I have 
other ways to handle things….knowing that the feeling will be gone when I 
wake up in the morning. [5  SUD+ADHD, male age 44] 
 
The SUD+ASD patients report feeling different from others. They want to live a "normal" 
life and thereby reduce their agitation. The desire to live a normal life motivates them 
to reorganize their lives although they tend to become preoccupied with thoughts 
about how to do this. They would like answers from clinicians or caregivers on how they 
can best arrange and to fill their lives. Having a clear picture of what to do allows them 
to relax.  
 
This is the kind of question I would ask my counselor, for I think it's much 
better to consult her about it. Like, this is what I’m up to, how to get 
there, what's the best thing to do. That’s what the counselor always does, 
she just leads me. That's what you need in a counselor. ….I cannot picture 
my future… for me it's better to ask others. [9 SUD+ASD, male age 33] 
 
Many of the SUD+ASD patients want a genuine relationship but find it difficult to 
initiate and maintain one as this requires a lot of energy. SUD+ASD patients perceive 
their role as partner or parent as quite difficult. Some say that they can no longer take 
the responsibility or no longer want to do this because taking care of themselves is 
difficult enough.  
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I'm not able to have them [the children] in my home, not even for the 
weekend, that wears me out. For the moment, that is. Maybe this will 
change, I don’t know. But I’m not able to….. Okay, have them stay over 
every now and then, but that alone takes so much energy. [5 SUD+ASD, male 
age 47] 
 
When SUD+ASD patients manage to get involved in activities that bring them into 
contact with society, its rules, and its customs, they report decreased agitation and —
at the same time— increased self-confidence and motivation to fill their lives in other 
domains.  
 
I've joined a group for medieval crafts, and that occupies a great deal of my 
thoughts. Thinking about what has to be done now, what will be our next 
event. [4 SUD+ASD, male age 31]  
 
Nevertheless, the majority of SUD+ASD patients who managed to arrange daytime 
activities for themselves report continued substance use. For people with SUD+ASD, 
filling the day is the most important task because periods without activity result in 
fretting and ultimately agitation.  
 
If I haven't planned anything at all for, let's say, the next three days. I then 
run the risk of drinking more. Then I’m not able to distinguish one day from 
another anymore, and I get stuck in my thoughts, not doing anything 
anymore. To me, planning is an absolute necessity. [8 SUD+ASD, male age 
41] 
 
Stage 4: Meaningful Life: experience quality of live 
 
Concept generation 
All respondents said that they want to live a worthwhile life. They want to feel 
satisfied with the life they live and somehow make a valuable contribution to society.  
 
Recovery outcome for the two groups of patients 
The SUD+ADHD patients relate that their self-knowledge has increased and, because of 
that, they know better what to expect of themselves. Knowing that a life without 
substance use is possible gives them hope and renewed motivation to see what life has 
to offer. The patients with SUD+ADHD report taking pride in how they have managed to 
reorganize their lives and have a satisfying life. 
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A life with ADHD doesn't have to be painful, as long as you're able to see the 
bright side. That's extremely important, having a positive attitude towards 
life, believing that you can. [3 SUD+ADHD, male age 57]  
 
Those SUD+ASD patients who successfully arrange daytime activities for themselves also 
become motivated to reorganize other domains of their lives. This, in turn, is reported 
to make their lives much more bearable and worthwhile although they still report 
experiencing life as quite difficult and struggling to survive. 
 
A calm life, peace and quiet in my head, a steady basis. For a large part, my 
life is quiet. There is peace in my head. And there is a stable base. A large 
part of me has settled down but not all of me. [4 SUD+ASD, male age 31]  
 
DISCUSSION   
The results of our qualitative, interview study shows the process of personal recovery 
to be the same for two groups of patients with dual-diagnoses: Four general themes 
representing four consecutive stages in the personal recovery process were identified: 
(1) crisis and diagnosis; (2) dealing with agitation, symptoms, and burden; (3) 
reorganization of life; and (4) meaningful life.  
 
The recovery outcomes for both groups indicate that substance use has served the 
purpose in the past of stopping the jumble of thoughts and emotions in their heads. In 
the end, however, the substance use led to crisis and — finally  — treatment. For both 
groups, hospitalization was reported to be helpful but for different reasons: for the 
SUD+ADHD group, hospitalization represented a turning point in their lives; for the 
SUD+ASD group, hospitalization gave their surroundings a break. Getting diagnosed was 
nevertheless the start of personal recovery for both groups.  
 
For particularly people with a dual diagnosis of SUD+ADHD, medication allows them to 
put the thoughts and emotions in their heads on hold and then contemplate what they 
could and would like to do in life. They report being able to start work towards new 
goals more or less on their own. They describe a process of personal recovery in which 
they gain faith in their capabilities, gain hope, and gain pride.  
 
People with a dual diagnosis of SUD+ASD describe their personal recovery as an ongoing 
struggle. Some of them do not manage to attain peace of mind. They are therefore not 
yet ready to rearrange various domains of their lives to accommodate their illness and 
report dependence on clinicians or caregivers to think along with them and provide 
answers. They further report that controlled substance use is sometimes helpful for 
their social participation and thereby helpful for their personal recovery. The SUD+ASD 
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patients describe the process of personal recovery as a matter of surviving although 
their lives are also described as more bearable. 
 
The identified consecutive stages of recovery are a useful starting point for a theory 
about the process of personal recovery in patients with a SUD and some other comorbid 
psychiatric disorder. Future research is needed to test these concepts in other patient 
populations and other treatment settings. And how the stages of recovery are 
interrelate to each other. 
 
Leamy et al.10 have recently reviewed 15 studies addressing the stages of personal 
recovery and offered a synthesis based on the transtheoretical model of behavioral 
change23. The stages of personal recovery identified in the present study and those in 
other studies closely correspond: (1) overwhelmed by the disability (crisis and 
diagnosis); (2) struggling with the disability (dealing with agitation, symptoms, and 
burden); (3) living with the disability (reorganization of life); and (4) living beyond the 
disability (meaningful life). 
 
The aspects of personal recovery with the most relevance for clinical research and 
practice are: connection, hope, identity, meaning in life, and empowerment7,10. These 
aspects differed for the two groups in our study and may explain the group differences 
in process and outcome. The SUD+ADHD patients report acquiring more hope and 
greater faith in their capabilities during the course of personal recovery. They also 
become more active agents of change within their own lives. And according to 
Glickman et al.24 and Feigin & Sapir25, when patients perceive their own skills to 
contribute to behavioral change, they experience recovery as more intense. This was 
true of the SUD+ADHD group in the present study. More generally, Gagne et al.6 have 
found people with SUD+ADHD in recovery to be more active agents of change than 
passive recipients of services. 
 
In contrast, the SUD+ASD patients in our study experienced considerable difficulty with 
becoming a more active agent of change. Limited empowerment and hope continues to 
make them feel incapable of dealing with their symptoms, which makes personal 
recovery a difficult and complex process for them. It is likely that the difficulties of the 
SUD+ASD patients with social interaction and communication play a key role here. The 
organization and receipt of support from others is particularly difficult for these 
patients even though they report heavy reliance on support from others for finding 
activities and filling their lives. As Gagne et al.6 have pointed out, patients recovering 
from mental illness and/or addiction often mention that the support of family and 
peers clearly makes a difference in their recoveries. According to Slade et al. 7, 
moreover, being able to start, maintain, and develop social relations is a prerequisite 
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for many recovery activities. Without this, continued doubts, worries, and feelings of 
stagnation may occur, as found for the SUD+ASD group in our study. 
 
Strikingly, four of the six SUD+ASD patients who were abstinent reported finding the 
process of personal recovery quite laborious while only one of the six SUD+ASD patients 
who still used reported this to be the case. This pattern suggests that controlled 
substance use can be useful for the treatment/recovery of some SUD+ASD patients. The 
pattern also fits with the finding that patients with a dual history of SUD+ASD tend to 
show more social traits than patients with a history of only ASD and no SUD26. Future 
research is nevertheless needed to unravel this pattern further. 
 
Study strengths and limitations 
A strength of the present study is that the data were analyzed by two researchers to 
ensure the accuracy of the themes identified and the authenticity of the coding, which 
also adds to the reliability of the work. A further strength is the cyclic nature of the 
data collection and analyses. The attainment of data saturation showed our sample size 
to be adequate27. A final strength is the validation of the results by the patients 
themselves showed the outcomes of our analyses to be credible28. A possible limitation 
is the inclusion of only a few females; the generalizability of our results is thus 
restricted. Another possible limitation is that homeless patients or otherwise 
disenfranchised patients were not included in the study population; the recovery 
process for such patients may differ from that of our patients who had sufficient 
financial resources to meet their everyday needs.  
 
Clinical implications  
This study reflects the opinions of patients on their illness and provides useful 
directions for everyday practice of mental health nurses.  Although both the SUD+ADHD 
and SUD+ASD groups go through the process of recovery in their own distinctive way, a 
shared  pattern of personal recovery stages can be distinguished, which includes: (1) 
crisis and diagnosis; (2) dealing with agitation, symptoms, and burden; (3) 
reorganization of life; and (4) achieving a meaningful life. Mental health nurses can 
offer recovery supporting care tailored to the challenging needs of these patients. The 
SUD+ADHD group is in need of prompt diagnosis, early start of medication and support 
in becoming abstinent, accepting limitations and defining new goals for the future. 
Overall, a coaching attitude of the mental health nurse is preferred. The SUD+ASD 
group is in need for diagnosis, support in controlled substance use and the arrangement 
of daily activities. Counseling should be aimed at the patient achieving a better 
understanding of what ASD means for daily live. Overall, an instructional, supportive, 
but also directive attitude of the mental health nurse is welcomed. 
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CONCLUSIONS 
For people diagnosed with SUD+ADHD and people diagnosed with SUD+ASD, the 
processes of personal recovery follow very similar stages. However, their personal 
recovery outcomes are different. Renewed faith in the future is a common outcome in 
those with SUD+ADHD. In contrast, little more than a focus on surviving is found among 
the SUD+ASD group. A coaching attitude aimed at the attainment and maintenance of 
full abstinence is preferred by the SUD+ADHD patients, whereas an instructional and 
directive attitude aimed at either abstinence or controlled substance use but also 
increased activity is preferred by most SUD+ASD patients. 
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PREAMBLE 
The American economist and Nobel prize winner Paul Krugman wrote a column in The 
New York Times about the fact that the term "patient" was disappearing from common 
parlance. He stated: 'How did it become normal, or for that matter even acceptable, 
to refer to medical patients as "consumers"? The relationship between patient and 
doctor used to be considered something special, almost sacred. Now politicians and 
supposed reformers talk about the act of receiving care as if it were no different from 
a commercial transaction, like buying a car — and their only complaint is that it isn't 
commercial enough.'(New York Times, 21 April 2011). I fully agree with this statement 
and would like to add that most psychiatric patients are indeed not well-informed 
consumers that are always willing or able to shop around for suitable mental health 
care. Similarly, mental health care doctors and nurses are not sales people but, rather, 
care professionals. For these reasons, throughout this thesis those who suffer from a 
severe and often persistent mental illness will be referred to as "patients" and not 
"clients" or "customers". 
 
In the following, a brief summary of the main findings of my research will be presented 
and then discussed with regard to integrated treatment, the substance use dilemma 
and personal recovery. Then some methodological considerations will be discussed and 
the main conclusions from the findings of the research will be drawn. Finally, 
suggestions for future research and recommendations for mental health care and 
nursing practice will be presented.  
 
SUMMARY OF MAIN FINDINGS 
In order to develop evidence-based nursing interventions for use in mental health care 
in the future, first more knowledge of the specific needs of patients requiring mental 
health care or, within the context of the present thesis, the population of SUD patients 
either with or without a comorbid ADHD or ASD is needed. For the development of 
evidence-based nursing interventions, the six steps of the Intervention Mapping 
Protocol (IMP) can be used1. The research reported in this thesis is concerned with the 
first two steps from the protocol, namely (1) gaining insight into patient needs and 
their underlying determinants, and an orientation on (2) performance and change 
objectives.  
The other four steps of the IMP are (3) selection of theory-based intervention methods 
and practical applications to change; (4) production of program components, design 
and production; (5) anticipation of program adoption, implementation and 
sustainability; and (6) anticipation of process and effect evaluation. These were not 
directly addressed in this thesis, but could be informed by our results.  
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The first step of the IMP (Chapters 2, 3, 4 and 5) 
Chapter 2 showed the needs of SUD patients either with or without a comorbid 
diagnosis of ADHD or ASD to differ substantially. The needs of SUD patients without 
ADHD or ASD were primarily in the domains of alcohol, psychiatric health and 
unemployment. The needs of SUD patients with comorbid ADHD were also concentrated 
in the domains of alcohol/drug, psychiatric health and unemployment, but additional 
physical health and financial needs were common. The needs of SUD patients with co-
occurring ASD were even more extensive and more severe: Their needs encompassed 
the domains of alcohol, psychiatric health, unemployment, finances, family/social 
relations, daytime activity, looking after the home and sex life.  
 
When patient needs were analyzed in terms of the 22 living areas of the Camberwell 
Assessment of Needs, classified as reflecting (a) day-to-day needs, (b) mental health 
care needs, (c) rehabilitation needs or (d) facility needs2, SUD patients reported needs 
in only one area, namely mental health care needs. SUD+ADHD patients reported needs 
in two areas, namely mental health care needs and facility needs. In contrast, the 
SUD+ASD patients reported needs in all four areas. Furthermore, the study of patient 
needs showed that all patient groups had unmet needs and were clearly dissatisfied 
with specific domains of their existence. The differences between the groups with 
regard to their self-perceived quality of life were, however, strikingly small, 
particularly when compared to the group differences revealed by the objective 
assessments of their needs.  
 
In Chapter 3, a closer look was taken at patient needs and self-perceived life 
satisfaction in terms of the everyday life consequences of substance use among the 
adult SUD patients with a comorbid diagnosis of ADHD or ASD. Everyday life 
consequences of having a dual disorder were quite similar for the two dual diagnosis 
groups despite differences in the underlying mechanisms (i.e., impulsivity in SUD+ADHD 
vs. passivity in SUD+ASD): both patient groups reported getting caught in a vicious 
circle of mental disorder symptoms and substance use to deal with the symptoms. 
Thoughts and emotions led to an increase of symptoms (i.e., impulsiveness or 
passivity), which in turn led to less structure, which then led again to increased 
substance use resulting in even more jumbled thoughts and emotions. In the long run, 
SUD increased the symptoms of ADHD or ASD and thus interfered with self-
management. Both groups functioned better when sufficient structure was present, but 
substance use wiped out structure and thus brought the patient with a mental health 
disorder into a vicious circle of substance use and increasing lack of structure. To 
interrupt this vicious circle, the SUD+ADHD patients tried to stop their substance use. 
The SUD+ASD patients, in contrast, reported being unable to function socially without 
substance use and therefore typically continued with this. Substance use is reported by 
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SUD+ASD patients to suppress insecurity and overstimulation or oversensitivity; 
substance use made it easier to tune into other people and situations; and substance 
use helped them to focus and react during social interactions. In contrast to the 
SUD+ADHD patients, SUD+ASD patients tried to achieve an acceptable level of 
substance use - mostly with professional guidance. 
 
Given the finding that substance use was often used as a form of (unsuccessful) coping 
with the ADHD or ASD symptoms, it was decided to investigate the overall coping styles 
of patients with SUD, SUD+ADHD or SUD+ASD. In Chapter 4, the overall coping styles of 
the patients were compared to those of a general population sample. All patient groups 
were found to use a more palliative, avoidant and passive styles of coping than the 
general population sample when faced with unpleasant events or problems. In addition, 
SUD+ASD patients used markedly more passive coping and they had less reassuring 
thoughts than SUD and SUD+ADHD patients.  
 
In Chapter 5, the perceived burden and expressed emotion of informal caregivers for 
SUD patients either with or without a comorbid diagnosis of ADHD or ASD were 
examined. This was done because of the well-documented importance of informal 
caregivers as partners in the care for patients with mental health problems and similar 
opinions expressed by the patients in the present study. Perceived burden and 
expressed emotion on the part of informal caregivers were also examined in recognition 
of the fact that the care for individuals with mental health problems can give rise to 
psychological problems on the part of the caregivers as well. 
 
The results showed a comorbid diagnosis of ADHD or ASD was not associated with a 
significantly more caregiver burden or expressed emotion relative to caregiver burden 
and expressed emotion for patients with SUD only. Unexpectedly, the informal 
caregivers of patients with SUD only tended to have higher ‒ but not significantly higher 
‒ levels of caregiver burden and levels of expressed emotion than the caregivers for 
patients with SUD+ASD. The high number of weekly contact hours with SUD only 
patients appeared to contribute to the high level of caregiver burden and expressed 
emotion in this group. 
 
An orientation on the second step of the IMP (Chapter 6) 
In Chapter 6, the process of personal recovery of patients with SUD and a comorbid 
diagnosis of ADHD or ASD were analyzed as an orientation on the second step of the 
intervention mapping protocol (IMP). In general both groups described their recovery 
goals being: to be put on a hold, to get informed, to become and stay abstinent or to 
switch to controlled use, to be able to handle the symptoms of their illness and to 
accept the limitations that come along, to re-invent how to live/structure their life 
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including re-establishing (supportive) relationships and participating in society, to know 
how to prevent and anticipate on problems. Furthermore, the in-depth qualitative 
interviews showed the process of personal recovery to be similar for the two groups of 
dual diagnosis patients: Four general themes representing the four consecutive stages 
of the personal recovery process could be identified: (1) crisis and diagnosis; (2) dealing 
with agitation, symptoms and burden; (3) reorganization of one's life; and (4) creation 
of a meaningful life. 
 
The recovery outcomes for both groups showed substance use to serve the purpose of 
bringing the jumble of thoughts and emotions in the heads of the patients to a halt in 
the past. In due course, however, substance use led to crisis and finally a need for 
treatment. Both groups reported hospitalization to be helpful, but for different 
reasons. For SUD+ADHD patients, their hospitalization represented a turning point  in 
their lives. For SUD+ASD patients, their hospitalization created a time-out for their 
surroundings. Receiving the additional diagnosis was nevertheless the start for the 
personal process of recovery in both groups.  
 
Medication helped SUD+ADHD patients to bring the thoughts and emotions in their 
heads to a halt. This then enabled them to become abstinent and to contemplate what 
they could and would like to do with their lives. These patients further reported being 
able to work towards new goals more or less on their own. They described a process of 
personal recovery in which they regained faith in their capabilities, hope and even 
some pride. In contrast, SUD+ASD patients described their personal recovery as an 
ongoing struggle with some of them not being able to attain peace of mind. They were 
therefore not yet ready to rearrange various domains of their lives to accommodate 
their mental illness and reported needing clinicians or caregivers to think along with 
them and provide answers to many questions. They further reported a "need" for 
controlled substance use to help them with social participation and thereby help them 
with their recovery. Many SUD+ASD patients described the process of personal 
"recovery" as a matter of surviving although they do described their lives as more 
bearable than before. Personal recovery continued to be a difficult and complex 
process for these patients. Strikingly, four of the six SUD+ASD patients who were 
abstinent reported finding the process of personal recovery quite laborious while only 
one of the six SUD+ASD patients who still used alcohol reported this to be the case.  
 
DISCUSSION OF THE MAIN FINDINGS  
Integrated treatment 
The results of our study showed that both SUD+ADHD and SUD+ASD patients struggled 
with their illness although based on different underlying mechanisms (impulsivity vs. 
passivity) and with different recovery outcomes. This conclusion of overriding 
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similarities showed substance use/abuse to be intricately intertwined with the 
developmental courses of both ADHD and ASD. This suggests, in turn, that the dual 
disorders must be treated in an integrated manner. Both dual diagnosis groups got 
caught in a vicious circle of symptoms and substance use, creating problems in multiple 
life areas due to ineffective coping styles The starting point for the SUD must be 
identified and addressed (i.e., jumbled thoughts and emotions in both groups; 
impulsivity in the ADHD dual-diagnosis group; passivity in the ASD dual-diagnosis group; 
decreased structure in both groups) and treatment should address both disorders 
simultaneously. Otherwise, the SUD will continue to recur in conjunction with 
symptoms of ADHD or ASD and the vicious circle in which these dual-disorder patients 
are get caught never gets broken.  
 
Principles for the integrated treatment of SUD+ADHD have already been presented in 
the 2004 Protocol for ADHD in SUD3. According to this protocol, the first of the four 
phases for integrated treatment, however, requires abstinence to qualify for further 
treatment. This approach is also used by van Emmerik-van Oortmerssen et al.4,5 in their 
integrated cognitive behaviour therapy (ICBT) for patients with SUD+ADHD. In contrast, 
Mariani and Levin6 argue that the management of patients with co-occurring ADHD and 
SUD calls for a truly comprehensive approach in which symptom burden and functional 
impairment are assessed and the two conditions (i.e., ADHD and SUD) are ideally 
treated simultaneously; otherwise symptoms of ADHD (e.g., impulsivity, poor planning) 
will interfere with SUD treatment and, conversely, substance use will interfere with 
ADHD treatment. This is confirmed by the present research findings showing that 
patients with a dual diagnosis indeed get caught in a vicious circle of symptoms and 
misled attempts to cope with them and by the foregoing statement that breaking just 
one of the links in this vicious circle is not likely to interrupt the circle.  
 
The substance use dilemma 
With regard to the needs and change objectives of SUD+ADHD patients, the results of 
this study are clear: Their primary goal in treatment is abstinence. Both the SUD and 
ADHD should nevertheless be treated simultaneously. Only then can the vicious circle of 
ADHD symptoms and substance use to cope with them be broken. Most of the 
SUD+ADHD patients prefer full abstinence either with or without pharmacotherapy 
supplemented with cognitive behaviour therapy4,5.  
 
With regard to the needs and change objectives of SUD+ASD patients, the conclusions 
are more complicated. For example, our findings are at odds with the basic tenets for 
the mental health treatment for individuals with a dual diagnosis in the Netherlands 
(i.e. to achieve full abstinence)7. Many, if not most, of the existing addiction treatment 
services offer abstinence-oriented treatment only. However, these singular treatments 
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have been shown to result in relatively low abstinence rates in patients with alcohol 
problems8-10. The findings in this thesis suggest that controlled substance use may well 
be justified in at least some SUD+ASD patients. Not only did the patients with SUD+ASD 
report that the thought of initiating social contact and becoming more socially active 
makes them anxious and insecure, they also reported that substance use helped them 
to overcome their social fears and uncertainties. In fact, four of the six patients with 
SUD+ASD patients opting for complete abstinence in our study reported doing worse 
without substance use and were experiencing the process of personal recovery as quite 
laborious and not very successful. In contrast, only one of the six SUD+ASD patients that 
still used alcohol reported such setbacks. The complicated pattern of findings regarding 
the needs and change objectives of SUD+ASD patients in our study thus suggests that 
controlled substance use can be a useful treatment goal on the way to recovery for 
some of the patients of this particular patient group. Support for this conclusion is 
provided by Rosenthal et al.11 who conclude that SUD+ASD patients may be helped with 
reduced drinking (i.e., controlled substance use) to engage in social activities and 
thereby master the behavioural repertoire needed to participate in social activities. A 
review by van Amsterdam and van den Brink in 201312 provides further empirical 
support for this position. They conclude: (a) that reduced-risk drinking is a viable 
option for at least some problem and dependent drinkers; (b) that abstinence and non-
abstinence oriented treatments appear to be equally effective; and (c) that allowing 
patients to choose their treatment goal increases success rates. In the present study, 
SUD+ASD patients frequently mentioned feeling lonely, and searching for some 
perspective in life, recognizing that social contact is of great importance for their 
quality of life and knowing that social support is of vital importance for their personal 
recovery. According to the literature, social support correlates with psychiatric 
patients' quality of life while the ASD has not13, and social support has been shown to 
be a prerequisite for many recovery activities in psychiatry14. Addiction treatment 
services and mental health services should therefore accept the SUD+ASD patient's 
choice of controlled substance use as the primary treatment goal when aimed at 
helping them to improve their quality of life.  
 
Personal recovery: dampened expectations  
The definition of personal recovery as finding a way of living a satisfying, hopeful, and 
contributing life15-17 is now widely accepted in the field of mental health care. Personal 
recovery is also the central point for mental health policy in many countries today, 
including the Netherlands18-20. In a policy agreement on mental health in the 
Netherlands, for example, it is now explicitly stated that patients should be the 
directors (and managers, when possible,) of their personal health care and that 
(personal) recovery and supportive care should be the guiding principle in cases of SUD. 
The concept of recovery today encompasses more than just successful clinical 
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treatment21. Recovery also encompasses - for instance - the SUD patient to be able to 
regulate himself, to monitor his own mental functioning and to fulfil social roles. It is 
assumed that this broadened concept of recovery will lead to higher levels of patient 
autonomy by enhancing self-regulation.   
 
The most relevant aspects of personal recovery for clinical practice and research are 
connection, hope, identity, meaning in life, and empowerment (CHIME)14,19.  
We found a clear match between today’s concept of personal recovery and the needs 
of SUD+ADHD patients. These patients reported ongoing progress on the aspects of 
hope, identity, meaning in life and, especially, empowerment. On part of the 
connection aspect they reported some problems, but did not describe feelings of 
disconnectedness. They described the process of personal recovery as a process in 
which they gained confidence, optimism, pride and became more active agents of 
change within their own lives. Those who perceived themselves as being recovered also 
reported taking pride in how they managed to reorganize their lives, experiencing 
increased life satisfaction and feeling that they were contributing in life. 
 
In contrast, most of the SUD patients with a comorbid ASD diagnosis do not fit so well 
into the present definition of personal recovery. These patients reported ongoing 
problems on all CHIME aspects. The current study showed that they continued to 
experience life as stressful, despite treatment. They were still unable to live a "normal" 
life. The struggle to handle jumbled thoughts and emotions persisted. This struggle 
made them feel incompetent to participate in society. These patients continued to 
need guidance from clinicians and caregivers on how to arrange their live. In general, 
they described the process of personal recovery as an ongoing struggle and largely a 
matter of surviving; they perceived their lives as only becoming more bearable. 
 
The foregoing clarifies that most of the patients with a dual diagnosis of SUD+ASD in 
the present study do not meet the goals of personal recovery as outlined in theory and 
declared in policy statements in the Netherlands. Society has a strong belief in the 
possibilities for achieving personal recovery, which basically overlooks patients with a 
dual diagnosis of SUD+ASD and leaves them with a lifelong handicap. Social interaction 
and communication are key elements in the personal recovery of patients with mental 
illness but lacking in many patients with ASD or a dual diagnosis of SUD+ASD. Given that 
ASD is chronic, patients may be able to improve somewhat in the social domain but not 
enough to meet the goals of personal recovery as it is articulated today. For these 
patients, it remains difficult - if not impossible - to become the director of their own 
personal health care and to find a path to a satisfying, hopeful, meaningful and 
autonomous life. When informal caregivers, clinicians, society and even patients cling 
to the goals of personal recovery, the result may be increased frustration, problems 
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and disappointment. Counterproductive. Awareness and acceptance of the reality that 
not everybody can lead a fully satisfying, hopeful, meaningful and autonomous life 
must thus be promoted.  
 
SOME METHODOLOGICAL CONSIDERATIONS 
The present studies had both strengths and limitations. In the following, some general 
considerations related to the design, measurement and analyses will be discussed. 
  
The most important contribution of this study is that it is, to our knowledge, the first 
to examine the needs and life satisfaction of SUD patients with ADHD or ASD. The 
acquired knowledge provides a foundation for the development of an evidence-based 
nursing treatment for these two patient groups. A further strength of the study is that 
the population of patients studied was heterogeneous with regard to treatment phase, 
age and primary substance of abuse. The use of three as opposed to two patient groups 
in some of the studies (see Chapters 2, 4 and 6) provides, moreover, insight into the 
differences between SUD only versus SUD+ADHD or SUD+ASD patients. The use of a 
relatively well-matched reference group (see Chapter 4) highlighted the differences 
between the SUD+ADHD and SUD+ASD patients and the general population. Yet another 
strength is the involvement of two researchers in the conduct and analysis of the 
qualitative interviews because it increased reliability and credibility (see Chapter 3 and 
4). 
 
In addition to these strengths, the present study also has some limitations. Males were 
highly overrepresented among the three patients groups, and the incidence of co-
occurring mental health conditions aside from ADHD and ASD was not assessed. 
Although ADHD and ASD appear to frequently co-occur with each other22,23, DSM-IV does 
not allow a concurrent diagnosis of ADHD and ASD. In the present study, only nine 
patients were diagnosed with SUD and both ADHD and ASD. Because of small numbers 
they were excluded from the analyses. Furthermore, the relatively small sample sizes 
for some of the patient groups precluded correction for multiple comparisons in some 
of the chapters and therefore the possibility of false positive findings (i.e., type I 
errors) cannot be excluded. Replication of this research using larger patient samples is 
thus needed. The validity of self-report questionnaires with patients who have been 
diagnosed with SUD+ADHD or SUD+ASD has yet to be documented and is therefore 
highly recommended for future research. Finally, the collection of questionnaire data 
may not have been without problems. For example, the internal consistency of at least 
some of the UCL subscales was relatively low in the patient groups. This may stem from 
some of the patients and particularly those in the SUD+ASD group having difficulties 
distinguishing between the responses of sometimes and often. This was also true for 
the MANSA, which means that the possibility of patients with SUD+ASD underestimating 
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their problems cannot be ruled out and that significant quality of life differences 
between the groups of patients in our research do exist in reality.  
 
MAIN CONCLUSIONS 
Our main conclusions can be summarized as follows. First, SUD+ADHD and SUD+ASD 
patients have serious needs. They also have considerably more and more extensive 
needs compared to SUD only patients. Both dual diagnosis groups also show major 
dissatisfaction with certain domains of their existence. Despite all this, there are only 
small differences between the SUD only and the dual diagnosis groups in perceived 
quality of life. It therefore seems important to not only ask about subjective aspects of 
life satisfaction, but also to inquire about more objective (unmet) needs.  
 
Both patient groups get caught in a vicious circle of symptoms and substance use for 
what appear to be mainly palliative coping purposes. Treatment to interrupt  this 
viscous circle should therefore be integral and not just aimed at the patient’s 
substance use.  
 
All SUD patients use more palliative, avoiding and passive coping strategies when 
confronted with unpleasant events and problems, than healthy controls. In addition, 
SUD patients with a comorbid diagnosis of ASD more frequently use passive coping 
strategies and have fewer reassuring thoughts than patients diagnosed with SUD alone 
or SUD+ADHD. The mental health care professional can thus put this knowledge to use 
in the treatment for specific groups of patients and thereby guide such patients 
towards more effective coping. 
 
After hospitalization, diagnosis and the start of medication, most SUD+ADHD patients 
are able to become the director and manager of their personal health. Their primary 
treatment goal with regard to SUD is total abstinence. Because of the vicious circle 
they are caught in, the treatment of SUD and the ADHD should be simultaneous. 
 
Hospitalization of SUD+ASD patients mainly gives their caregivers a break. Most patients 
continue to be dependent on professional and informal care to direct and manage their 
personal health. Their primary treatment goals for SUD is often controlled substance 
use rather than total abstinence as controlled substance use may help them achieve 
some social aspects of personal recovery. 
 
More contact hours between caregiver and patient were associated with higher levels 
of caregiver burden, higher levels of perceived stress on the part of caregivers and 
greater perceptions of expressed emotion. Therefore, periodically identifying the 
number of contact hours between caregiver and patient can be used as a method to 
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early recognize the possibility of increasing burden and stress in caregivers. And thus to 
be able to prevent them from becoming in need of care themselves.  
 
SUGGESTIONS FOR FUTURE RESEARCH 
The results of the current study can be used as the basis to further develop supportive 
care along the lines of the Intervention Mapping Protocol regarding the SUD+ADHD and 
SUD+ASD groups.  
 
For a better understanding of the effects of SUD on patients with ADHD or ASD, the 
present study should be replicated and extended with two additional patient groups: 
patient with ADHD or ASD, i.e., without comorbid SUD. Our research showed that the 
SUD+ASD group had a broader range of (intensive) needs than the other two groups. 
However, whether this is due to SUD, to ASD or the combination of SUD+ASD could not 
be determined on the basis of the present data, and should therefore be addressed in 
future studies. Also, because of males being highly overrepresented among the three 
patients groups in the present study, future studies should incorporate more female 
patients. 
 
Furthermore, with regard to the group of patients having a dual diagnosis of SUD+ASD, 
controlled substance use was found to be useful for treatment and recovery purposes. 
This finding fits with the results of other research showing that patients with a history 
of SUD+ASD to show more social traits than patients with a history of ASD alone24. 
Future research must nevertheless strive to unravel this complex pattern of findings 
further. In particular, the possibility of controlled substance use allowing the patient 
with ASD (and a history of SUD) to function better should be examined in greater detail: 
Is it only the patient's perception (with, as a danger, that controlled substance use 
further impairs their social functioning in the long run) or does controlled substance use 
really help patients with ASD master the social interaction skills they need so much? 
Along these lines, additional research into alternative methods for boosting the 
communication and socialization capacities of patients with ASD or SUD+ASD is 
recommended. 
 
The start of the process of personal recovery for patients with SUD+ADHD and patients 
with SUD+ASD is establishing and communicating the diagnosis. It is therefore 
recommended that, in addition to a medical diagnosis, a functional diagnosis be 
determined. Based on this combination of information and negotiations with the 
patient, an integrated treatment programme can be started early and the vicious circle 
of symptoms and substance use can thus be broken for these patients. Both patients 
with a diagnosis of SUD+ADHD and patients with a diagnosis of SUD+ASD have more care 
needs than meet the eye. There are no self-report questionnaires that can diagnose the 
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needs of these patient groups, which means that these tools should be developed and 
validated in the future. The assessment tools should incorporate information on 
informal caregivers as well. These people have been shown to be crucial for the 
recovery of patients25 but are also at risk of becoming mental health patients 
themselves26 and should therefore be monitored.  
 
RECOMMENDATIONS FOR MENTAL HEALTH PRACTICE  
Given that SUD, ADHD and ASD are chronic disorders that can result in lifetime 
limitations in various domains of functioning of patients, such patients are of particular 
interest to nursing professionals, because they often deal with the consequences of an 
illness or handicap and are trained to maintain or enhance the patient’s quality of life 
despite chronic limitations. 
 
Care for SUD and co-occurring ASD or ADHD patients 
For both dual diagnosis patient groups, the present research shows that interventions 
should be aimed at breaking the vicious circle in which patients can get caught (i.e., 
jumbled thoughts and emotions; increased symptoms of impulsiveness in cases of ADHD 
and passivity in cases of ASD; decreased structure as a result; substance use in an 
attempt to deal with symptoms but even more jumbled thoughts and emotions as a 
result; and so forth). More than one component of the circle should be targeted to help 
patients break out of it. Both groups are in need of a timely medical and functional 
diagnosis. Both groups of patients should be helped to establish and maintain structure 
in their lives, and their self-management skills should be strengthened to help them do 
this. Both groups of patients should be guided towards more active, adaptive and 
problem-focused ways of coping. The care provided for such patients should support 
the process of personal recovery and not just clinical recovery. In doing this, the 
strengths and limitations of different groups of patients should be recognized along 
with marked differences in the extent to which the goals of personal recovery must be 
realized for treatment to be considered successful. For both patient groups, clinicians 
should also work to incorporate informal caregivers into their care. Yet the number of 
weekly contact hours with an informal caregiver and the informal caregiver’s expressed 
emotion should be monitored as the burden of informal care giving can become too 
much.  
 
Specific care for SUD+ADHD patients 
Patients with a dual diagnosis of SUD+ADHD are likely to respond well to medication 
although recent research suggests that they do not respond well to treatment with a 
standard dose of methylphenidate27. Other recent research, however, suggests that a 
normal dose of atomoxetine28, high to very high dose of methylphenidate29 and high 
doses of extended release mixed amphetamine salts30 are promising. When effective, 
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medication enables SUD+ADHD patients to settle down and become an active agent in 
their own personal recovery. Support for becoming and staying abstinent is thus vital. 
Abstinence is not only a prerequisite for personal recovery among these patients, it is 
also needed to maintain and promote effective coping strategies (e.g., active problem 
solving and reassuring thoughts). The development of an individual relapse prevention 
plan which addresses high-risk situations for substance use is also therefore 
recommended for each patient.   
 
SUD+ADHD patients further need goals to focus on in life, which makes the definition of 
new but nevertheless realistic goals important for this group. Given a generally passive 
manner of coping, they may also need support with clear planning of how to fill the 
day, which relationships to continue and how to address specific needs. In addition, 
relapse management should be developed by training patients to recognize stress, 
reflect on their stress, consider behavioural alternatives to reduce stress and recover 
early from stress4,5. Overall, the SUD+ADHD patients should be helped to refrain from 
action, establish priorities and accept their limitations, which means that a coaching 
role for mental health nurses should be welcomed. Such mental health coaching should 
be aimed at prompting the patient to become an active agent in his or her own 
personal recovery by just providing information, feedback, encouragement and 
support. The patient is the active agent setting his or her own goals. 
 
Specific care for SUD+ASD patients 
In general, patients with a dual diagnosis of SUD+ASD can be expected to not respond 
so well to medication and to experience lifetime limitations on their functioning in the 
domains of social interaction and communication. A more laborious process of personal 
recovery can thus be foreseen. Most of the SUD+ASD patients are not likely to become 
active agents in their personal development/recovery, which means that the clinician 
may have to provide answers and active guidance in many areas of life. For this patient 
group (and possibly ASD alone), the mental health nurse can be expected to serve as 
the primary change agent, identify problems to be solved and even solve the problems, 
not only when the patient specifically asks them to do this but also when unsolicited. 
Clinical practice shows that ASD patients tend to adhere quite strictly to treatment 
agreements and feel most comfortable with guidelines on what to do and what not to 
do. Controlled substance use can be included in a relapse prevention plan (i.e., 
specification of what, when and how substances may be used), just as 
pharmacotherapy directed at reduced alcohol consumption. The SUD+ASD patient 
should generally be helped to come into action, focus, establish priorities and accept 
their limitations. In doing this, an instructive and supportive but also directive role for 
the mental health nurse is recommended. The care offered by the mental health nurse 
should be clear, structured and predictable; it should not, however, be aimed at 
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reflection but at informing the patient and demonstrating styles of coping (for 
example) for the patient. 
 
The future of mental healthcare 
As of 1 January 2014, the organization of mental health care in the Netherlands has 
drastically changed. Patients are now allocated to and transferred between three 
echelons: 1) specialized mental health care; 2) general basic mental health care; and 
3) primary health care with mental health care support as part of this. An advisory 
group on the care for chronic mental health patients emphasized - also in 2014 the 
importance of a clear consensus on the current required care for these patients31. At 
the same time, this advisory group noted that mental health professionals must make 
sure that patients receive the most suitable treatment for their condition within the 
changing Dutch health system. In theory, Functional Assertive Community Treatment 
(FACT) (echelon 1) is recommended for all patients meeting the definition of "severe 
and persistent mental illness" (SPMI)32. In practice, however, FACT is generally provided 
only for patients with schizophrenia, bipolar disorder and severe depression. A growing 
number of clinicians are now wondering why chronic developmental disorders are not 
included, and therefore are transferred from echelon 1 to 2 or 3. Thus not receiving 
the care needed. The terms "severe mental illness", "serious mental illness" and "severe 
and persistent mental illness" (SPMI) are commonly used. However, an internationally 
agreed-upon definition does not exist as yet33. When Schinnar et al.34 reviewed 17 
definitions of severe and persistent mental illness, they were found not only to vary but 
also to be inconsistent. Inspection of the recent literature on SPMI is even more 
revealing as it shows a definition of SPMI to be hardly ever given and thus simply 
absent35-40. SPMIs are often described as psychiatric disorders with complex symptoms 
which continue over time, contribute to serious difficulties in the personal and social 
functioning of the individual, reduce the individual’s quality of life and require ongoing 
treatment and management32,41,42. Patients with a SPMI may be able to function 
independently for extended periods of time, but they may require intensive support at 
other times (e.g., when they experience a stressful event) in the domains of housing, 
school, work, social functioning and daily life32,41,42. Mental health care teams should 
thus realize that SPMI is not directly related to the psychiatric classification of a 
disorder (i.e., a case of schizophrenia, bipolar disorder or severe depression) but to the 
extent and chronic nature of a patient's functional impairment. We hope that the 
results of the present study provide sufficient evidence for the inclusion of patients 
with a dual diagnosis of SUD+ADHD or SUD+ASD in the group of SPMI patients targeted 
by FACT teams in the Netherlands today. 
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Om bewezen-effectieve verpleegkundige interventies voor de GGZ te kunnen 
ontwikkelen moet er voldoende bekend zijn over de specifieke behoeften van patiënten 
die geestelijke gezondheidszorg nodig hebben. Voor het ontwikkelen van dergelijke 
interventies kunnen de zes stappen van het Intervention Mapping Protocol (IMP) worden 
gebruikt: (1) het verkrijgen van inzicht in de behoeften van deze patiënten en de 
onderliggende determinanten en (2) het verhelderen van gedrags- en veranderdoelen. 
De volgende vier stappen van IMP zijn: (3) selectie van theorie gebaseerde interventies 
en praktische applicaties gericht op verandering; (4) vaststellen van 
programmacomponenten en het ontwerpen en realiseren van het programma; (5) 
anticiperen op de adaptatie, implementatie en de consolidatie van het programma; (6) 
anticiperen op de proces- en effectevaluatie. Het onderzoek in dit proefschrift is 
gericht op de eerste twee stappen van dit het protocol voor verslaafde (SUD) patiënten 
met of zonder ADHD of een autisme spectrumstoornis (ASS). De resultaten van dit 
proefschrift kunnen als input gebruikt worden voor de laatste vier stappen. 
 
Design, populatie en metingen  
Tussen april 2010 en oktober 2013 zijn bij een gespecialiseerd dubbel diagnose 
behandelcentrum en een verslavingskliniek in Nederland 122 volwassen patiënten met 
SUD met of zonder een comorbide diagnose van ADHD of ASS geselecteerd. In 
kwantitatieve studies worden problemen, behoeften en subjectief ervaren kwaliteit 
van leven en coping stijlen onderzocht. Hiervoor zijn de EuropAsi, CAN, MANSA en UCL 
lijsten afgenomen. Uit dezelfde populatie nemen 23 patiënten met SUD en een 
comorbide diagnose van ADHD of ASS deel aan een verdiepende studie over de 
consequenties van SUD voor het dagelijks leven. De data zijn verkregen door middel 
van het kwalitatief semigestructureerd interview middels een topiclijst. Hiernaast is 
een kwantitatieve studie verricht naar de belasting en expressed emotion van 60 
informele verzorgers (naastbetrokkenen) van de groep van 122 volwassen SUD patiënten 
met of zonder een comorbide diagnose van ADHD of ASS. Hiervoor zijn de IEQ, GHQ en 
LEE lijsten afgenomen. Als laatste nemen 21 volwassen patiënten met SUD en ADHD of 
ASS van een gespecialiseerd dubbel diagnose behandelcentrum deel aan een, middels 
een topiclijst, kwalitatief semigestructureerd interview over het proces van persoonlijk 
herstel.   
  
DE EERSTE STAP VAN IMP (HOOFDSTUKKEN 2, 3, 4 EN 5) 
 
Hoofdstuk 2 laat zien dat de behoeften van SUD-patiënten met of zonder ADHD of ASS 
substantieel van elkaar verschillen. De behoeften van SUD-patiënten zonder ADHD of 
ASS liggen primair binnen de domeinen alcohol/drugs, psychische gezondheid en 
werkloosheid. Bij SUD-patiënten met ADHD gaat het ook om de domeinen 
alcohol/drugs, psychische gezondheid en werkloosheid, maar er zijn ook behoeften op 
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de domeinen lichamelijke gezondheid en financiën. De behoeften van SUD-patiënten 
met ASS zijn nog omvangrijker. Ze omvatten de domeinen alcohol/drugs, psychische 
gezondheid, werkloosheid, financiën, familie/ sociale relaties, daginvulling, huishouden 
en seksualiteit.         
 
De behoeften van de patiënt zijn ook geanalyseerd volgens de 22 leefgebieden van de 
Camberwell Assessment of Needs, die overkoepelend gerangschikt zijn als (a) 
dagelijkse behoeften, (b) geestelijke gezondheidszorg behoeften, (c) rehabilitatie 
behoeften en (d) facilitaire behoeften. In deze studie rapporteren SUD-patiënten 
zonder ADHD of ASS slechts behoeften op één overkoepelend gebied: geestelijke 
gezondheidszorg. SUD+ADHD patiënten rapporteren behoeften op twee overkoepelende 
gebieden: geestelijke gezondheidszorg en faciliteiten. SUD+ASS patiënten rapporteren 
behoeften op alle overkoepelende gebieden. Het onderzoek laat ook zien dat alle 
patiëntgroepen onvervulde zorgbehoeften hebben en dat ze ontevreden zijn over 
specifieke aspecten van hun bestaan. De verschillen tussen de groepen in subjectieve 
beleving van de kwaliteit van leven zijn echter opvallend klein, in het bijzonder in 
vergelijking met de forse verschillen die gevonden zijn in hun objectieve behoeften. 
Dat laatste betekent dat er bij deze patiënten altijd zowel naar objectieve behoeften 
als naar subjectieve aspecten van het leven gevraagd moet worden. 
 
In hoofdstuk 3 wordt nauwkeurig gekeken naar de consequenties van het gebruik van 
verslavende middelen bij SUD-patiënten met ADHD of ASS. De consequenties van het 
hebben van een dubbele diagnose voor het dagelijks leven zijn vergelijkbaar voor beide 
groepen, maar de onderliggende mechanismen verschillen: impulsiviteit bij de 
SUD+ADHD groep versus passiviteit voor de SUD+ASS groep: beide groepen rapporteren 
dat ze ten aanzien van het omgaan met hun symptomen gevangen zitten in een 
vicieuze cirkel van psychiatrische symptomen en middelengebruik. Onprettige 
gedachten en emoties leiden tot een toename van symptomen (impulsiviteit of 
passiviteit), welke vervolgens tot een afname van structuur leiden, wat weer tot een 
toename van middelengebruik leidt en tot nog grotere chaos van gedachten en 
emoties. Op termijn veroorzaakt het gebruik van middelen altijd weer een toename 
van de ADHD of ASS symptomen, wat het zelfmanagement weer belemmert. Beide 
groepen functioneren beter als er voldoende structuur in hun leven is, maar omdat het 
middelengebruik de structuur ondermijnt belanden ze in een vicieuze cirkel van 
middelengebruik en toenemend gebrek aan structuur. Om dit proces te doorbreken 
proberen SUD+ADHD patiënten volledig te stoppen met het gebruik van middelen, 
terwijl SUD+ASS patiënten er vaak de voorkeur aan geven om te minderen met het 
gebruik omdat ze denken dat ze zonder het gebruik van middelen niet sociaal kunnen 
functioneren. Ze doen dat meestal met professionele begeleiding. 
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Omdat uit bovenstaande resultaten blijkt dat middelen door deze patiënten meestal 
gebruikt worden als een vorm van (onsuccesvolle/ineffectieve) coping met hun ADHD of 
ASS symptomen, hebben we ook onderzoek gedaan naar de copingstijlen van patiënten 
met SUD, SUD+ADHD of SUD+ASS. In hoofdstuk 4 worden de algemene copingstijlen van 
deze groepen patiënten met elkaar en met een steekproef van de algemene bevolking 
vergeleken. Alle patiëntgroepen blijken in vergelijking met de algemene bevolking 
meer palliatieve, vermijdende en passieve coping te hanteren bij onaangename 
gebeurtenissen of problemen. Verder rapporteren de SUD+ASS patiënten aanmerkelijk 
meer passieve coping en hebben ze minder geruststellende gedachten dan de SUD en 
SUD+ADHD patiënten. 
 
In hoofdstuk 5 wordt de ervaren belasting en expressed emotion van informele 
verzorgers (naastbetrokkenen) van SUD-patiënten met of zonder ADHD of ASS 
onderzocht, omdat zij vaak van groot belang zijn bij de behandeling van en de zorg 
voor deze patiënten en omdat deze zorg ook kan leiden tot problemen bij deze 
informele zorgverleners. De resultaten laten zien dat een bijkomende diagnose ADHD of 
ASS niet geassocieerd is met een grotere ervaren belasting of met meer expressed 
emotion ten opzichte van de groep die de zorg heeft voor patiënten met alleen SUD. 
Integendeel, de naastbetrokkenen van de groep met alleen SUD rapporteren (niet 
significant) hogere niveaus van ervaren belasting en expressed emotion dan de 
verzorgers van de SUD+ASS groep. Het grote aantal wekelijkse contacturen tussen 
verzorgers en patiënten met alleen SUD blijkt bij te dragen aan de hogere niveaus van 
ervaren belasting en expressed emotion in deze groep.     
 
DE TWEEDE STAP VAN IMP (HOOFDSTUK 6) 
 
In hoofdstuk 6 wordt het proces van persoonlijk herstel van patiënten met SUD met 
ADHD of ASS beschreven en geanalyseerd als oriëntatie op de tweede stap van het 
intervention mapping protocol (IMP). In het algemeen beschrijven beide groepen hun 
hersteldoelen als: "stil gezet" willen worden, geïnformeerd willen worden, abstinent 
willen worden of minder willen gebruiken, in staat willen zijn om met de symptomen 
van ziekte om te gaan en het accepteren van de beperkingen die dit met zich 
meebrengt, willen herontdekken hoe het leven te leven/structuren inclusief het 
herstellen van (ondersteunende) relaties en participeren in de maatschappij en willen 
weten hoe problemen te vermijden of er op te anticiperen. Verder laten de diepte-
interviews zien dat het proces van persoonlijk herstel vergelijkbaar is voor beide 
patiëntgroepen met voor beide groepen vier overkoepelende thema's, die de vier 
opeenvolgende fasen van het proces van persoonlijk herstel representeren: (1) crisis en 
diagnose; (2) omgaan met agitatie, symptomen en belasting; (3) reorganisatie van het 
leven; en (4) creëren van een betekenisvol leven. 
 Samenvatting 129 
De hersteluitkomsten van beide groepen laten zien dat het doel van gebruik van 
middelen in eerste instantie het stoppen van de chaos aan gedachten en emoties in de 
hoofden van de patiënten is. In tweede instantie leidt het middelengebruik echter tot 
crisis en uiteindelijk tot opname en behandeling. Beide groepen benoemen de opname 
als nuttig, maar ze doen dat om uiteenlopende redenen. Voor de SUD+ADHD patiënten 
representeert de opname een keerpunt in hun leven. Voor de SUD+ASS patiënten 
creëert de opname vooral een time-out voor hun omgeving. Het krijgen van de 
bijkomende diagnose (ADHD of ASS) is niettemin de start van het proces van persoonlijk 
herstel voor beide groepen.     
 
Medicatie helpt de SUD+ADHD groep om de chaos aan gedachten en emoties te 
stoppen. Dit stelt hen in staat om abstinent te worden en om te overdenken wat zij 
met hun leven willen. Deze patiënten rapporteren verder dat ze weer in staat zijn om 
min of meer op eigen kracht aan hun doelen te werken. Ze beschrijven een proces van 
persoonlijk herstel waarin zij vertrouwen in de eigen capaciteiten, hoop en trots 
hebben herwonnen. Dit in tegenstelling tot de SUD+ASS patiënten, die hun proces van 
persoonlijk herstel als een voortdurende strijd beschrijven en waarbij enkele patiënten 
aangeven nog geen innerlijke rust te hebben gevonden. SUD+ASS patiënten zijn er vaak 
nog niet aan toe om de diverse domeinen van hun leven opnieuw in te richten teneinde 
deze in harmonie met hun aandoening te brengen en rapporteren dat ze hulpverleners 
en naastbetrokkenen blijvend nodig hebben om met hen mee te denken en antwoorden 
te geven op de vele vragen die ze daar nog steeds over hebben. Verder rapporteren ze 
een duidelijke behoefte aan gereguleerd middelengebruik, omdat dat hen helpt om 
sociaal te kunnen participeren en daarmee bijdraagt aan persoonlijk herstel. Een groot 
deel van de SUD+ASS patiënten beschrijft het proces van persoonlijk “herstel” als 
proberen te overleven, hoewel ze hun leven wel als meer dragelijk zien. Herstel blijft 
voor hen echter een moeizaam en complex proces. Opvallend is dat vier van de zes 
abstinente SUD+ASS patiënten rapporteren dat zij het proces van persoonlijk herstel 
zeer moeizaam vinden, terwijl slechts één van de zes SUD+ASS patiënten die nog 
(gecontroleerd) alcohol gebruikten deze mening is toegedaan. Mogelijk helpt 
gecontroleerd gebruik van middelen inderdaad bij het bereiken van persoonlijk herstel 
bij deze groep patiënten. 
 
hoofdstuk 7 is de Engelse samenvatting van dit proefschrift en een discussie van de 
bevindingen. Het hoofdstuk eindigt met een korte bespreking van de  methodologische 
sterktes en beperkingen en de belangrijkste conclusies en aanbevelingen voor nader 
onderzoek en de klinische praktijk. 
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Conclusies 
De belangrijkste conclusies kunnen als volgt worden samengevat. SUD+ADHD en 
SUD+ASS patiënten hebben aanzienlijke zorgbehoeften. Ze hebben meer en meer 
omvangrijke behoeften dan de groep met alleen SUD. Beide dubbele-diagnose groepen 
zijn ontevreden over bepaalde levensgebieden. Toch zijn er slechts kleine verschillen 
tussen de groep met alleen SUD en de dubbele-diagnose groepen ten aanzien van de 
ervaren kwaliteit van leven. Daarom is het belangrijk om niet alleen de subjectieve 
aspecten van de kwaliteit van leven te bevragen, maar om ook navraag te doen naar de 
meer objectieve behoeften.   
 
Beide comorbide patiëntengroepen raken in een vicieuze cirkel van symptomen en 
middelengebruik. Het doel van het middelengebruik blijkt voornamelijk palliatieve 
coping te zijn. Daarom moet de behandeling van deze patiënten gericht op het 
doorbreken van deze vicieuze cirkel integraal zijn, en niet enkel gericht op het gebruik 
van middelen door de patiënt. 
 
Alle SUD-patiënten gebruiken meer palliatieve, ontwijkende en passieve coping 
strategieën dan gezonde controles. Daarnaast wordt door SUD-patiënten met een 
comorbide ASS diagnose vaker gebruik gemaakt van passieve coping en hebben ze 
minder geruststellende gedachten in vergelijking met patiënten met alleen SUD of 
SUD+ADHD. De behandelaar kan deze kennis bij de behandeling van specifieke 
patiëntgroepen gebruiken om deze patiënten naar een meer effectieve wijze van 
coping te begeleiden. 
 
De meeste SUD+ADHD patiënten zij in staat om, na opname, diagnose en het starten 
van de medicamenteuze behandeling, hun persoonlijke gezondheid te dirigeren en te 
managen. Hun primaire behandeldoel ten aanzien van SUD is volledige abstinentie. 
Vanwege de vicieuze cirkel waarin ze gevangen zitten moet de behandeling van SUD en 
ADHD gelijktijdig en integraal plaatsvinden. 
 
De opname van SUD+ASS patiënten geeft vooral ook hun naastbetrokkenen even rust. 
De meeste patiënten zijn blijvend afhankelijk van formele en informele zorg om hun 
persoonlijke gezondheid te dirigeren en te managen. Het primaire behandeldoel ten 
aanzien van SUD is vaker gereguleerd gebruik dan volledige abstinentie, omdat 
gereguleerd gebruik kan helpen doelen ten aanzien van een aantal sociale aspecten van 
persoonlijk herstel te bereiken.  
 
Een toename van het aantal uren contact tussen naastbetrokkene en patiënt is 
geassocieerd met hogere niveaus van belasting van de naastbetrokkene, hogere niveaus 
van ervaren stress bij de naastbetrokkene en meer ervaren expressed emotion. Daarom 
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kan het periodiek inventariseren van het aantal contacturen tussen naastbetrokkene en 
patiënt gebruikt worden als vroegtijdige signalering van een mogelijke toename van 
belasting en stress bij de naastbetrokkene. Op deze wijze kan voorkomen worden dat 
deze overbelast raakt en hiervoor zorg behoeft. 
 
Aanbevelingen voor de praktijk 
Omdat SUD, ADHD en ASS chronische stoornissen zijn die tot levenslange beperkingen 
op diverse domeinen van het functioneren van de patiënt kunnen leiden verdienen deze 
patiënten in het bijzondere aandacht van de verpleegkundige, omdat deze vaak de 
behandeling van de consequenties van ziekte en handicap op zich neemt en opgeleid is 
om de kwaliteit van leven van de patiënt te bevorderen. 
 
Zorg voor patiënten met SUD en ADHD of ASS       
Dit onderzoek laat zien dat voor beide dubbele-diagnose groepen behandeling gericht 
moet zijn op het doorbreken van de vicieuze cirkel waarin patiënten gevangen kunnen 
raken. Dat begint ermee dat voor beide groepen tijdig een medische en functionele 
diagnose wordt gesteld. Beide patiëntgroepen moeten geholpen worden om structuur in 
hun leven te brengen en te behouden, en hun zelfmanagement vaardigheden moeten 
versterkt worden. Beide groepen moeten begeleid worden naar een meer actieve, 
adaptieve en probleemgerichte wijze van coping. De zorg aan deze patiënten moet 
gericht zijn op het proces van persoonlijk herstel, en niet uitsluitend op klinisch 
herstel. Hierbij moet niet alleen met de sterktes en zwaktes van de verschillende 
patiënten rekening gehouden worden, maar ook met verschillen in de mate waarin 
doelen gehaald moeten zijn om de behandeling, volgens de patiënt zelf, als succesvol 
te kunnen aanmerken. Voor beide groepen moet de behandelaar zich inspannen om de 
naastbetrokkene in de behandeling en de zorg voor de patiënt te betrekken. Omdat de 
belasting van de naastbetrokkene als gevolg van het verlenen van informele zorg te 
hoog kan worden, moeten ten behoeve van vroegsignalering van problemen het aantal 
contacturen met de patiënt en de expressed emotion van de naastbetrokkene 
regelmatig geëvalueerd worden. 
 
Specifieke zorg voor SUD+ADHD patiënten    
Patiënten met een dubbele diagnose SUD+ADHD reageren over het algemeen goed op 
medicatie, hoewel onderzoek suggereert dat ze niet altijd goed reageren op een 
standaard dosering methylfenidaat. Recent onderzoek suggereert echter dat een 
normale dosering atomoxetine, een hoge tot zeer hoge dosering methylfenidaat of een 
hoge dosering langwerkend amfetamine wellicht beter zijn. Als de medicatie effectief 
is stelt dit de SUD+ADHD patiënt in staat om zijn rust te hervinden en een actieve 
belangenbehartiger van het eigen persoonlijk herstel te worden. Abstinentie is niet 
alleen een eerste vereiste voor persoonlijk herstel voor deze patiënten, maar is ook 
132 Samenvatting 
noodzakelijk om effectieve coping strategieën te behouden en te bevorderen. Het 
gebruik van een signaleringsplan voor hoog risico situaties met betrekking tot 
middelengebruik wordt daarom aanbevolen voor elke patiënt. Verder hebben 
SUD+ADHD patiënten (realistische) doelen in het leven nodig om zich op te richten. 
Omdat deze groep in het algemeen een passieve wijze van coping hanteert is er vaak 
ook ondersteuning nodig bij het plannen van dagbesteding, het beslissen welke relaties 
te continueren en hoe in specifieke behoeften te voorzien. Als aanvulling moet 
terugvalpreventie voorzien in het trainen van de patiënt in het kunnen herkennen van 
stress, het reflecteren op stress, het overwegen van gedragsalternatieven om stress te 
verminderen en in het vroegtijdig kunnen herstellen van stress. In het algemeen 
moeten SUD+ADHD patiënten worden geholpen om “stil te staan”, bij het stellen van 
prioriteiten en bij het accepteren van hun beperkingen, wat betekent dat een 
coachende houding van de verpleegkundige aanbevolen wordt. Een dergelijke 
coachende houding moet gericht zijn op het stimuleren van de patiënt om een actieve 
belangenbehartiger van zijn of haar persoonlijke herstel te worden door het geven van 
informatie en feedback en het aanmoedigen en ondersteunen van de patiënt. Het is de 
patiënt die de doelen stelt. 
 
Specifieke zorg voor SUD+ASS patiënten 
In het algemeen reageren patiënten met een dubbele diagnose SUD+ASS niet erg goed 
op medicatie en ervaren zij levenslange beperkingen in de sociale interactie en 
communicatie met anderen. Een moeizamer proces van persoonlijk herstel is daarom te 
verwachten. De meeste SUD+ASS patiënten worden geen actieve belangenbehartigers 
van hun persoonlijke ontwikkeling/herstel, wat betekent dat de behandelaar actief 
sturing zal moeten geven op een heel aantal levensgebieden. Het is te verwachten dat 
de verpleegkundige bij deze patiënten (en waarschijnlijk ook de groep met alleen ASS) 
de functie van belangenbehartiger moet vervullen en problemen moet identificeren en 
oplossen. Niet alleen als de patiënt hier zelf om vraagt maar ook ongevraagd. De 
klinische praktijk laat zien dat ASS patiënten ertoe neigen zich strikt aan afspraken te 
houden en het prettig vinden duidelijke richtlijnen te hebben voor wat wel en wat niet 
te doen. Gereguleerd gebruik kan het best in een terugvalplan opgenomen worden 
evenals farmacotherapie gericht op gereduceerd alcohol gebruik. In het algemeen moet 
de SUD+ASS geholpen worden om tot actie te komen, te focussen, prioriteiten te 
stellen en beperkingen te accepteren. Hierbij wordt een instructieve en 
ondersteunende, maar vaak ook directieve houding van de verpleegkundige 
aanbevolen. De zorg die verleend wordt moet voor de patiënt duidelijk, gestructureerd 
en voorspelbaar zijn; ze moet echter niet gericht zijn op reflectie maar op het 
informeren van de patiënt en het demonstreren van (bijvoorbeeld) stijlen van coping. 
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Ik ben er echt trots op en het is natuurlijk prachtig dat mijn naam op de voorkant van 
deze uitgave staat, maar zonder de medewerking van een aanzienlijke hoeveelheid 
personen was zij nooit tot stand gekomen. Daarom wil ik op deze plaats een ieder die 
zijn of haar medewerking heeft verleend van harte bedanken voor deze bijdrage.  
 
Mijn dank gaat uit naar de patiënten en hun naastbetrokkenen die belangeloos 
deelnamen aan de studies. Door de open- en ruimhartige wijze waarop jullie mij 
toestonden niet alleen deelgenoot te worden van jullie leven met de ziekte en al de 
problemen, frustraties en onbegrip die er aan verbonden zijn, maar ook van de 
successen en momenten van vreugde hebben jullie mij in staat gesteld dit onderzoek te 
realiseren. Ik spreek de hoop uit dat als tegenprestatie de resultaten uit dit 
proefschrift jullie en je lotgenoten ten goede zullen komen op de weg naar een hoop- 
en betekenisvol leven.  
 
Mijn promotieteam, Theo, Wim en Peter, wil ik bedanken voor de prettige en 
harmonieuze samenwerking. Niet in de laatste plaats als gevolg van jullie 
relativeringsvermogen en gevoel voor humor. Het is voor mij een eer dat jullie mij 
wilden begeleiden. 
  
Geachte promotor prof. dr. Van Achterberg, beste Theo. Jij bent vanaf de start 
betrokken geweest bij dit traject en gaf me ruimte en vertrouwen. Heel veel dank voor 
jouw wetenschappelijke bijdrage op het gebied van de verpleegkunde. Jouw jarenlange 
ervaring in de volle breedte van het verrichten van verpleegkundig onderzoek kwam tot 
uiting in je feedback, en was zeer inspirerend en waardevol voor mij. Jouw altijd frisse 
en optimistische blik, in combinatie met je uitnodigende houding om feedback of steun 
te vragen heeft een uitermate belangrijke rol gespeeld bij de totstandkoming van dit 
proefschrift. Mede hierdoor kon ik de moed en het plezier erin houden op lastige 
momenten.  
 
Geachte promotor prof. dr. Van den Brink, beste Wim. Naar aanleiding van de eerste 
contouren van mijn onderwerpkeuze, waarin duidelijk werd dat verslaving er onderdeel 
van zou uitmaken, stelde ik voor jou te benaderen voor de functie van promotor. Theo 
en Peter waren enthousiast. Nadat ik je nadere informatie over mijn plannen had 
toegezonden kreeg ik binnen een dag een 'ja' van jou. Jouw snelheid en 
besluitvaardigheid bleken ook tijdens ons promotietraject ongekend. Vragen, 
voorstellen en verder al wat een promovendus maar afvuurt op haar promotoren 
beantwoordde je voordat ik met mijn ogen kon knipperen. Of het nu een doordeweekse 
dag, 's avonds of weekend was. Zelfs in het vliegtuig of hotelkamer wist je hiervoor nog 
tijd vrij te maken. Voeg daar jouw vermogen tot verwondering, je messcherpe 
analyses, encyclopedische kennis van verslaving in brede zin, enorme 
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onderzoekservaring en deskundigheid, relativerend vermogen en down-to-earth 
medemenselijkheid aan toe, en het moge duidelijk zijn dat wat je hebt bijgedragen 
aan dit proefschrift en mijn leerproces voor mij van onschatbare waarde is. Door jou 
heb ik mogen ervaren en leren dat het verleggen van persoonlijke grenzen niet zozeer 
een kwestie van kunnen, maar een kwestie van willen is. 
 
Geachte copromotor dr. Goossens, beste Peter. Onze historie reikt verder dan dit 
promotieonderzoek. Ons eerste contact stamt uit de tijd dat wij soortgelijke functies 
vervulden. Jij was werkzaam bij het toenmalige Adhesie, ik bij het toenmalige Zwolse 
Poort. Beide hebben we eerst onze bachelor verpleegkunde behaald, om daarna een 
doctoraal in de verplegingswetenschappen te verwerven. Waar ik de MANP titel 
behaalde, promoveerde jij. Gelukkig maar. Want wat kon er leuker en beter voor mij 
zijn dan dat mijn gewaardeerde collega mijn copromotor zou worden. Doordat je net 
zelf gepromoveerd was stonden al de drempels, twijfels en onzekerheden die een 
promovendus ten deel vallen jou nog helder voor ogen. Ook jij was een 
buitenpromovendus. Wat betekende dat jij wist hoe het is om de voordelen van het, bij 
wijze van spreken, op de gang even snel kunnen inwinnen van advies te moeten 
ontberen. Dit alles maakte dat jij je als geen ander kon verplaatsen in mijn positie, en 
was je in staat mij van tips en trucs te voorzien. Wij delen de passie voor het 
verpleegkundig beroep en voor het ontwikkelen en dissemineren van kennis over de 
psychiatrische verpleegkunde. 
 
De leden van de leescommissie, Prof. dr. R.J. van der Gaag, Prof. dr. A.H. Schene en 
Prof. dr. B. van Meijel wil ik hartelijk danken voor het kritisch beoordelen van het 
manuscript. 
 
De Dimence groep in het algemeen en Herma van der Wal en Ernst Klunder in het 
bijzonder wil ik bedanken voor het in mij gestelde vertrouwen en de geboden 
faciliteiten. Ook wil ik de Commissie Wetenschappelijk Onderzoek van Dimence 
bedanken voor de steun en adviezen. Bijzondere dank gaat uit naar Gerlinde Paas, die 
de geboden faciliteit slagvaardig voor mij inrichtte. 
 
Zonder de welwillende medewerking van Centrum Maliebaan te Utrecht in het 
algemeen, en Dick van Etten in het bijzonder was dit onderzoek niet mogelijk geweest. 
Uiteraard moet ik hier ook de leden van het team verslavingspsychiatrie Anita Aarts, 
Ronne van den Brenk, Yoche Klos, Cassandra Steenkist, Peter Sturm en Patricia van 
Wijngaarden, Ton Voorhorst en Wout van Ark bedanken. Zij leidden mij naar potentiële 
respondenten, en vormden zo de brug naar de data waarop dit wetenschappelijke 
product gebouwd is. 
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Jooske van Bussbach, mijn statistische toverfee. Geduldig wees je me de weg en bleef 
je herhalen dat ik een hele snelle leerling was. De enthousiaste wijze waarop jij 
ondersteuning biedt op het gebied van statistische analyses is aanstekelijk. Zelfs ik heb 
er nu lol in gekregen. Je bent voor mij een bron van inspiratie.   
  
Mijn mede-onderzoekers Karin Slager en Roeline Verkerk wil ik bedanken voor hun 
enthousiasme en nauwgezette hulp bij de kwalitatieve interviews. De besprekingen met 
jullie vond ik inspirerend en buitengewoon gezellig.  
 
Al 'mijn' verpleegkundig specialisten in opleiding wil ik bedanken voor de belangstelling 
en de relativering die de ontmoetingen met jullie mij brachten. Als we spraken over de 
complexe dynamiek rondom het doen van onderzoek had dat vanzelfsprekend ook 
betrekking op mezelf. En na die gesprekken was ook ik weer beter in staat om de goede 
dingen te doen.  
 
Sandra van der Weijde heeft mij door haar logistieke werkzaamheden en accurate data 
management veel werk uit handen genomen. Onvermoeibaar en volhardend! Mijn 
hartelijke dank hiervoor. Ik ben er niet zeker van dat het zonder jouw hulp allemaal 
wel goed gekomen was. 
 
Diana Westerkamp is een zeer betrouwbare en consciëntieuze research 
verpleegkundige. Langer dan een jaar reden we regelmatig samen naar Utrecht om 
data te verzamelen en lijsten af te nemen. Ik denk nog vaak aan de, soms bizarre, 
voorvallen die ons de slappe lach bezorgden. Ook na de dataverzameling bleef je een 
luisterend oor bieden voor de pieken en dalen die bij een achtbaantraject als deze 
voorbij komen. Uiteraard onder het genot van mijn favoriete drank: koffie! Ontzettend 
bedankt voor je hulp en steun.  
 
Mijn mede-promovendus en lotgenoot Marjolein Helleman wil ik bedanken voor haar 
niet aflatende collegiale belangstelling en adviezen. Zoals je het soms tegen mij zei, zo 
zeg ik het nu tegen jou: Kom op, nog even doorzetten en je bent er!  
 
Mijn hartelijke dank aan Coby Gelsma voor het beantwoorden van mijn vragen over de 
Level of Expressed Emotion/LEE lijst en aan Bob van Wijngaarden voor het fiat om de 
Involvement Evaluation Questionnaire/IEQ lijst aan te mogen passen aan mijn 
doelgroep en het beantwoorden van vragen over de lijst. 
 
Jenny Katoele, bibliothecaris bij de Dimence groep, wist telkens weer en 
onvoorstelbaar snel te vinden waar ik al dagen naar op zoek was. Mijn dank is groot.  
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Erik de Groot hielp mij bij het bouwen van het data bestand en dacht mee over de 
statistische analyses. Altijd even vriendelijk en bereid. Hiervoor ben ik je veel dank 
verschuldigd. 
 
En natuurlijk de leiding van het Specialistisch Centrum Ontwikkelingsstoornissen; Bram 
Sizoo en Eddy de Vries. Jullie geven mij de gelegenheid een verpleegkundige 
onderzoekslijn op te zetten en zo verder te werken aan mijn academische vorming en, 
wellicht nog belangijker, patiënten te zien en me vanuit de praktijk te laten voeden 
om de zorg voor deze groep verder te verbeteren. Bram, ook dank voor je heldere en 
scherpe feedback op mijn artikelen. Hiermee bracht je het materiaal naar een hoger 
level.  
 
Mijn inspirerende en gezellige paranimfen, collega’s en vriendinnen Nynke Boonstra en 
Wilma Bremer: me door jullie gesteund te weten ga ik vol vertrouwen de verdediging 
tegemoet! 
 
Jolanda van Haren van de afdeling IQ healthcare van het Radboudumc, die deze uitgave 
van opmaak tot druk heeft verzorgd.  
 
En niet te vergeten het altijd steunend thuisfront; Siebe, Max, Rutger en Simon. 
Mannen Bedankt!  
 
 
 
Het is een rijke tocht geweest, maar ik ben verheugd haar nu te mogen voltooien. 
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Naast haar functie als opleider VS ggz adviseert Linda diverse interne en externe 
gremia, en heeft als voorzitter verschillende projecten binnen Dimence geleid. 
Waaronder het voorschrijven van UR geneesmiddelen door VS ggz, Excellente Zorg en 
behandelverantwoordelijkheid VS ggz. Ook begeleidt zij o.a. studenten VS ggz/Master 
of Advanced Nursing Practice en verplegingswetenschap bij hun masterthesis en 
organiseert zij samen met haar collega opleiders uit Noord-Nederland de jaarlijkse bij- 
en nascholing voor VS ggz.  
In samenwerking met deze groep opleiders heeft zij recent een boek uitgegeven, ‘De 
verpleegkundig specialist GGZ als spil in een vernieuwende, cliëntgerichte, 
kosteneffectieve GGZ’, waarin 12 praktijkverhalen van verpleegkundig specialisten zijn 
opgetekend. 
 
Linda en haar levenspartner Siebe zijn de trotse ouders van drie geweldige zonen: Max, 
Rutger en Simon. 
 
